{"messages":[{"status":"ok","category":"all"}], "collection":[{"title":"Validation of parent-report questionnaires for large-scale online screening of avoidant\/restrictive food intake disorder in children and adolescents","authors":"Friskson, D.; Dahlback, F.; Myrberg, L. L.; Hog, L.; Micali, N.; Bulik, C.; Dinkler, L.","author_corresponding":"Lisa Dinkler","author_corresponding_institution":"Karolinska Institutet","doi":"10.64898\/2026.06.25.26356338","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.06.25.26356338.source.xml","abstract":"Objective: Studies assessing the validity of screening measures for avoidant\/restrictive food intake disorder (ARFID) remain scarce. We evaluated the diagnostic performance and validity of an online, parent-reported screening approach for ARFID in a population-based sample of children. Methods: Participants were drawn from the ARFID Initiative Sweden (ARIES) cohort and included 65 children aged 6-14 years. Parents completed three screening questionnaires (Pica, ARFID, and Rumination Disorder Interview-ARFID Questionnaire [PARDI-AR-Q], Nine-Item ARFID Screen [NIAS], and Parent Eating Disorder Examination Questionnaire [PEDE-Q]), followed by a diagnostic interview (PARDI). Diagnostic performance indices (sensitivity, specificity, positive predictive value [PPV], and negative predictive value [NPV]) were calculated. Convergent validity was assessed via correlations between questionnaire and interview dimensions. Results: The combined screening algorithm demonstrated perfect sensitivity and NPV, indicating accurate detection of all ARFID cases and exclusion of non-cases. Specificity was high (0.83), and PPVs ranged from 0.91 to 0.95, decreasing to 0.78 under a more conservative operationalization of ARFID Criterion A4 (psychosocial impairment). Diagnostic performance varied across ARFID criteria: PPVs were low for medically anchored Criteria A1-A3 but high for Criterion A4 (psychosocial impairment; PPV=0.95). Correlations between screening measures and corresponding interview dimensions were generally moderate to strong, supporting convergent validity. Children meeting threshold ARFID criteria showed significantly greater symptom severity than subthreshold cases at screening. Discussion: These findings support the use of a multi-instrument, parent-reported screening approach for ARFID in large-scale pediatric research and highlight the centrality of psychosocial impairment, underscoring the need for standardized operationalization of this criterion.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"A Robust Cell-Free RNA Approach for the Early Detection of Colorectal Cancer","authors":"Monteagudo-Mesas, P.; Sanchez, L.; Asole, G.; Neto, B.; Tuni-Dominguez, C.; Gonzalez, L.; Rusu, E. C.; Cabus, L.; Panadero-Fajardo, S.; Catalina, P.; Garcia, S.; Simon-Extremera, P.; Padilla Garcia, L.; Lagarde, J.; Sanders, P.; Weber, M.","author_corresponding":"Marc Weber","author_corresponding_institution":"Flomics Biotech, SL, Carrer de Roc Boronat 31, 08005 Barcelona, Spain","doi":"10.64898\/2026.07.01.26357015","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357015.source.xml","abstract":"Colorectal cancer (CRC) screening remains limited by patient adherence and sub-optimal sensitivity for early-stage disease. While liquid biopsy has revolutionized cancer diagnostics, cfDNA-based methods often struggle with early-stage detection due to low analyte levels. Here, we present a robust cell-free RNA (cfRNA) platform for the early detection of CRC. Using a retrospective cohort of 255 healthy controls and 250 CRC patients, we implemented an optimized workflow featuring a RUVg-based normalization strategy to remove platelet-driven transcriptomic noise. We identified differentially expressed genes enriched in key CRC-associated biological pathways, including inflammation, EMT, and metabolic dysregulation. An XGBoost classifier trained on these features achieved a mean AUC of 0.92 in cross-validation and 0.89 in a validation cohort, demonstrating 67% sensitivity at 90% specificity. Notably, our platform showed particular efficacy in identifying early stage cancer (stage I and II), achieving 73.7% sensitivity at 90% specificity. These findings suggest that cfRNA profiling offers a powerful, non-invasive orthogonal approach to CRC screening, capable of overcoming the sensitivity limitations of DNA-based assays in early-stage disease.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Complex structural variation, phylogeny, and disease associations of the mucin pangenome","authors":"Plender, E. G.; Prodanov, T.; Lin, J.; Wong, I.; Wertz, J.; Gordon, W. W.; Bamshad, M. J.; Munson, K. M.; O'Neal, W. K.; Bloom, J. D.; Human Pangenome Reference Consortium,  ; Marschall, T.; Eichler, E. E.","author_corresponding":"Evan E Eichler","author_corresponding_institution":"Univ. of Washington","doi":"10.64898\/2026.07.01.26356476","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26356476.source.xml","abstract":"Mucins are large glycoproteins that provide hydration and barrier function to epithelial tissues. Although genetically heterogeneous, all mucins harbor a large exon composed of variable number tandem repeats (VNTRs). Short-read sequencing has limited our understanding of mucin VNTR diversity and makes disease association studies challenging. We leverage 296 long-read phased genome assemblies to characterize 14 mucin family members, achieving [&ge;]97% accuracy across 572 haplotypes. Phylogenetic haplogroup analysis reveals extraordinary structural heterozygosity, with MUC4 harboring the greatest allelic diversity (n=240 distinct lengths) and MUC12 the greatest size range ({Delta} = 55,233 bp; 23,080 amino acids). Ten mucins show significant population stratification (pFDR < 0.05). At the MUC4\/MUC20 locus, we characterize higher-order structural variation, including a recurrent inversion, copy number variation, and interlocus gene conversion. Optimized genotyping achieves [&ge;]95% haplogroup concordance across 10 loci. We apply this to 4,637 deeply phenotyped cystic fibrosis patients and identify a significant association between short MUC1 VNTRs and severe disease (p=0.0056), demonstrating the pangenome's utility for complex locus genotyping and disease discovery.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Genetic Determinants of Pulmonary Artery Size in over 50,000 Subjects with and without COPD","authors":"Foris, V.; Kim, K.; Tern, C.; Qian, Y.; Yu, J.; Washko, G.; Wade, R. C.; Wells, J. M.; Lin, H.; O'Connor, G. T.; Smith, A. V.; Gabriel, S. B.; Gupta, N.; Silverman, E. K.; Boueiz, A.; Cho, M. H.","author_corresponding":"Vasile Foris","author_corresponding_institution":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA 2 Division of Re","doi":"10.64898\/2026.07.01.26357039","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357039.source.xml","abstract":"Rationale: Pulmonary artery (PA) enlargement is a non-invasive imaging biomarker associated with pulmonary hypertension and mortality in COPD; however, its genetic determinants remain incompletely understood. Objectives: To characterize the genetic architecture of PA size across COPD-enriched and population-based cohorts. Methods: We performed genome-wide association analyses of PA diameter using whole-genome sequencing in COPDGene (n=9,418) and ECLIPSE (n=1,859), and imputed-genotype data from the UK Biobank (n=37,073). We replicated lead variants in the Framingham Heart Study (FHS; n=3,289), incorporated all four studies into a joint meta-analysis, and identified independent signals through conditional analyses. Candidate effector genes were prioritized using coding variant annotation, colocalization, and integrative regulatory evidence. Measurements and Main Results: We identified 44 independent genome-wide significant PA diameter signals within 39 loci, including 8 variants replicated in FHS, novel associations near FRMD4B, SLC20A2, BORCS7-ASMT, and KCNRG, and 5 signals in conditional analysis including multiple signals at ANO1. Genetic effects were concordant across imaging modalities and cohorts of differing COPD burden. Effector-gene prioritization nominated ABCC8, PDGFD, HMCN1, CCNE1, and TBX20, implicating pathways in vascular remodeling, developmental regulation, smooth muscle and endothelial function, ion-channel signaling, and extracellular matrix organization. Colocalization with pulse pressure GWAS demonstrated substantial shared causal variation between pulmonary and systemic vascular biology. Conclusions: In this largest genetic study of pulmonary vascular imaging to date, PA diameter exhibits a polygenic architecture consistent across imaging modalities and cohorts of differing COPD burden. The prioritized effector genes bridge rare-variant pulmonary hypertension biology with common-variant systemic vascular biology.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Retinal Transcriptome-Wide Association Study Identifies Novel Alzheimer's Disease Risk Genes","authors":"Zhang, Y.; Chen, B. D.; Sun, H.; Shi, R.; Li, Y.; Du, J.; Horimoto, A. R. V. R.","author_corresponding":"Jiawen Du","author_corresponding_institution":"UNC-Chapel Hill","doi":"10.64898\/2026.07.01.26357036","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357036.source.xml","abstract":"INTRODUCTION: Alzheimer's disease (AD) is the leading cause of dementia worldwide. The retina shares molecular pathways with the brain, yet no study has systematically linked retinal gene expression to AD risk. METHODS: We performed transcriptome-wide association studies (TWAS) using two independent retinal eQTL panels (Strunz et al., n = 311; EyeGEx, n = 406) and a large meta-analyzed AD genome-wide association study (GWAS) (Bellenguez et al., 111,326 cases, 677,663 controls). Genes were further validated with GWAS in the independent Alzheimer's Disease Sequencing Project (ADSP) using a matched eQTL-panel strategy. RESULTS: We identified 62 AD-associated genes across the two eQTL panels using Bellenguez et al. as the discovery cohort. Of these, 31 were replicated in the ADSP cohort. The findings highlight shared complement-mediated immune dysregulation (CD55, CD46, TREM2) and provide functional transcriptomic evidence to prioritize novel causal drivers of AD pathogenesis, including STYX and the LRRC37 gene family. DISCUSSION: Retinal data capture core AD genetic architecture and reveal novel risk genes, highlighting the retina as a molecularly informative tissue for dementia research.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Supervised Contrastive Learning-based Digital Biomarker Discovery for Wearable IMU Gait Signals","authors":"Mohtavipour, S. M.","author_corresponding":"Seyed Mehdi Mohtavipour","author_corresponding_institution":"Iran University of Science and Technology","doi":"10.64898\/2026.07.02.26357115","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357115.source.xml","abstract":"Wearable inertial measurement units (IMUs) provide a practical and objective approach for gait assessment in clinical populations. Although several handcrafted gait features have been proposed, these features may not fully capture the multidimensional signal characteristics associated with different pathological gait patterns. This study proposes a digital biomarker called Embedding-Distance Gait Biomarker (EDGB) based on supervised contrastive representation learning of wearable IMU signals. A compact multi-input convolutional neural network is developed to encode raw acceleration, angular velocity, and their temporal derivatives into a 32-dimensional latent representation. Class-specific prototypes are computed from the training embeddings of healthy, neurological, and orthopedic participants. The proposed EDGB is then derived from the distances between each trial embedding and the learned group prototypes. The proposed architecture is evaluated on the publicly available Voisard clinical gait dataset using a subject-level split, with 20% of participants held out for testing to prevent leakage across repeated trials. On unseen test subjects, the proposed biomarker distinguished healthy from neurological, healthy from orthopedic, and neurological from orthopedic gait patterns with AUCs of 90.59%, 88.47%, and 99.50%, respectively. The biomarker also demonstrated a large group effect, with clinical category explaining 71% of its variance. Reliability analysis showed significant consistency across repeated trials, with an ICC (2,1) of 0.82, indicating that most variability reflected between-subject differences rather than within-subject trial-to-trial fluctuations.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"The Microbiome-Inflammation Axis in Pediatric Cardiac Surgery: Decoding Functional Bacterial Responses","authors":"Qiu, H.; Elango, M.; Riethoven, J.-J. M.; Haynatzki, G.; Ibrahimiye, A.; Hancock Friesen, C.; Alfaidi, M. A.; Subramanyan, R. K.; Salomon, J.","author_corresponding":"Jeffrey Salomon","author_corresponding_institution":"University of Nebraska Medical Center","doi":"10.64898\/2026.07.01.26357082","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357082.source.xml","abstract":"Background: Gut injury after pediatric cardiac surgery remains an ongoing challenge, resulting in increased morbidity and mortality for children with congenital heart disease (CHD) and a significant burden on the healthcare system. It remains unclear what the driving forces are that result in this pro-inflammatory state following pediatric cardiac surgery with cardiopulmonary bypass. Understanding key components involved in the gut composition, gut barrier function, and systemic inflammation in children with CHD after cardiac surgery is critical to improve outcomes. Methods: A prospective study of patients aged 0-5 years with CHD undergoing cardiac surgery (CPB group) or non-CHD undergoing non-cardiac surgery (Comparison group). We collected pre-operative and post-operative stool and plasma to evaluate the microbiome, metabolites, markers of gut barrier function, and inflammatory cytokines. Clinical variables were collected to evaluate markers of inflammation. These variables were compared between the two groups to evaluate signatures and develop unique biomarker profiles. Results: We enrolled 62 patients (CPB, n=46; Comp, n=16). CPB patients had increased pro-inflammatory microbiota and reduced diversity metrics pre-operatively, which were exacerbated post-operatively. The CPB group also had increased pro-inflammatory eicosanoids and reduced gut and heart protective short-chain fatty acids versus the Comparison group. The CPB group had increased pro-inflammatory and reduced anti-inflammatory cytokines post-operatively. The CPB group also had increased markers of gut barrier dysfunction versus the Comparison group. Mediation analysis showed the microbial functional shift was associated with increased PGE2 and reduced butyric acid in the CPB group, associated with increased cytokines and clinical markers of inflammation post-operatively. Conclusion: We demonstrate unique gut microbial and metabolites profiles associated with gut permeability and systemic inflammation in children with CHD undergoing cardiac surgery highlighting a unique microbiome-inflammation axis in this patient population. Further studies to evaluate causal links with these profiles will identify potential targets to improve outcomes for these patients.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Identifying implementation units that would benefit from alternative treatment strategies to accelerate the elimination of onchocerciasis transmission in Africa","authors":"Ramani, A.; Dixon, M. A.; Walker, M.; Browning, R.; Konzen, E.; Spencer, S. E. F.; Fronterre, C.; Basanez, M.-G.","author_corresponding":"Mar\u00eda-Gloria Bas\u00e1\u00f1ez","author_corresponding_institution":"Imperial College London","doi":"10.64898\/2026.07.02.26357114","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357114.source.xml","abstract":"Background: The World Health Organization proposes that elimination of onchocerciasis transmission (EOT) be verified in 12 endemic countries by 2030. In sub-Saharan Africa (SSA), where most cases occur, Niger is the only country that has been verified to date. Despite decades of ivermectin mass drug administration (MDA), infection persists in West and Central Africa. Alternative treatment strategies (ATS) are necessary to accelerate progress towards EOT by 2030 and beyond. Methods: We used the EPIONCHO-IBM transmission model to project the number of years, from 2026, to reduce microfilarial (mf) prevalence below 1% across 1,634 implementation units (IUs) in 19 SSA countries. We fitted the model to geostatistically-derived mf prevalence in 1975, 2000 and 2018, and projected mf prevalence through to 2025. We classified IUs according to their baseline endemicity, intervention history programmatic performance, and current (2025) MDA frequency (annual or biannual). For those IUs that would not reach < 1% mf prevalence by 2030 if current strategies were continued, we simulated ATS (increasing treatment frequency, improving coverage, and adopting moxidectin MDA) from 2026 to 2040. Results: Of the 1,486 IUs currently under annual ivermectin MDA, 45% would require ATS. In those low-moderate endemicity IUs, biannual ivermectin would have a comparable impact to that of switching to annual moxidectin; in those with high endemicity, adopting biannual moxidectin would be more impactful. Of the 148 IUs currently receiving biannual ivermectin, 24% would benefit from ATS, switching to biannual moxidectin being the best option. Conclusion: This work brings into sharper focus which IU profiles are most likely to require ATS across SSA. In highly-endemic IUs with long intervention histories, biannual moxidectin MDA may be required under our modelling assumptions, with substantial uncertainty surrounding the permanent sterilising effect, of the two drugs under comparison, upon adult female worms. National programmes aiming to reach EOT will have options that need to be balanced against financial considerations. Implementation studies will also be important for translating these modelling projections into national policy decisions, particularly where different intervention strategies generate similar epidemiological benefits. Economic and epidemiological evaluations of repeated moxidectin MDA are needed to inform these decisions.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Prevalence and determinants of respiratory symptoms and functional disorders among children exposed to particulate matter through domestic and maternal occupational solid fuel use in Abidjan, Cote dIvoire - a cross-sectional study","authors":"Pajot, A.; Dje, S. A.; Tanoh, F. D. A.; Liousse, C.; Thivillon, T.; Doumbia, M.; Gnamien, S.; Marie, Y.; Fayon, M.; Yoboue, V.; Marcy, O.","author_corresponding":"Auriane Pajot","author_corresponding_institution":"University of Bordeaux: Universite de Bordeaux","doi":"10.64898\/2026.07.01.26357005","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357005.source.xml","abstract":"ABTRACT Background Children from low- and middle-income countries are particularly vulnerable to air pollution, a major environmental health risk, due to the immaturity of their lungs and their proximity to sources of household pollution. This study aimed to investigated the effect of exposure to biomass combustion through domestic and maternal occupational activities on respiratory health of children living in disadvantaged urban areas of Abidjan, Cote dIvoire. Methods Between February and December 2023, we conducted a cross-sectional observational study among children <16 years from households of women using biomass fuel for cooking (Group (G) 1), engaged in occupational fish smoking activities (G2), or primarily using gas for domestic cooking (G3). We assessed reported respiratory symptoms through standardized questionnaires and the presence of lung function impairments (LFI) though pulmonary function tests (spirometry and Rint). We assessed the association between study groups and key covariates with respiratory symptoms and LFI using mixed-effects regression models. Results Of 210 children enrolled - 119 (56.8%) female, median age 9 (6-12) years, 82 (39.0%) in G1, 47 (22.4%) in G2, and 81 (38.6%) in G3 - 15 (7.1%) reported wheezing in the last 12 months, 82 (39.0%) reported dry cough at night, 9 (4.9%) presented with dyspnea and 5 (2.7%) had chest pain on clinical examination, for an overall proportion of children with reported respiratory symptoms of 43.8% (92\/210). Of 176 children who underwent pulmonary function testing, 59 (33.5%) had LFI detected, including 34 (45.9%) in G1, 8 (22.2%) in G2, and 17 (25.8%) in G3 (p = 0.011). Study group was associated with respiratory symptoms (G1 vs G3; aOR 3.82, 95% CI 1.68-8.68; p < 0.001), as well as with LFI (p = 0.042). Girls were at greater risk of LFI than boys (aOR 2.69, 95% CI 1.24-5.80; p = 0.012). Children whose mothers used charcoal or wood as cooking fuel had higher odds of respiratory symptoms (OR 2.61, 95% CI 1.22-5.58; p = 0.013) but no association was found with LFI (p = 0.459) compared with unexposed children. Conclusion Respiratory symptoms and lung function impairments were highly prevalent among children living disadvantaged, especially when mothers cook with wood or charcoal. Targeted maternal awareness and broader interventions to reduce household air pollution in disadvantaged urban areas are urgently needed to protect long-term respiratory health.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"FAP\u03b1-positive fibroblasts in expert-reviewed colorectal hyperplastic polyps identify patients at increased risk of metachronous adenoma: a retrospective cohort study","authors":"Fenie, N.; Palasse, J.; Delisle, M. B.; FERRAND, A.","author_corresponding":"Audrey FERRAND","author_corresponding_institution":"Institut des Maladies Metaboliques et Cardiovasculaires","doi":"10.64898\/2026.07.02.26357112","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"gastroenterology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357112.source.xml","abstract":"Aims: Serrated lesions contribute substantially to colorectal cancer (CRC), while routine management of small distal hyperplastic polyps (HPs) assumes low risk. Surveillance guidelines nevertheless incorporate uncertainty at the HP\/SSL interface and recommend shortened intervals for large serrated lesions. We tested whether fibroblast activation protein-alpha; (FAPalpha) expression by stromal fibroblasts within expert-reviewed HPs stratifies risk of subsequent neoplasia. Methods and results: In a single centre historical cohort, FAPalpha; immunohistochemistry (Abcam ab53066, 1:200) was performed on FFPE colon tissues from 64 patients (normal colon n=10; HP n=39; low grade TA n=6; high-grade TA n=4; adenocarcinoma n=5). FAPalpha positive stromal fibroblasts were quantified in 20 randomly selected fields at magnification 1000 by two blinded readers (ICC 0.93). Among 39 patients with expert reviewed index HPs and colonoscopic follow up, the endpoint was metachronous adenoma occurring in the same general colonic area as the index HP, with proximal defined as ascending colon and distal as descending colon. Follow-up colonoscopies were scheduled every 2 years for up to 10 years. ROC analysis identified an optimal threshold of [&ge;]9 FAPalpha positive fibroblasts (AUC 0.8658; sensitivity 81.25%, specificity 87.93%). FAPalpha high status (44% of HPs) was associated with shortened neoplasm free survival (log-rank p=0.0012): five-year neoplasm free survival 41% versus 91% for FAPalpha; no\/low. In multivariable Cox modelling, FAPalpha high status remained independently associated with metachronous adenoma (HR 4.5, 95% CI 1.2-16.8, p=0.022). Conclusion: FAPalpha+ fibroblasts in expert-reviewed colorectal HPs identify a high-risk subgroup for metachronous adenoma, supporting stromal activation markers as a feasible pathology-anchored stratification tool.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"The Rise of Brazil's Primary Care Digitalization: 12 Billion Records Across 27 Federative Units as a Foundation for Real-World Evidence and Scientific Democratization","authors":"Pereira, P. M.; Girotto, A. N.; Silva, G. M.; Duregger, G.","author_corresponding":"Pedro Marton Pereira Sr.","author_corresponding_institution":"Instituto epHealth","doi":"10.64898\/2026.07.01.26356080","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"primary care research","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26356080.source.xml","abstract":"Background: Brazil operates one of the world's largest national primary health care information systems. Since 2013, the Health Information System for Primary Care (SISAB), the digital platform of the e-SUS primary care strategy, has collected standardized records of all clinical and community health activities performed by Family Health Strategy teams across all Brazilian municipalities. Yet comprehensive longitudinal analyses of this national data infrastructure remain scarce in the international literature. Methods: Descriptive ecological study with time-series analysis using publicly available secondary data extracted from SISAB on May 18, 2026. Annual records were collected for four production types (Individual Care, Dental Care, Procedures, and Home Visits), disaggregated by all 27 Federative Units, covering April 2013 through March 2026. Per capita indicators were calculated using the 2022 Brazilian Demographic Census population by state. Results: The cumulative total of SISAB records from April 2013 through March 2026 is 12,421,073,299. Annual volume grew from 53.3 million in 2014 (first full year) to 1.96 billion in 2025, an approximately 37-fold increase over 11 years. A 9.0% decline in 2020 was associated with the COVID-19 pandemic, with full recovery by 2021. Procedures rose from 21.6% to 35.9% of total records between 2014 and 2025, reflecting deepening clinical record completeness. Per capita records varied 3.2-fold across federative units, from 29.0 (Distrito Federal) to 92.9 (Tocantins). Home visits, performed predominantly by Community Health Workers, accounted for 41.9% of all records, with the highest per capita rates concentrated in the Northeast region. Conclusions: SISAB constitutes a longitudinal national data infrastructure of exceptional scale, covering populations historically underrepresented in biomedical research: rural, Amazonian, and peri-urban communities. With over 12 years of continuous data and 184 million active registered patients, this system represents a strategic foundation for real-world evidence generation and the democratization of health science. Realizing this potential requires investment in data quality, interoperability, ethical governance, and scientific capacity aligned with Brazilian General Data Protection Law (Law n. 13,709\/2018). Keywords: Primary Health Care; Health Information Systems; Family Health Strategy; Digital Health; Brazil; Community Health Workers; Real-World Evidence.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"The Combination of Oxytocin with Mindfulness-Based Group Therapy Reduces Negative Symptoms in Schizophrenia Spectrum Disorders: A Triple-Blind, Placebo-Controlled, Randomized, Controlled Clinical Pilot Trial (OXYMIND)","authors":"Zierhut, M.; Alt, M.; Hahne, I. M.; Bergmann, N.; Opper, F.; Braun, K.; Braun, A.; Kraft, J.; Ta, T. M. T.; Ripke, S.; Bajbouj, M.; Hahn, E.; Boege, K.","author_corresponding":"Marco Zierhut","author_corresponding_institution":"Charite - Universitaetsmedizin","doi":"10.64898\/2026.07.01.26356996","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26356996.source.xml","abstract":"Background Negative symptoms in schizophrenia spectrum disorders (SSD) remain insufficiently treated and require novel therapeutic approaches. Oxytocin may improve negative symptoms, although its effects appear highly context-dependent according to the social salience hypothesis. We conducted a randomized, triple-blind, placebo-controlled pilot study combining intranasal oxytocin with mindfulness-based group therapy (MBGT), hypothesizing that the positive social context of MBGT would enhance oxytocin-related effects. Methods 47 participants with SSD (34% female) were randomized to receive either 24 IU oxytocin (MBGT+OXT; n = 26) or placebo (MBGT+PLA; n = 21) before four MBGT sessions. Primary outcome was negative symptoms assessed with the Positive and Negative Syndrome Scale negative subscale (PANSS-N) at post-intervention and 4-week follow-up. Secondary outcomes included the Brief Negative Symptom Scale (BNSS), Self-Evaluation of Negative Symptoms Scale (SNS), and additional clinical measures. Linear mixed models estimated within- and between-group effects. Results Overall dropout rate was 14.89%, with one dropout potentially treatment-related. Blinding was successful. Participants completed 95.63% of sessions. Only the MBGT+OXT group showed significant improvements in PANSS-N from baseline to post-intervention (d = -0.74) and follow-up (d = -0.77), with a small between-group effect at follow-up (d = 0.39). BNSS total improved significantly only in the MBGT+OXT group from baseline to post-intervention (d = -0.88) and follow-up (d = -0.91), with between-group effects favoring MBGT+OXT at follow-up (d = -0.38). No serious adverse events occurred. Conclusions These findings suggest, oxytocin combined with MBGT may improve negative symptoms in SSD and support further large-scale trials. Clinical Trials Registration: https:\/\/clinicaltrials.gov\/study\/NCT06136390, Registration number: NCT06136390","funder":"NA","published":"NA","server":"medRxiv"},{"title":"How can spectrum bias impact expectations of test performance: a secondary modeling study estimating novel swab-based tuberculosis test outcomes across populations","authors":"Zaidi, S.; Garg, T.; Vo, L. N. Q.; Sander, M.; Codlin, A. J.; Byrne, R. L.; Lem, V.; Banu, S.; Bimba, J.; Santos, V. S.; Mbuli, C.; Nguyen, H. T.; Choko, A.; Wandiga, S.; John, S.; Squire, B.; Wingfield, T.; Creswell, J.","author_corresponding":"Sarah Zaidi","author_corresponding_institution":"Stop TB Partnership, Geneva, Switzerland","doi":"10.64898\/2026.07.02.26357020","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357020.source.xml","abstract":"Background New swab-based near-point-of-care (NPOC) tests offer a potentially lower-cost, simpler alternative to Xpert MTB\/RIF Ultra (Xpert-Ultra) testing for tuberculosis (TB) diagnosis. However, it is critical to understand how their performance may differ across diverse populations to inform programmatic rollout and real-world clinical decision-making. Methods We modeled the performance of testing sputum swabs with the MiniDock MTB assay and the Xpert MTB\/RIF (Xpert) using positive percentage agreement (PPA) with Xpert-Ultra, disaggregated by semi-quantitative grade. PPA for MiniDock MTB was derived from a random-effects meta-analysis of three diagnostic accuracy studies. PPA for Xpert was derived from data from an early diagnostic study. PPA estimates were applied to 1,248 positive Xpert-Ultra test results from Phase 1 of the Start4All study across seven countries, disaggregated by facility-based (n=1,033) and community-based (n=215) participant recruitment, comparing a single overall PPA to an Xpert Ultra semi-quantitative grade-stratified model (from Trace to High). Results Pooled overall PPA was 84.8% (95% CI: 67.1-93.8%) for MiniDock MTB and 93.1% (90.3-95.2%) for Xpert. Grade-stratified modeling revealed lower PPAs at \"Very Low\" and \"Trace\" semi-quantitative grades: MiniDock MTB 56.5% and 33.8%; Xpert 66.7% and 23.1%, respectively. When grade-stratified estimates were applied to the Start4All data, both tests performed similarly, missing 241\/1,248 and 228\/1,248 positive Xpert-Ultra results, respectively. The single-value model overestimated performance most markedly in community settings, predicting 10.8% and 19.1% more positive results than the grade-stratified model for MiniDock MTB and Xpert, respectively. Conclusion MiniDock MTB sputum swabs perform comparably to Xpert when assessed using grade-stratified modeling. Both tests are likely to miss a greater proportion of people with Xpert-Ultra positive results in community settings, where paucibacillary disease is more common. Using single point estimates for diagnostic accuracy can substantially overestimate real-world performance, highlighting the importance of evaluating diagnostics across the full spectrum of TB disease.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Assessing Rehabilitation Systems in Conflict: A Policy Analysis of Prosthetic and Orthotic Services in Gaza, Palestine","authors":"Riccio-Ackerman, F.; Meah, T.; Elessi, K.; Alkhatib, H.; Mohammadi, F.; Afifi, R.; Herr, H.; Totah, D.","author_corresponding":"Tarek Meah","author_corresponding_institution":"Massachusetts Institute of Technology","doi":"10.64898\/2026.07.01.26357060","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357060.source.xml","abstract":"The Gaza Strip is facing unprecedented levels of destruction to its healthcare system--including the provision of rehabilitation services--since the Israeli Defense Forces began its most recent military operation in October 2023. The Rehabilitation Task Force (RTF) is the governing body tasked with overseeing the provision of these services, including prosthetics and orthotics (P&O), in Gaza. Using the RTFs published documents--including reports on the state of P&O services, technical reports, and manuals\/guidelines for various forms of rehabilitation services--this study aims to assess the capacity of Gazas P&O sector to meet the needs of Palestinians seeking P&O services. The study team analyzed the RTFs documents on P&O capacity and generated ratings according to the World Health Organizations Standards for Prosthetics and Orthotics. The results of our study demonstrate that, despite the extremely challenging circumstances, Gazas P&O sector excels in the domain of Policy. The targeted destruction of the rehabilitation sector and intentional withholding of resources preclude the Gaza Ministry of Health from meeting the standards in the domains of Products, Personnel, and Provision of Services. This systemic erosion of rehabilitative medical care translates into a reduced capacity to restore function and mobility to the tens of thousands of people in Gaza currently in need of such care. As such, urgent measures are required to restore, uphold, and expand the capacity of the P&O sector to serve the rights of persons with disabilities in Gaza.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Biological Pathways Linking Integrated Interventions to Infant Growth in the first 6 months of life: Findings from a Mediator Analysis of the WINGS Randomized Controlled Trial","authors":"Chowdhury, R.; Tripathi, D.; Devi, S.; Taneja, S.; Majumder, P. P.; Strand, T. A.; Pandey, R. M.; Kurpad, A. V.; Mukherjee, S.; Bhandari, N.","author_corresponding":"Ranadip Chowdhury","author_corresponding_institution":"Society for Applied Studies","doi":"10.64898\/2026.07.01.26357069","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357069.source.xml","abstract":"Background Growth faltering during infancy remains a major public health concern in low- and middle-income countries. We examined whether birth size, infant gut microbiome, growth and inflammatory biomarkers, and breast milk macro and micronutrients mediated the effects of an integrated intervention package on infant growth at 6 months of life. Methods This mediation analysis was nested within the Women and Infants Integrated Interventions for Growth Study (WINGS), a factorial randomized controlled trial conducted in urban low- and middle-income communities in Delhi, India. The intervention package included nutrition, health, water, sanitation and hygiene (WASH), and psychosocial support delivered during the preconception, pregnancy, and early childhood. The analysis included 296 mother-infant dyads from the group received intervention from preconception throughout pregnancy and childhood and the group received routine care. Using a counterfactual causal mediation framework, we assessed the mediating roles of birth size, infant biomarkers at 3 months; insulin-like growth factor-1 [IGF-1], C-reactive protein [CRP], and Bifidobacterium breve species, and breast milk biomarkers at three months (vitamin B12 and total protein). Outcomes included length-for-age z-score (LAZ), weight-for-age z-score (WAZ), weight-for-length z-score (WLZ) at 6 months, and changes in these anthropometric indices between 3 and 6 months. Multiple mediators were evaluated simultaneously using parametric regression models adjusted for maternal height, maternal body mass index, family possess below poverty line card, and place of birth. Results The intervention package significantly improved WAZ at 6 months (total effect 0.31; 95% CI 0.04-0.58). This effect was significantly mediated through birth size; reduction of small for gestational age (SGA) (average causal mediation effect 0.15; 95% CI 0.04-0.28), accounting for approximately 44% of the total effect. Conclusions Improved fetal growth, reflected by reduced SGA, was the principal biological pathway through which the integrated intervention package mediated infant growth at six months.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Health-system readiness for integrating ceiling nets into malaria vector control in Kenya: perspectives of health managers","authors":"MBUGUA, S. M.; Kongere, J.; Kagaya, W.; Mwaura, P.; Ko, Y.; Omondi, P.; Mujuni, M.; Kasililika, A.; Kisiangani, I.; Kanoi, B. N.; Kaneko, A.; Gitaka, J.","author_corresponding":"SAMUEL  MUNGAI MBUGUA","author_corresponding_institution":"United States International University-Africa","doi":"10.64898\/2026.07.02.26357099","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357099.source.xml","abstract":"Malaria transmission has been reduced considerably in some Kenyan regions; however, it remains high in the Lake Victoria basin. Ceiling nets fall under house screening as interventions in vector control under the World Health Organizations Guidelines on Malaria and has a conditional recommendation with low-to moderate-certainty evidence of impact against malaria. This study aimed at assessing the perceptions of health system managers on the health system readiness in integrating ceiling nets into malaria vector control in and implementation pathways.A cross-sectional, qualitative, action research design was used aimed at providing actionable solutions to health systems challenges in the inclusion of ceiling nets as a complementary vector control strategy in the comprehensive approach on malaria prevention in Suba West sub-county, Homa Bay county. Key-informant interviews on perspectives on health system readiness for ceiling net integration into routine programmatic vector control strategies were conducted among health system managers. Qualitative data was captured using audio tapes and field notes, transcribed and analyzed using case-based in-depth inductive and deductive analysis using a thematic framework to classify and organize data into themes.Key emergent themes included perception and experiences in malaria vector control strategies, role of community health in malaria vector control strategies, systemic barriers and facilitators in malaria vector control, perspectives on integration of the ceiling nets in malaria vector control. This study demonstrates that health system managers perceive ceiling nets as a feasible, acceptable, and operationally integrablecomplement to existing malaria vector control strategies, while also identifying concrete system bottlenecks that must be addressed for scale-up. The ceiling nets showed high acceptability, appropriateness of fit in structurally heterogenous housing structures and high feasibility as an addition to a comprehensive complementary vector control strategy.The findings inform decision-ready implementation pathways of complementary ceiling nets in existing vector control strategies. Ceiling nets are perceived by frontline health system managers as a system-ready, acceptable house-modification intervention that can close critical protection gaps left by bed-net-centric malaria control, provided community health platforms and supply chains are deliberately leveraged. Successful scale up implementation hinges on a structured approach of integration that includes community buy-in, task-shifting of community health promoters in ceiling net installation, effective supply chains, and robust monitoring and evaluation systems to track, maintain and assess system level indicators and community level indicators.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Implementation outputs and outcomes of a community-based maternal and newborn care model in rural Galmudug, Somalia: an implementation research study","authors":"Kozuki, N.; Kimemia, G.; Abdi, H. A.; Abdi, A.; Maalim, A.; Mothupi, M. C.; Miris, M.; Mohamud, A. M.; Nanda, G.; Omar, M. A.; Cochrane-George, M.; Machora, D.; Jama, M.","author_corresponding":"Naoko Kozuki","author_corresponding_institution":"Johns Hopkins Bloomberg School of Public Health","doi":"10.64898\/2026.07.01.26357076","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357076.source.xml","abstract":"Maternal and newborn health (MNH) outcomes in Somalia remain among the worst globally, driven in large part by limited access to facility-based care, particularly in rural and underserved communities; approximately one in five births take place in a health facility.  To address major MNH service delivery gap in rural Somalia, the International Rescue Committee implemented a community-based maternal and newborn care (CBMNC) program, delivering a package of evidence-based interventions across selected villages. An implementation research study was conducted to generate transferable learning to inform the scale-up of comparable community-based MNH programs in similar low-resource and humanitarian settings.  The study triangulated and synthesized data from existing primary research data (e.g. population-based surveys before and after program implementation, qualitative program acceptability study, cost-efficiency analyses), program monitoring data, and program documentation.  The data were organized using Proctor et al.s Implementation Research Outcomes Framework, exploring the outcomes of acceptability, appropriateness, feasibility, fidelity, adoption, implementation cost, penetration, and sustainability.  The synthesis consisted of meta-summaries across sub-domains under each outcome area. The program delivered through 34 community health workers (CHW) served 1,165 women across a 24-month period. The program demonstrated strong acceptability among participants, who reported trust in CHWs, respect for cultural and religious norms, and tangible improvements in their pregnancy health knowledge. CHWs similarly expressed intrinsic motivation and a sense of fulfillment in their roles, despite notable challenges around workload, geographic barriers, and financial burdens.  The model showed reasonable epidemiological and sociocultural fit, though some recommended health behaviors conflicted with entrenched traditional practices, such as avoiding colostrum or giving sugar water to newborns. Equity gaps were identified, particularly the underrepresentation of women with disabilities. Feasibility was constrained by household dispersal, seasonal mobility, complex task management, and an initially irregular visit schedule, which CHWs ultimately simplified to a monthly system.  CHW competency improved markedly over time, with average assessment scores reaching 94% by the program's end. Coverage was broad, with 88% of women who delivered during the program period enrolled. Sustainability considerations remained underdeveloped, representing a key area for future programming. The CBMNC model demonstrated potential to expand access to MNH services in rural settings, with CHWs earning broad trust and acceptance among women and communities, and the intervention widely regarded as a good epidemiological, sociocultural, and contextual fit. Nevertheless, the findings make clear that achieving successful and sustainable scale-up will require more than replicating the care package itself. Practical challenges, including CHW workload, referral pathways, health literacy, and equitable reach to marginalized groups, must be deliberately addressed. Ultimately, expansion efforts must invest as much in strengthening the underlying systems that enable effective delivery as in the content of care provided.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Validation of non-contact sensor quantification of heart rate and respiratory rate dynamics using real-world pretraining and label-efficient fine-tuning on polysomnograms","authors":"Gupta, K. S.; Harrington, N.; Pedros-Valls, R.; DeYoung, P.; Owens, R. L.; Orr, J. E.; King, K. R.","author_corresponding":"Kevin R King","author_corresponding_institution":"UC San Diego","doi":"10.64898\/2026.07.01.26356016","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"respiratory medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26356016.source.xml","abstract":"Non-contact mechanical bed sensors can passively and longitudinally monitor the dynamics of cardiopulmonary physiology to detect changes from patient-specific baselines and facilitate care. This requires accurate longitudinal quantification of established metrics like respiratory rate (RR) and heart rate (HR) from the underlying raw waveforms, validated against ground truth labeled datasets like simultaneous polysomnography (PSG). Whereas head-to-head labeled datasets are scarce and costly to collect, unlabeled real-world datasets are often abundant. Here, we show that non-optimized heuristic algorithms can be used to soft-label large real-world data (>40M minutes across >50,000 nights) for pretraining models. This enables label-efficient fine-tuning on small numbers of head-to-head PSG-labeled datasets while maximizing generalizability and robustness to hyperparameters. The result is a highly performant validated model with mean absolute errors (MAE) of 0.6 brpm for RR and 1.1 bpm for HR across 1-minute windows. Although demonstrated in the context of bed sensor cardiopulmonary quantification, these methods are applicable to development of sensor algorithms whenever labeled ground truth data is scarce and unlabeled real-world data is abundant.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Trends in medication abortion service delivery in the U.S., 2020-2025","authors":"Kaller, S.; Schroeder, R.; Berglas, N. F.; Stewart, C.; Upadhyay, U. D.","author_corresponding":"Shelly Kaller","author_corresponding_institution":"University of California San Francisco","doi":"10.64898\/2026.07.01.26357048","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"sexual and reproductive health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357048.source.xml","abstract":"Objective: Since 2020, medication abortion provision in the U.S. has been reshaped by changing abortion policies and expanded telehealth access, yet little is known about how medication abortion service delivery has evolved. We examined national trends in service delivery from 2020 to 2025, including changes in abortion facility types, telehealth provision, and gestational limits. Study Design: Using ANSIRHs Abortion Facility Database, a national census of publicly advertising abortion facilities (2020 to 2025), we analyzed trends in medication abortion service delivery. Systematic web searches and mystery shopper calls gathered data on facility types, telehealth provision, and gestational limits. Data analysis included frequencies and comparisons across regions and states. Results: Medication abortion-only facilities increased nationally, from 35% of facilities in 2020 to 65% in 2025, with substantial growth in abortion-restrictive regions such as the Midwest and South. By 2025, 99% of facilities provided medication abortion. Telehealth provision expanded from 7 facilities in 2020 to 606 facilities by 2025, driven by growth in both brick-and-mortar facilities offering telehealth care and new virtual clinics. Overall, 46% of all facilities offered medication abortion by telehealth in 2025. Gestational limits for medication abortion increased nationally, from <1% of facilities offering medication abortion after 11 weeks in 2020 to 38% in 2025. Conclusions: Medication abortion service delivery has adapted to legal and logistical challenges by increasing telehealth options and expanding gestational limits. These changes improve access for abortion seekers, especially those living in restrictive environments. Sustaining abortion access will require ongoing provider adaptation and supportive policy environments.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Understanding the acceptability, barriers and facilitators to implementing the 4CMenB vaccine for the prevention of gonorrhoea in gay, bisexual and other men who have sex with men","authors":"Osman, R.; Jajja, A.; Weil, B.; Doyle, T.; Berners-Lee, B.; Lorencatto, F.; Mohammed, H.; Campbell, H.; Ladhani, S. N.; Mandal, S.; Sabin, C.; Saunders, J.; Nicholls, E. J.","author_corresponding":"Roeann Osman","author_corresponding_institution":"United Kingdom Health Security Agency","doi":"10.64898\/2026.06.25.26355673","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"sexual and reproductive health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.06.25.26355673.source.xml","abstract":"Background In November 2023, the Joint Committee on Vaccination and Immunisation advised the UK government that a targeted, opportunistic vaccination programme using 4CMenB to prevent gonorrhoea primarily in gay, bisexual and other men who have sex with men (GBMSM) at higher risk of infection should be introduced in sexual health services (SHSs). Data on the acceptability of 4CMenB vaccination and factors influencing uptake were needed. Methods Three focus group discussions (FGDs) were conducted with 17 GBMSM aged [&ge;]18 years, resident in England, who self-reported bacterial sexually transmitted infection or [&ge;]5 sexual partners in the previous 12 months. One FGD with five sexual healthcare professionals (HCPs) was conducted. Data were analysed using reflexive thematic analysis. Themes were organised using the Vaccine Uptake Continuum and interpreted using the Social Ecological Model. Results Acceptability of 4CMenB vaccination was high among GBMSM and HCP participants. GBMSM described vaccination as supporting sexual wellbeing and reducing anxiety about gonorrhoea, particularly when positioned alongside existing prevention strategies like HIV pre-exposure prophylaxis and Doxycycline post-exposure prophylaxis. While the estimated effectiveness of ~30-35% was perceived as modest, it did not deter acceptability, but reduced willingness to actively seek vaccination. Structural constraints, including limited SHS capacity, appointment availability, and restrictive eligibility criteria, were identified as barriers to equitable uptake. Community-based and outreach delivery models were widely supported as strategies to improve access. HCPs drew on experience from mpox vaccination to anticipate implementation challenges, emphasising the need for clear guidance, staff training, and sustainable resourcing. Mixed views were expressed regarding additional protection against meningitis, which was generally considered a secondary influence on decision-making. Conclusions 4CMenB vaccination for gonorrhoea was acceptable for both GBMSM and HCPs; however, uptake is likely to depend on ease of access, clear communication, and system-level support. Addressing structural constraints and supporting community-based delivery may help achieve equitable delivery of 4CMenB.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Effects of high-intensity interval training with or without resistance training on Alzheimer's disease brain signatures in individuals with coronary artery disease: the Heart-Brain randomized controlled trial.","authors":"Sanchez-Martinez, J.; Solis-Urra, P.; Toval, A.; Coca-Pulido, A.; Rodriguez Palacios, M. T.; Sanchez-Aranda, L.; Bakker, E. A.; Martin Fuentes, I.; Fernandez-Ortega, J.; Alonso-Cuenca, R. M.; Olvera-Rojas, M.; Fernandez Gamez, B.; Erickson, K. I.; Moreno Escobar, E.; Garcia-Orta, R.; Esteban-Cornejo, I.; Ortega, F. B.","author_corresponding":"Javier Sanchez-Martinez","author_corresponding_institution":"Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada, Granada 1","doi":"10.64898\/2026.07.02.26357035","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"sports medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357035.source.xml","abstract":"Background: Coronary artery disease (CAD) increases the risk of cognitive impairment, dementia, and brain structural alterations. This heart-brain connection suggests that exercise-induced cardiovascular responses may influence brain regions vulnerable to Alzheimer's disease (AD), the most common cause of dementia. This study aimed to examine the effects of 12-weeks of either high-intensity interval training (HIIT) plus resistance training (RT) or HIIT alone on AD brain signatures in individuals with CAD, to explore moderating factors, and to assess associations between changes in AD brain signatures and cognition and physical fitness. Methods: This secondary analysis of a single-site, three-arm, single-blinded randomized controlled trial included 105 individuals with CAD (50-75 years; 21% female) randomly allocated to HIIT+RT, HIIT, or usual care (UC) groups. T1- and diffusion-weighted magnetic resonance imaging were acquired before and after the 12-week intervention. Primary outcomes were thickness\/volume and gray matter mean diffusivity (GMMD) signatures, derived from seven cortical regions and the hippocampus. Moderators included age, sex, education, and baseline AD brain signatures. Results: For the thickness\/volume signature, no between-group differences in changes were observed between HIIT+RT and UC (+0.13 standardized mean difference [SMD]; 95% CI, -0.07 to 0.33) or between HIIT and UC (-0.1 SMD; 95% CI, -0.3 to 0.1); however, a small but significant between-group difference in change was found between HIIT+RT and HIIT, in favor of HIIT+RT (+0.23 SMD; 95% CI, 0.03 to 0.42). For the GMMD signature, no significant between-group differences in changes were found between HIIT+RT and UC (+0.08 SMD; 95% CI, -0.18 to 0.34), HIIT and UC (+0.1 SMD; 95% CI, -0.16 to 0.36), or HIIT+RT and HIIT (-0.02 SMD; 95% CI, -0.28 to 0.23). No moderation effects were identified, and no associations were observed between changes in AD brain signatures and cognition or physical fitness. Conclusion: A 12-week HIIT+RT intervention was more effective than HIIT alone in increasing the thickness\/volume signature in individuals with CAD, yet no differences were observed compared to UC and the interventions did not affect the GMMD signature. These findings suggest that the intra-session inclusion of RT with HIIT may enhance AD-related brain macrostructure in individuals with CAD more than just HIIT training.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Developing a Specialized Dravet Syndrome Ontology for Rare Disease Informatics and AI Applications","authors":"Golnari, P.; Prantzalos, K.; Upadhyaya, D. P.; Buchhalter, J.; Sahoo, S. S.","author_corresponding":"Satya S Sahoo","author_corresponding_institution":"Case Western Reserve University School of Medicine","doi":"10.64898\/2026.07.01.26357055","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357055.source.xml","abstract":"Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy whose clinical and research representation requires integration of heterogeneous knowledge spanning seizures, development, behavior, SUDEP\/autonomic risk, genetics, comorbidities, electrophysiology, pharmacology, and drug responsiveness. We report the development of a DS-focused ontology created by expert-guided specialization of a previously published epilepsy ontology. Scope expansion was defined through a scientific advisory board, structured review meetings, and iterative ontology curation in OWL. The resulting resource reorganized DS content across nine major domains and expanded the publicly released ontology from the pre-extension baseline to the current BioPortal version. Beyond structural growth, the ontology was assessed through expert-guided curation and downstream task-based reuse, including two published ontology-enabled LLM studies and an ongoing ontology-derived DS knowledge graph and AI assistant platform. These results suggest that disease-focused ontology specialization can provide durable infrastructure for DS data harmonization, knowledge representation, and AI-enabled translational informatics.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Impact of Operator Technique Preference on Thrombectomy Reperfusion Outcomes","authors":"Yelam, T.; Martins, P. N.; Dolia, J.; Batista dos Reis, S.; Grossberg, J. A.; Pabaney, A. H.; G Nogueira, R.; Al-Bayati, A. R.; Haussen, D. C.","author_corresponding":"Theja Yelam","author_corresponding_institution":"Emory University School of Medicine \/ Grady Memorial Hospital Marcus Stroke and Neuroscience Center","doi":"10.64898\/2026.07.01.26357084","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357084.source.xml","abstract":"ABSTRACT Background: Randomized trials have shown comparable reperfusion rates among stent-retriever, contact-aspiration, and combined thrombectomy techniques. We aim to evaluate the association between operator device-selection preference and procedural performance metrics. Methods: Retrospective analysis of prospective data from a comprehensive stroke center. Preferred technique was defined as a technique used in >50% of an operator's thrombectomies. Main exposure: proportion of usage of a given technique by operators in a certain period; primary endpoint: rate of first-pass effect(FPE). Results: 1405 patients fit inclusion criteria. The first time period(2019- mid 2022\/n=839) included 4 operators(3 experienced\/1 starting practice), with CoT being overall used in 58.9%, SR in 24.4%, and CA in 16.7%. The second( mid 2022-2024\/n=566) included 4 total operators(2 experienced\/2 starting), with CA reaching 48.2%, CoT 39.8% and SR 12.0%. The distribution of techniques varied between intra-\/inter-operators and most(75.0%) had a preferred technique. The technique with the highest FPE rate was never the most used technique. The chances of operators achieving FPE were not dependent on the previous cumulative success for a given technique. Increasing case volume was associated with higher FPE on average, but the learning rate differed by technique and only contact aspiration had a significant learning curve. The parenchymal hemorrhage rates were comparable for individual operators regardless of technique. Conclusion: Neurointerventionists tended to rely on a preferred technique, which did not necessarily lead to superior reperfusion outcomes. The cumulative success with a given technique did not increase the likelihood of attaining FPE in subsequent cases. Among new operators, a learning curve for contact aspiration was observed.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Cohort profile: the Cohort for Risk Prediction Model Evaluation (CORE) for external validation of models identifying high-risk pregnant women in the early second trimester, North India","authors":"Jain, R. s.; Sharma, N.; Khurana, A.; Wadhwa, N.; Tripathi, R.; Jain, A.; Bhatnagar, S.; Thiruvengadam, R.; Desiraju, B. K.","author_corresponding":"Bapu Koundinya Desiraju","author_corresponding_institution":"THSTI","doi":"10.64898\/2026.07.02.26357113","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"obstetrics and gynecology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357113.source.xml","abstract":"Purpose: The Cohort for Risk Prediction Model Evaluation (CORE) was established to externally validate prediction models that identify high-risk pregnancies in the early second trimester. Such models are often developed on small, single-source datasets and seldom tested elsewhere. Recent evidence shows that only about 6-10% models are ever externally validated which raises concerns about whether they perform reliably in new and diverse populations. In the maternal perinatal space, CORE addresses this gap by providing an Indian second-trimester cohort with harmonised imaging and outcome data on which existing risk prediction models can be validated. Participants. CORE includes 964 pregnant women aged over 18 years, enrolled at the Hamdard Institute of Medical Sciences and Research (HIMSR), New Delhi, between August 2021 and March 2023. Women were recruited before 20 weeks of gestation and followed up at 18-22 weeks for an ultrasound scan and at delivery. At all time points, a structured set of sociodemographic, clinical, and obstetric data was captured, together with ultrasound images at 18-20 weeks from which fetal biometry and cervical length were measured. Findings to date: The median maternal age was 27.6 years; 51% had a normal body-mass index (BMI) and 30% were overweight. There were almost equal number of Nulliparous (480, 50%) and multiparous (484, 50%). About 41% prevalence of history of prior preterm in multiparous women. Outcomes were available for 750 participants (23 abortions, 3 stillbirths, 724 singleton live births). Among the 724 live births, 80\/724 (11%) were preterm, 190\/716 (26.5%) were small for gestational age (SGA) and 40\/716 (5.6%) were large for gestational age (LGA) by INTERGROWTH-21st standards and 260\/716 (35.6%) of newborns were categorized into small vulnerable newborn (SVN). Future plans. CORE will be used to externally validate and, in aggregate with similar cohorts, help improve risk-prediction models for pregnant women in India and comparable settings. We invite collaborators to use this resource; clinical and imaging data are available under a controlled-access model on reasonable request. Strengths and limitations of this study Prospective cohort with data-collection and ultrasound protocols harmonised with the GARBH-Ini and AMANHI cohorts, enabling like-for-like pooled and cross-cohort analyses. A two-tier ultrasound quality-assurance process, with retention of both clean (unannotated) and caliper-annotated images, supports validation of image-based prediction models. Sample size informed by precision-based guidance for the external validation of prediction models, providing adequate power to assess model discrimination for the principal outcomes. Single-site, hospital-based recruitment from a limited geographical catchment, which constrains direct generalisability and makes the cohort most valuable when pooled with comparable cohorts. No continuous follow-up between 20 weeks of gestation and delivery, limiting the assessment of temporal change and longer-term outcomes.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"The Effect of Marital Status on Suicide Risk Among Patients with Breast Cancer: A Population-Based sIPTW Competing Risk Analysis","authors":"Zou, X.; Shi, J.","author_corresponding":"Jingyi Shi","author_corresponding_institution":"Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, UK.","doi":"10.64898\/2026.07.01.26357044","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357044.source.xml","abstract":"Background: Breast cancer survivors often experience psychological distress that may increase suicide risk. Marital status, a proxy for social support, may influence this risk, but its role within a competing-risk framework is unclear. This study examined the association between marital status and suicide mortality and assessed modification by socioeconomic and geographic factors. Methods: This is a population-based cohort study using SEER data, including adults diagnosed with primary breast cancer from 2000 to 2022. Marital status was classified as married\/partnered or unmarried\/non-partnered. Baseline characteristics were balanced using subdistribution inverse probability of treatment weighting (sIPTW). Suicide mortality was analyzed using sIPTW-weighted Fine-Gray competing-risk models, treating non-suicide deaths as competing events. Landmark, subgroup, interaction, and sensitivity analyses were performed. Results: Among 825,047 patients, 40.7% were unmarried. Covariates were well balanced after weighting (SMD <0.01). During follow-up, 529 suicide deaths occurred. Unmarried status was associated with higher suicide mortality (sHR = 1.34, 95% CI: 1.12-1.60). Male sex and estrogen receptor-negative tumors increased risk, while older age and non-White race were protective. Findings were consistent in Cox models (HR = 1.45) and sensitivity analyses (sHR = 1.42). Landmark analyses showed persistent associations at 1, 3, and 5 years. The association was attenuated in the highest income quartile but not modified by rural-urban status. Conclusions: Unmarried breast cancer patients had higher suicide mortality. These findings support integrating psychosocial assessment and targeted suicide prevention into survivorship care, especially for socially vulnerable groups.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Shared decision-making about uveal melanoma treatment in the Netherlands: non-neutral framing of medical information","authors":"Shirzada, A.; Vlug, L.; Marinkovic, M.; Luyten, G. P. M.; Bleeker, J. C.; Vu, T. H. K.; Rasch, C. R. N.; Horeweg, N.; Pieterse, A.","author_corresponding":"Aryana Shirzada","author_corresponding_institution":"Leiden University Medical Center","doi":"10.64898\/2026.06.25.26356547","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"ophthalmology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.06.25.26356547.source.xml","abstract":"Background: A subset of uveal melanomas can be treated using either enucleation or proton beam therapy (PBT), which offer similar oncological outcomes. The most appropriate treatment depends on a patient's preference. To allow patients to genuinely determine their preference, it is recommended to describe options as neutrally as possible. This study assesses to what extent ocular oncologists use and perceive non-neutral framing behaviour, and if it is related to patient satisfaction with decision-making. Methods: Consultations of ocular oncologists with patients newly-diagnosed with uveal melanoma were audio recorded, transcribed verbatim, and coded for ocular oncologists' explicit and implicit non-neutral framing behaviours. Explicit non-neutral framing was defined as: explicitly mentioning a preferred option at least once, without relating it to the patient. Implicit non-neutral framing was defined as: describing an option (un)favourably, without providing a medically substantive clarification alongside. Results: 110 patients provided consent for the audio recordings. Non-neutral framing was found in 84% (n=92\/110) of consultations. We found explicit behaviour in 38% (42\/110) and implicit behaviour in 76% (84\/110, median=1, range, 0-4) of consultations. The most frequent implicit framing was presenting options by positively or negatively emphasizing one option. Non-neutral framing behaviours were not significantly related to patient satisfaction with decision-making. Conclusion: This study shows that in most consultations some non-neutral framing was present, which did not impact patients' satisfaction with decision-making. Nonetheless, ocular oncologists should be aware that how they describe options may influence preferences in ways that do not align with the patient's values.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Expert perspectives on improving services for patients with periprosthetic femoral fractures: a qualitative study","authors":"Gibson, H.; Chekar, C. K.; Goodwin, D. K.; Shelton, C.; Smith, T. O.; Johansen, A.; Aryaie, M.; Muruet, W.; Reed, M.; Evans, J. T.; Whitehouse, M.; Baxter, M.; Bottle, A.; Benn, J.","author_corresponding":"Helen Gibson","author_corresponding_institution":"University of Leeds","doi":"10.64898\/2026.07.01.26357068","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"orthopedics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357068.source.xml","abstract":"Background The incidence of post-operative periprosthetic femoral fractures (POPFFs) is increasing. However, specific clinical guidance relating to patient management does not exist, resulting in variations in care and outcomes. This study aimed to elicit and synthesise expert knowledge in POPFF service delivery and explore views on variations in service provision and the factors influencing these. Methods Semi-structured interviews were undertaken with healthcare professionals with expertise in POPFF care from England and Wales to explore current practices, challenges, service variations and perceived future opportunities. Participants were identified through specialist research and clinical networks for POPFF and hip fracture care, authors of key publications on the subject, national leads for POPFF\/hip fracture networks, and research team contacts. Interviews were analysed using thematic analysis. Results Ten interviews were undertaken with experts in POPFF services across a range of professional roles. Four themes were identified: conceptualisation of POPFF (by different professional groups and in different service settings) and understanding of POPFF patient needs; sources of variation in management and care of POPFF patients; service model rationales, advantages and disadvantages; and potential strategies to improve POPFF care. Conclusion When designing POPFF services, we suggest that four key areas need consideration: the extent to which POPFF patients are a distinct group with particular care needs; the necessity for and consequences of patient transfer between wards and hospitals; the resourcing of extensive multidisciplinary support for POPFF patients; and the need for national initiatives to encourage service developments. These findings should form the basis of future clinical guidance. Sensitivity to contextual factors driving variation in services is needed to ultimately improve care for POPFF patients.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Protocol for a Modified Delphi Consensus Study on the * Clinical Assessment of Children with Suspected Olfactory Dysfunction","authors":"Bhargava, E. K.; Whitcroft, K. L.; Gellrich, J.; Fishman, G.; Propst, E. J.; Zou, L.; Hummel, T.","author_corresponding":"Eishaan Kamta Bhargava","author_corresponding_institution":"The University of Sheffield","doi":"10.64898\/2026.07.01.26357062","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"otolaryngology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357062.source.xml","abstract":"Background Olfactory dysfunction (OD) affects approximately 22% of the general population, yet children account for only around 2% of specialist olfactory clinic attendees -- a striking disparity that likely reflects systematic under-detection rather than lower disease prevalence. There are currently no internationally endorsed clinical guidelines governing the assessment of children with suspected OD. A recent international survey of 167 paediatric otolaryngologists across 36 countries found that more than half never perform psychophysical olfactory testing, a majority routinely order neuroimaging, and that multidisciplinary collaboration is largely lacking - findings that collectively motivate this consensus effort. Materials and Methods This is a prospectively registered, multi-round modified Delphi consensus study. A steering committee of seven international experts spanning paediatric otorhinolaryngology, chemosensory science, neuropaediatrics, and research methodology will generate an initial set of candidate consensus statements across 12 pre-defined clinical domains, derived from a structured narrative evidence review and practice-gap data. A panel of 15-25 international experts will vote anonymously over two to three sequential rounds using a 9-point Likert scale. Consensus is defined a priori as a median score [&ge;]7 with [&ge;]75% of panellists rating 7-9 and an IQR of [&le;]2. A post-Delphi virtual ratification meeting will follow voting rounds. Patient and Public Involvement (PPI) is embedded throughout: a family advisory group of 4-6 parents, caregivers, and young people with lived experience of paediatric OD, recruited in partnership with anosmie.org, will review candidate statements before Round 1, and PPI findings will inform statement framing before expert voting begins. This study was assessed using the Health Research Authority (HRA) online decision tool for England and found not to require NHS Research Ethics Committee (REC) review. The study will be conducted in accordance with the Research Governance Framework for Health and Social Care (2nd Edition). Discussion The final consensus statements and supporting methodology will be submitted for peer-reviewed publication. The study will be reported in compliance with the ACCORD and DELPHISTAR reporting standards for consensus methods. The protocol has been pre-registered prospectively on the Open Science Framework (OSF) prior to data collection.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"PD-L1-linked spatial decoupling of tumour-immune interactions in EBV-positive DLBCL","authors":"Kunstner, A.; Kuemmel, M.; Faehnrich, A.; Derer, S.; Raschdorf, A.; Witte, H. M.; Maluje, Y.; Faerber, B.; Roesner, T.; Michelson, L.; Stiller, F.; Merz, M. M.; Bernard, V.; Stoelting, S.; Kolbe, D.; Peter, W.; Merz, H.; von Bubnoff, N.; Feller, A. C.; Busch, H.; Lohneis, P.; Gebauer, N.","author_corresponding":"Axel Kunstner","author_corresponding_institution":"University of Luebeck","doi":"10.64898\/2026.07.02.26357123","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357123.source.xml","abstract":"EBV-positive diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma enriched in elderly patients, in which PD-L1 genomic gains cooperate with viral signalling to promote immune escape. However, the spatial mechanisms by which PD-L1 reshapes the tumour microenvironment remain unresolved. Here, we integrate genomic profiling with spatial transcriptomics, spatial proteomics, and single-cell RNA sequencing to resolve the tumour-immune architecture of EBV-positive DLBCL. PD-L1 gain tumours exhibit a striking decoupling of immune proximity and immune engagement: T cells accumulate in close proximity to tumour cells yet direct tumour-immune contact is largely absent. Tumour boundaries are enriched for cancer-associated fibroblasts and display transcriptional signatures of metabolic immune suppression, while tumour-proximal T cells exhibit pronounced exhaustion. Together, these findings reveal a PD-L1 driven spatial immune evasion architecture that permits immune infiltration while enforcing multilayered suppression through fibroblast-mediated exclusion, metabolic constraint, and T-cell dysfunction, ultimately preventing effective anti-tumour immunity in EBV-positive DLBCL.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Atypical energy-related symptoms define biologically distinct subtypes of major depressive disorder","authors":"Harder, A.; Wang, R.; Bergstedt, J.; Huider, F.; Kurvits, S.; Thorp, J.; Gong, T.; Assary, E.; Thijssen, A. B.; Merola, G. P.; Goula, A. A.; Bentwood, S.; Karlsson, R.; Pasman, J. A.; Fabbri, C.; Hickie, I. B.; Peyrot, W. J.; Levinson, D. F.; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,  ; Potash, J. B.; Shi, J.; Medland, S. E.; Mitchell, B. L.; Kwong, A. S. F.; Eley, T. C.; Lewis, C. M.; Hamilton, S. P.; Martin, N. G.; Boomsma, D. I.; Lehto, K.; Wray, N. R.; Breen, G.; Penninx, B. W. J. H.; Milaneschi, Y.; Marshall, S.; Thomson, P. A.; Lu, Y.","author_corresponding":"Arvid Harder","author_corresponding_institution":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden","doi":"10.64898\/2026.07.02.26357101","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357101.source.xml","abstract":"Major depressive disorder (MDD) is a complex psychiatric disorder, characterized by a range of mood, cognitive, and neurovegetative symptoms. Current diagnostic criteria treat opposite symptom directions as equivalent; weight gain or loss, and increased or decreased sleep, each count toward a single diagnosis. We defined three subgroups of individuals meeting criteria for MDD: AERS+ (hypersomnia with increased appetite\/weight gain), AERS- (insomnia with appetite\/weight loss), and an Uncategorized group, and conducted genome-wide association meta-analyses for each (N_eff = 47,858, 156,624, and 215,828, respectively). We identified 27 genome-wide significant loci across subtypes, 4 for AERS+, 10 for AERS- and 13 for Uncategorized. AERS+ showed higher SNP-based heritability (10.9%) and lower polygenicity (1.7% of SNPs) than AERS- (7.9%; 2.9%) or Uncategorized (8.6%; 5.3%), with larger effect sizes at its associated loci. The AERS+ and AERS- subtypes were moderately genetically correlated (r_g= 0.64, se = 0.04). Metabolic traits emerged as a primary differentiator: AERS+ correlated positively with BMI, metabolic syndrome, and related traits, whereas AERS- correlated weakly in the opposite direction. These findings show that the directionality of neurovegetative symptoms indexes genetic heterogeneity within MDD, with metabolic biology as a central axis of differentiation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Selection of Mutations in HIV-1 Nucleocapsid and Integrase in Individuals Living with HIV Experiencing Virologic Failure After Initiating or Switching to Tenofovir-Lamivudine-Dolutegravir","authors":"Penrose, K. J.; Hikichi, Y.; Sethi, R.; Goetz, B. J.; Siffert, L. O.; Valiyaparmbil, S. A.; Wallis, C. L.; McCarthy, C.; Wooley, E.; Chandran, U. R.; Kityo, C. M.; Flexner, C.; Hughes, M. D.; Koenig, S. P.; Freed, E. O.; Mellors, J. W.; Parikh, U. M.; ACTG A5381\/Hakim Study Team,  ","author_corresponding":"Urvi M. Parikh","author_corresponding_institution":"University of Pittsburgh, Pittsburgh, Pennsylvania, USA","doi":"10.64898\/2026.07.02.26356352","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"hiv aids","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26356352.source.xml","abstract":"Background: Tenofovir-lamivudine-dolutegravir (TLD) is an effective, single-tablet ART regimen but the causes of virologic failure that can occur despite adherence to TLD are incompletely understood, especially when resistance mutations in integrase (IN) are absent. Noncanonical resistance mutations in nucleocapsid (NC) have been selected in cell culture and are associated with decreased dolutegravir (DTG) susceptibility in vitro. Samples from the ACTG A5381\/Hakim study were examined to assess the potential contribution of NC mutations to virologic failure on TLD. Methods: A5381\/Hakim was an observational cohort study that enrolled individuals with HIV-1 RNA >1000 copies\/mL when initiating TLD as first line ART or switching from failing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based or protease inhibitor (PI)-based ART. Whole HIV RNA genome next generation sequencing was performed on paired plasma samples from study entry and confirmed virologic failure in 56 participants receiving TLD for [&ge;] six months. Mutations relative to the HIV-1HXB2 reference genome were identified with DeepChek(R) software using a mutation reporting threshold of five percent mixed-base frequency. Canonical drug resistance mutations (DRMs) were identified within the DeepChek(R) software using the Stanford HIVdb v9.8 algorithm. Site-directed NC and IN mutants were tested for susceptibility to DTG, raltegravir and cabotegravir in the TZM-bl HIV-1 indicator cell line and evaluated for infectivity and replication in multi-round assays. Results: Mutations in NC that emerged between TLD initiation and virologic failure were identified in 11 of 56 (20%) participants. Of these 11, three participants also had IN mutations at virologic failure but not at study entry, suggesting dual selection. Selected mutations in the NC zinc-finger domain included V13I, K20R, E21V, N27I\/S, A30T, K34R, K38R, K41G\/R\/N, Q45R and\/or M46I, alone or in combination with other NC and\/or IN mutations. Specific NC mutations (K20R, N27I, A30T, K41N, M46I) conferred a significant decrease in DTG susceptibility. The combination of certain NC with IN mutations (e.g. NC N27I and IN R263K) conferred greater reduction in susceptibility to DTG in vitro than either mutation alone. Conclusions: This work provides the first clinical evidence of NC mutation selection in individuals on failing TLD ART and shows that NC mutations, combined with IN mutations, can further decrease susceptibility to DTG. Our findings support additional investigations of the contributions of mutations outside of IN to virologic failure of integrase inhibitor-containing ART regimens.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Epidemiological and Programmatic Insights into Progress toward Ending AIDS by 2030: Lessons from Viet Nams HIV Response","authors":"Manh, P. D.; Otani, M.; Nguyen, V.; Huong, P. T. T.; Duc, B. H.; Morishita, F.; Tam, N. T. M.; Linh, D. T. T.; Nhan, D. T.; Yadav, R. P. H.; Izumi, K.","author_corresponding":"Van Nguyen","author_corresponding_institution":"WHO Country  Office in Viet Nam","doi":"10.64898\/2026.07.01.26357006","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"hiv aids","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357006.source.xml","abstract":"Introduction Viet Nam has achieved one of the fastest declines in new HIV infections in the WHO Western Pacific Region. In 2020, the Government launched the National Strategy to End the AIDS Epidemic by 2030. At its midpoint in 2025, a national epidemiological and programmatic review was undertaken to assess the countrys progress and remaining challenges. Methods We conducted a review of the national HIV surveillance and programme data and the Joint United Nations Programme on HIV\/AIDS database, focusing on four components: disease burden, prevention, testing, and treatment programmes. Results Estimated annual new HIV infections among adults declined from 14,000 (2010) to 6,117 (2024), a 57% reduction, while the number of PLHIV stabilised at 267,455 in 2024. The epidemic has shifted from being mainly among people who inject drugs (PWID) in the 1990s and early 2000s to being increasingly concentrated among men who have sex with men (MSM) and transgender people (TG), who accounted for 58% of new infections in 2024. In 2024, 88% of people living with HIV (PLHIV) knew their status, 79% of those diagnosed received antiretroviral therapy (ART), and 96% of people on ART achieved viral suppression. Harm reduction outcomes were strong, with opioid substitution therapy (OST) coverage around 40% since 2020 and safe injecting practices among PWID above 90% over the last ten years. The pre-exposure prophylaxis programme expanded rapidly in recent years, reaching 17.4% of the MSM. HIV testing volume was 3.4 million in 2024, with an increasing number of confirmatory testing laboratories. HIV status awareness in 2024 was below the 80% national target for sex workers (59.0%), PWID (62.5%), and MSM (79.2%), but exceeded the target for TG (94.1%). The high rate of viral load suppression indicates strong adherence and reflects the overall quality of treatment services. Conclusions Viet Nams progress reflects two decades of sustained harm reduction among people who inject drugs, early adoption of community-led and decentralised HIV testing innovations, rapid scale-up of PrEP, and consistently high viral suppression among people on ART. These combined system and community-based approaches offer transferable lessons for other low- and middle-income countries.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Complementary and alternative medicine use among patients with tuberculosis at a tertiary hospital in Sierra Leone: A cross-sectional study","authors":"Jalloh, I. P.; Sandy, S. F. F.; Kanu, M. S.; Sankoh, Z.; Bah, F. B.; Kanu, A.; Barrie, A.; Jalloh, F.; Smalle, I. O.; Abiri, O. T.; Lakoh, S.; Jalloh, M. B.; Baldeh, M.; Njai, A. U.; Bah, A. K.","author_corresponding":"Abdul Karim Bah","author_corresponding_institution":"COMAHS: University of Sierra Leone College of Medicine and Allied Health Sciences","doi":"10.64898\/2026.07.01.26357075","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357075.source.xml","abstract":"Background: Complementary and alternative medicine (CAM) is widely used alongside biomedical treatment in sub-Saharan Africa, yet evidence among patients with tuberculosis (TB) is limited. Concurrent herbal and anti-TB drug use raises concerns about safety, communication, and symptom attribution. We aimed to estimate the prevalence and describe patterns of CAM use, and to explore sociodemographic associations and disclosure practices among adults receiving TB care. Methods: We conducted a cross-sectional study at Connaught Hospital, Freetown, between February and April 2024. Adults ([&ge;]18 years) with microbiologically confirmed TB were consecutively enrolled. Structured interviews assessed CAM use in the past 12 months, modalities, motivations, adverse experiences, and disclosure. Prevalence was estimated using descriptive statistics. Multivariable logistic regression explored sociodemographic associations with CAM use. Results: Among 160 participants (median age 35 years; 68.1% male), 109 (68.1%, 95% CI 60.6-74.8) reported CAM use. Herbal remedies were the most common modality (74.3% of users), particularly ginger (34.9%) and garlic (20.2%). The primary motivation was symptom relief (73.4%). Only 27.6% of CAM users disclosed use to a healthcare provider, most commonly because they reported not being asked (57.5%). In multivariable analysis, only student status was independently associated with lower odds of CAM use (aOR 0.16, 95% CI 0.05-0.56). Conclusions: CAM use was common among adults receiving TB care and was characterized by frequent herbal use and low disclosure. Routine, non-judgmental inquiry about CAM use may improve communication and patient safety during TB treatment.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Deep Learning based Quantification of Root Exposure in Lower Anterior Teeth using Intraoral camera image","authors":"Choi, H.; Choi, Y.-H.; Park, E. Y.; Kang, S.; Kim, E.-K.","author_corresponding":"Eun-Kyong Kim","author_corresponding_institution":"Kyungpook National University college of scince & Technology","doi":"10.64898\/2026.07.02.26357104","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"dentistry and oral medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357104.source.xml","abstract":"This study compared and evaluated two widely used deep learning-based artificial intelligence (AI) models, U-Net++ and YOLOv11, for quantifying tooth and root exposure on intraoral camera images of the mandibular anterior lingual region. Intraoral images of the mandibular anterior lingual region were collected from 291 patients (mean age, 52.8 years) at a university hospital dental clinic with institutional review board approval (YUMC IRB 2021-07-019-002). A total of 266 eligible images (mean, 5.50 teeth per image; 3.70 teeth with root exposure) were annotated. YOLOv11 and U-Net++ were fine-tuned using five-fold cross-validation with data augmentation. Model performance was evaluated on a held-out test set of 40 images using Dice coefficient, Intersection over Union (IoU), accuracy, mean Average Precision at an IoU threshold of 0.5 (mAP50), Lins concordance correlation coefficient (CCC), and intraclass correlation coefficient (ICC). Confidence intervals were estimated using 10,000 bootstrap iterations. For tooth segmentation, U-Net++ demonstrated superior performance, with high accuracy (0.981), Dice coefficient (0.971), and IoU (0.944). In contrast, for root segmentation, YOLOv11 outperformed U-Net++, achieving higher Dice (0.860 vs. 0.746) and IoU (0.762 vs. 0.631). Notably, YOLOv11 showed stronger agreement with the ground truth for quantifying the exposed root ratio (ERR) (CCC, 0.973; ICC, 0.975). These findings suggest that accurate detection of root exposure is important for assessing periodontal tissue loss and that YOLOv11 is a promising model for root exposure quantification in intraoral images. YOLOv11-based quantification of root exposure may serve as a useful adjunctive AI tool for screening and monitoring periodontal conditions and may support individualized treatment planning.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Designing infection prevalence and seroprevalence surveys for learning infection dynamics","authors":"Creswell, R.; Golding, N.; Ryan, G. E.; Eales, O.; Price, D. J.; McCaw, J. M.; Shearer, F. M.","author_corresponding":"Richard Creswell","author_corresponding_institution":"The University of Melbourne","doi":"10.64898\/2026.07.01.26356511","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26356511.source.xml","abstract":"Knowledge of the true number of infections over time is valuable for accurately predicting the future course of an epidemic and planning effective interventions, but the number of cases reported offers only a noisy underestimate of the true number of infections. Disease surveillance strategies based on assessing subsets of the population for current infection (infection prevalence surveys) or antibody presence (seroprevalence surveys) yield crucial information about the number truly infected, but are expensive. To explore impact of survey design considerations--both sample size and sampling frequency--on inference of the number of incident infections over time, we coupled agent-based simulations of respiratory virus epidemics with simulations of infection prevalence and seroprevalence surveys. While returns diminish with increased sample size, we find inference generally improved by increasing survey frequency relative to participants-per-round for any given sample size. After survey rounds reach a sufficient frequency, comparable inference performance may be achieved with either more frequent rounds or more participants per round. Rolling designs with tests conducted each day tend to outperform designs in which testing is divided into discrete rounds. We also show that misspecified assumptions about seroreversion may substantially decrease the quality of inference results.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Single-nucleus transcriptomic analysis of pediatric pancreas reveals cellular heterogeneity and early neoplasia signatures during chronic pancreatitis","authors":"Ahmed, F.; Xie, X.; Dixit, A.; Moreno-Fernandez, M. E.; Patel, E. H.; Gurria, J.; Khoury, K.; Christian, P.; Bottino, R.; Kumaragurubaran, R.; Adeleke, D.; Wasserfall, C. H.; Wang, Y.; Abu-El-Haija, M.","author_corresponding":"Faizan Ahmed","author_corresponding_institution":"Cincinnati Children's Hospital Medical Center","doi":"10.64898\/2026.07.01.26357053","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"gastroenterology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357053.source.xml","abstract":"Background: Pediatric chronic pancreatitis (CP) carries an elevated lifetime risk of pancreatic ductal adenocarcinoma (PDAC), yet the cellular and molecular mechanisms driving disease progression and early neoplastic transformation remain undefined. Methods: We performed single-nucleus RNA sequencing (snRNA-seq) on pancreatic tissue from 15 pediatric CP individuals and 6 healthy controls (HC). Findings were integrated with peripheral blood flow cytometry immunophenotyping of 8 CP and 7 HC individuals and validated by histopathological assessment. Findings: We identified 15 distinct cell populations and profound cellular remodeling in CP, including a 46% reduction in acinar cells and emergence of inflammatory fibroblasts as the dominant stromal population. Acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia (PanIN) populations bearing early PDAC-associated transcriptional signatures were detected in most CP samples. Cell-cell interaction analysis revealed that 68% of CP-specific ligand-receptor interactions converged on ADM and PanIN populations via ECM-integrin and inflammatory pathways. Peripheral blood flow cytometry demonstrated concordant systemic immune activation, including elevated monocyte CCR2 and CD80, increased CD69 on T cells, and upregulated ROR{gamma}t in regulatory T cells. Interpretation: This atlas defines the cellular landscape and intercellular signaling networks underlying pediatric CP, identifying inflammatory fibroblasts and early neoplastic cell states as central features. These findings provide a molecular foundation for understanding cancer risk in pediatric CP and provide a resource to prioritize studies into potential therapeutic targets and biomarkers. Funding: This work was supported by the Network for Pancreatic Organ donors with Diabetes (nPOD) and The Leona M. & Harry B. Helmsley Charitable Trust.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Microbial and immune determinants of disease severity and death in pediatric pneumonia.","authors":"Hanze Villavicencio, K.; Tanes, C.; Malekshahi, C.; Cutillo, D.; Knoll, M. D.; Prosperi, C.; Kalaycioglu, M.; Harris, M.; Utz, P. J.; Mattei, L.; Beiting, D.","author_corresponding":"Daniel Beiting","author_corresponding_institution":"University of Pennsylvania","doi":"10.64898\/2026.07.02.26356561","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"pediatrics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26356561.source.xml","abstract":"Pneumonia is a leading cause of death globally and disproportionately affects children in lower- and middle-income countries. To explore microbial and immune correlates of disease and death, we performed metagenomic sequencing of upper respiratory tract (URT) microbiome in 309 children in Mali with pneumonia and 150 age- and season- and site-matched controls. We show that the URT microbiome matures throughout early life and is influenced by breastfeeding. URT microbiome maturation was disrupted during pneumonia resulting in loss of commensal species and expansion of pathobionts, which was linked to disease severity and death. Analysis of serum antibody levels revealed that low levels of passively acquired antibody from mothers, deficient antibody responses to RSV, and persistent autoantibody to cytokines were associated with pneumonia mortality in an age-dependent manner. These findings underscore the complex nature of pneumonia and identify microbial and immune factors for risk stratification and therapeutic interventions in pediatric pneumonia.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Group interpersonal psychotherapy for depression in Uganda: intervention effects and the influence of social desirability bias in a pilot cluster randomized trial","authors":"Atuhumuza, E.; Ssanyu, J. N.; Fraker, A.; Nakalungi, S.; Ndeezi, M.; Mujune, V.; Oloya, C.; Naisanga, M.; McManus, J.; Huang, C. H.; Kasujja, R.","author_corresponding":"Elly Atuhumuza","author_corresponding_institution":"StrongMinds","doi":"10.64898\/2026.07.01.26357066","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357066.source.xml","abstract":"Introduction: Group interpersonal psychotherapy (IPT-G) can expand access to depression care, but assessment conditions may influence outcomes. This pilot cluster-randomized trial was designed to refine outcome-measurement procedures and generate preliminary effect estimates to inform a larger trial. We evaluated a six-week model, examining associations between follow-up assessment conditions and depressive symptoms. Methods: In Mayuge, Uganda, female participants aged [&ge;]13 years with Patient Health Questionnaire-9 (PHQ-9) scores [&ge;]10 were randomized by village to IPT-G or enhanced treatment as usual. Primary outcome was the PHQ-9 score. Assessments occurred at baseline, two weeks and three months post-treatment. During early two-week follow-up, therapy facilitators remained visible near interview locations while mobilizing participants; thereafter, they left before subsequent interviews. At three months, interviews were conducted independently and participants were randomly assigned to receive a prompt emphasizing confidentiality, accurate reporting and that incentives were not contingent on responses. We examined associations between these two conditions and PHQ-9 scores. Results: Of 292 randomized participants, 263 provided three-month data. Mean PHQ-9 scores were lower in intervention than control participants at two weeks (1.73 versus 15.14; mean difference [MD] -13.41, 95% confidence interval [CI] -16.10 to -10.71) and three months (3.19 versus 10.97; MD -7.78, 95% CI -9.66 to -5.90; both p<0.001). Among intervention participants, prior assessment without facilitators and receipt of the confidentiality and honest-reporting prompt were jointly associated with 4.41-point higher PHQ-9 scores versus the reference condition (95% CI 2.37 to 6.45; p<0.001). In exploratory sensitivity analysis, an intervention subgroup exposed to both conditions had lower three-month PHQ-9 scores than controls (MD -5.19, 95% CI -7.39 to -2.99; p<0.001). Conclusions: Six-week IPT-G was associated with significant symptom reductions, but follow-up procedures influenced the apparent benefit, highlighting the need for independent outcome assessment in community-delivered psychological intervention trials. Trial registration: Pan African Clinical Trials Registry, PACTR202606549854263; retrospectively registered.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"The VOICE-DEP study protocol: multimodal analysis of voice and discourse during medical interviews to support diagnosis and longitudinal monitoring of major depressive disorder","authors":"Zabalza-Zudaire, M.; Sayar-Beristain, O.; Fructos, P.; Nunez, F. E.; Carpio, F. F.; Garcia, E.; Ortiz, A.; Ortuno, F.; Aldaz, A.; Molero, P.","author_corresponding":"Patricio Molero","author_corresponding_institution":"University of Navarra: Universidad de Navarra","doi":"10.64898\/2026.07.01.26357063","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357063.source.xml","abstract":"Background: Major depressive disorder is a severe, recurrent and disabling condition. Although diagnosis and clinical monitoring are based on medical interviews and validated rating scales, speech and discourse analysis may provide complementary digital biomarkers reflecting depressive severity and clinical evolution. However, current evidence remains limited by methodological heterogeneity, predominantly cross-sectional designs, limited longitudinal data and underrepresentation of non-English-speaking clinical populations. Objective: The aim of the VOICE-DEP study is to develop and formalize a standardized, reproducible and clinically grounded protocol for the multimodal analysis of voice and discourse during medical interviews as a tool to support the diagnosis of depressive disorder and to assess whether speech-derived biomarkers change over time in parallel with clinical severity measures. Methods: VOICE-DEP is an observational, prospective, longitudinal pilot study of patients with major depressive disorder with a healthy control group, conducted in a hospital-based clinical setting in Spain. The study will include 25 adult patients with moderate or severe unipolar depression, with or without psychotic symptoms, and 50 healthy controls without a personal history of psychiatric disorders. Patients will be assessed at five time points: baseline (V0) and four monthly follow-up visits at 30, 60, 90 and 120 days. Healthy controls will be assessed once at baseline. The planned dataset comprises 175 voice recordings: 125 from patients and 50 from controls. At each assessment, the Montgomery-Asberg Depression Rating Scale related part of the medical interview, lasting approximately 10-30 minutes and including an initial free-speech segment, will be recorded using a standardized audio protocol. Acoustic, paralinguistic and linguistic features will be extracted and analyzed in relation to clinician-rated severity measures and self-reported symptoms. Ethics: This protocol has been reviewed and approved by the local Research Ethics Committee, which complies with the international standards of GCP CPMP\/ICH\/135\/95 (Comunidad Foral de Navarra Research Ethics Committee; reference code: 2026.110). Written informed consent will be obtained from all participants before any study procedure. Voice recordings and clinical data will be pseudonymized, stored securely and processed in accordance with applicable Spanish and European data protection regulations. Expected outcomes: This protocol is expected to generate a clinically grounded Spanish-language longitudinal speech corpus and a transparent analytical framework for evaluating voice- and discourse-derived biomarkers as complementary tools for depression assessment and monitoring","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Visible Immigration Enforcement Arrests and Mental Health Among Hispanic Adults in the United States","authors":"Aslim, E.; Tekin, D.; Venkataramani, A.","author_corresponding":"Atheendar Venkataramani","author_corresponding_institution":"University of Pennsylvania","doi":"10.64898\/2026.07.02.26357125","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357125.source.xml","abstract":"Objectives: To assess whether higher state-level community-based U.S. Immigration and Customs Enforcement (ICE) arrest rates are associated with adverse mental health outcomes among Hispanic and non-Hispanic adults in the United States. Design: Retrospective analysis using individual-level data from the 2023 and 2024 Behavioral Risk Factor Surveillance System (BRFSS) linked to monthly state-level ICE arrest records from the Deportation Data Project. Two-way fixed effects models assessed associations between mental health outcomes and ICE arrests, net of secular trends, state-specific time invariant factors, and individual covariates. Setting\/participants: The sample included 534,099 US adults aged 18 years or older residing in all 50 states and the District of Columbia surveyed between September 2023 and December 2024. Analyses exploited within-state month-to-month variation in enforcement intensity with state and year-month fixed effects. Outcome measures: Number of poor mental health days in the past 30 days; any poor mental health days (binary); mental health status (3-level categorical); frequent mental distress ([&ge;]14 poor mental health days); and a composite indicator combining depressive disorder diagnosis with frequent mental distress. Results: Among 534,099 respondents (approximately 10% Hispanic), higher ICE arrest rates were significantly associated with worse mental health among Hispanic adults, including 0.19 additional poor mental health days per month (p < 0.05), a 2.2% higher likelihood of reporting any poor mental health days (p < 0.01), and a 2.4% increase in composite mental health problems (p < 0.01). Associations were concentrated among Hispanic women and those with a high school diploma or less. Among non-Hispanic adults, estimates were small and precisely centered around zero across outcomes. Similar findings obtained in difference-in-differences event study models, models including lagged exposures, and models with leave-one-out state exclusions. Conclusion: Higher community-based immigration enforcement was associated with worse mental health outcomes among Hispanic adults but not among non-Hispanic adults. Contemporary enforcement strategies may have broader psychological spillover effects within Hispanic communities, and mental health may be an underrecognized social cost of interior immigration enforcement.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Identifying Active Paragonimiasis in Rural Nagaland in Northeastern India- a Community-Based Cross-Sectional Study","authors":"Ramesh, R. M.; Panmei, K.; Lohe, A.; Deborah, A. A.; Humtsoe, T.; Khamo, V.; Ajjampur, S. S. R.; Joseph, A.","author_corresponding":"Rohan  Michael Ramesh","author_corresponding_institution":"Christian Medical College Vellore","doi":"10.64898\/2026.07.02.26357096","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357096.source.xml","abstract":"Background Paragonimiasis is a neglected tropical disease (NTD) and of significant public health concern in northeastern India where it is frequently misdiagnosed as pulmonary tuberculosis. Transmission occurs through consumption of raw or undercooked freshwater crustaceans, a widespread dietary practice in this region. Accurate diagnosis will ensure cheap, effective treatment with praziquantel and avoid unnecessary prolonged tuberculosis therapy. This study determines the prevalence, specific risk factors for infection, and showcases a clinical scoring model to screen for active paragonimiasis in endemic areas. Methodology\/Principal Findings A community-based cross-sectional survey was conducted in Medziphema block, Nagaland, in northeastern India screening 2,942 residents aged over 10 years. Participants reporting chronic cough ([&ge;]2 weeks) provided sputum and serum samples (93,3.16%). Sputum examination was screened for Paragonimus ova and acid-fast bacilli, and serum samples were tested for IgG antibodies against Paragonimus heterotremus using anti-Extra Secretory antigen by ELISA (positive case defined as titre [&ge;]0.5 IU). IgG-confirmed paragonimiasis was detected in 30 individuals, yielding a population prevalence of 1.02% (30\/2942) and 32.3% (30\/93) amongst symptomatic participants. Sputum microscopy demonstrated limited sensitivity (3.3%), detecting cysts in only one confirmed case. Tuberculosis co-infection was documented in 6.7% of sero-positive cases.  Multivariable regression identified significant associations with increasing age (adjusted (aOR) 1.04) previous tuberculosis history (aOR 4.62), monthly snail consumption frequency (aOR 1.05), ever smoking (aOR 3.51), and education beyond middle school (aOR 2.93). Haemoptysis (aOR 9.86) was the strongest symptomatic predictor. Clinical scoring models were developed, with haemoptysis consistently emerging as the most robust predictor across all models. Conclusions\/Significance Pulmonary paragonimiasis constitutes a prevalent yet under-recognised condition in several southeast-Asian communities, necessitating systematic screening as a differential diagnosis for pulmonary tuberculosis. The clinical scoring model facilitates early case identification in resource-constrained settings. Public health interventions must address dietary practices, particularly consumption of raw or undercooked freshwater crustaceans, to interrupt transmission.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Combined triglyceride-glucose and frailty index (TyGFI) and risk of endometrial cancer in U.S. women aged >=45: NHANES 2011-2018 analysis integrating data engineering and machine learning with logistic modeling","authors":"Zhou, Y.; Ma, J.; Zhang, Y.","author_corresponding":"Yingna Zhou","author_corresponding_institution":"Yunnan C","doi":"10.64898\/2026.07.02.26357105","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357105.source.xml","abstract":"Endometrial cancer (EC) incidence is closely linked to metabolic and hormonal factors. The TyGFI, a composite indicator integrating the triglyceride-glucose index and frailty index, may capture combined risk dimensions relevant to EC etiology and prediction. This study aimed to evaluate the association between TyGFI and EC prevalence among U.S. women aged 45 years and older, and to explore its predictive utility using machine-learning approaches. Data were drawn from the National Health and Nutrition Examination Survey 2011-2018 cycles. The exposure was TyGFI, and the outcome was EC status ascertained from self-reported cancer history and standardized questionnaires. From an initial 39,156 participants, we excluded males, individuals aged under 45 years, those missing TyGFI components or EC data, and extreme TyGFI values, yielding a final cohort of 2,837 women. We performed exploratory feature selection and built six predictive models using machine-learning algorithms to identify key predictors and evaluate TyGFI's contribution to model performance. Survey-weighted multivariable logistic regression estimated the association between TyGFI and EC prevalence with sequential adjustment for covariates. In a weighted sample representing 30,489,082 U.S. women aged 45 years and older, higher TyGFI was significantly associated with EC prevalence. After full adjustment, each unit increase in TyGFI corresponded to a 57% increase in the odds of EC (odds ratio 1.570; 95% confidence interval 1.033-2.370; p = 0.0322), with a significant dose-response trend across quartiles (p for trend = 0.0257). Among six machine-learning models, CatBoost achieved the highest predictive performance, with an area under the curve of 0.999. SHAP analysis identified TyGFI as the most influential predictor, followed by age and serum albumin. In this nationally representative sample of middle-aged and older U.S. women, TyGFI was significantly associated with EC prevalence and emerged as the dominant predictor in machine-learning models. These findings suggest that TyGFI may enhance risk stratification for EC beyond established reproductive and metabolic factors, though prospective studies are warranted to validate its clinical utility.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Knowledge Base and Emerging Frontiers in Post-Tuberculosis Lung Disease Research (2015-2025): A Bibliometric Analysis Based on the Web of Science","authors":"Zhu, T.; Feng, Y.; Dai, Y.; Yu, J.; Zhang, Z.; Liu, Z.","author_corresponding":"Tingting Zhu","author_corresponding_institution":"Lishui Hospital of Traditional Chinese Medicine affiliated to Zhejiang Chinese Medical University","doi":"10.64898\/2026.07.01.26357080","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357080.source.xml","abstract":"Background: Post-tuberculosis lung disease (PTLD) constitutes a substantial global public health burden, yet its overall research landscape has not been systematically quantified. This bibliometric study characterizes global research trends and the knowledge architecture of PTLD publications issued between 2015 and 2025. Methods: We retrieved PTLD-related literature from the Web of Science Core Collection using search terms including \"post-tuberculosis lung disease\" and \"tuberculosis sequelae\". Only English original articles were retained, yielding a final dataset of 353 publications. We adopted VOSviewer, CiteSpace and the Bibliometrix R package to visualize annual publication outputs, cross-country and institutional collaborations, author co-authorship networks, keyword co-occurrence patterns, and citation burst dynamics. Results: Annual publications rose from 13 in 2015 to 67 in 2025, with 71.4% of all papers published from 2021 to 2025. The five most productive nations were the United States (72 papers), India (61), China (51), the United Kingdom (49), and South Africa (38). The US and UK occupied core hub positions in international collaboration networks. Leading institutions included Stellenbosch University (20 articles), the University of Cape Town (14), and the University of Liverpool\/Liverpool School of Tropical Medicine (10). Keyword co-occurrence clustering identified eight thematic groups, with dominant hotspots covering post-tuberculosis bronchiectasis, pulmonary function impairment, chronic pulmonary aspergillosis (CPA), and quality of life. The keywords with the strongest recent citation bursts were \"post-tuberculosis lung disease\" (strength = 3.79), \"prevalence\" (3.70), and \"quality of life\" (2.51). Research frontiers extending to 2025 center on standardized PTLD conceptual framing, pulmonary rehabilitation, and long-term clinical outcome assessment. Conclusions: PTLD research has shifted from merely describing structural lung damage toward standardized disease definitions, functional pulmonary testing, complication management, and patient quality-of-life improvement. Future research priorities should include prospective multicenter cohort studies, individualized pulmonary rehabilitation programs, and host-directed therapies to mitigate the global burden of chronic PTLD.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"LRRK2 in Focus: A Global Browser Linking Genetic Diversity to Functional Effects","authors":"Grant, S. M.; van Midden, V.; Fernandez-Toledo, E.; Cham, M.; Sammler, E.; Alessi, D.; The Global Parkinson's Genetics Program,  ; Morris, H.; Blauwendraat, C.; Singleton, A. B.; Lange, L. M.","author_corresponding":"Lara M Lange","author_corresponding_institution":"Laboratory of Neurogenetics, National Institute on Aging","doi":"10.64898\/2026.07.01.26357034","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc0","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357034.source.xml","abstract":"Background: LRRK2 variants are major contributors to Parkinsons disease (PD). Many pathogenic variants increase kinase activity, underscoring the value of functional assays in nominating therapeutic targets and kinase inhibitors as potential disease-modifying therapies. Objective: To develop an interactive resource that provides functional context and ancestry-specific variant frequencies. Methods: Genotyping and short-read sequencing data were analyzed for 101,678 individuals (61,709 PD, 39,969 controls) from the Global Parkinsons Genetics Program (GP2) and integrated with clinical and in-vitro biochemical kinase activity information. Results: The LRRK2 Browser (http:\/\/gp2.org\/lrrk2browser) displays ancestry-specific genetic data for 19,596 LRRK2 variants (968 exonic, 14 disease-associated) across 11 populations, and functional data for 171 variants. Clinical annotations include age, age at onset, and family history of PD. Discussion: The publicly available LRRK2 Browser represents an open-access, multi-ancestry resource to support LRRK2 variant interpretation. It aims to enhance the translational potential of genetic and functional data for precision medicine and the implementation of gene-targeted therapies in diverse populations.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Vision-Based Automated Severity Rating of REM Sleep Behavior Disorder: From Heuristic Features to Foundation Models","authors":"Hwang, J.; van Pesch, N.; Raval, B.; Abdelfattah, M.; Gafsi, A.; Bertolaso, A.; Ryu, K. H.; Marwaha, S.; Sum-Ping, O.; Cesari, M.; Stefani, A.; Brink-Kjaer, A.; Mignot, E.; Alahi, A.; During, E.","author_corresponding":"Emmanuel During","author_corresponding_institution":"Icahn School of Medicine at Mount Sinai","doi":"10.64898\/2026.07.02.26356954","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26356954.source.xml","abstract":"Automated severity rating of rapid eye movement (REM) sleep behavior disorder (RBD) movements would enable multi-night monitoring to detect potentially injurious behaviors and provide objective endpoints for clinical trials. We compared a heuristic classifier using optical flow-derived features against V-JEPA2, a self-supervised video foundation model, for clip-level severity classification (3329 mild versus 284 moderate-to-severe) of in-laboratory video-polysomnography infrared recordings in 86 isolated RBD patients. V-JEPA2 with checkpoint fine-tuning and maximum optical flow-based frame sampling achieved the best performance across both evaluation conditions -- Macro F1 of 0.76 and 93% accuracy in the clip-level split, and 0.68 and 85% in the patient-level split -- outperforming heuristic and domain-specific pretrained models. Clip duration was the dominant heuristic predictor. Whole-night severity scores preserved patient-level ordering despite systematic overestimation, with V-JEPA2 achieving a mean absolute error of 25% versus 52% for the heuristic classifier. These findings establish a foundation for objective, home-deployable monitoring of RBD severity.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Maternal and perinatal outcomes among pregnant women with sickle cell disease in Uganda: a prospective cohort study.","authors":"Akello, J.; Kiguli, S.; Ndeezi, G.; Sekikubo, M.; Mwaka, S.; Munabi, I.; Namazzi, R.; Mununbe, D.; Mukunya, D.; Pebolo, P.; Mugabe, K.; Rujumba, J.; Nakimuli, A.","author_corresponding":"Jackline Akello","author_corresponding_institution":"Makerere University College of Health Sciences","doi":"10.64898\/2026.07.02.26357097","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"obstetrics and gynecology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357097.source.xml","abstract":"Background: Pregnancy in women with sickle cell disease (SCD) is associated with substantial maternal and perinatal risk, but prospective data from Uganda remain limited. We described the clinical profile, maternal complications, and fetal and neonatal outcomes among pregnant women with confirmed SCD receiving tertiary-level care in Uganda. Methods: We conducted a hospital-based prospective cohort study of 159 pregnant women with confirmed HbSS at Kawempe National Referral Hospital and Mbale Regional Referral Hospital, Uganda, between October 2024 and March 2026. Participants were recruited consecutively during antenatal care or at admission for delivery and followed until maternal discharge. Outcomes were summarized descriptively using explicit denominators. Maternal complications were reported at woman level, while fetal and neonatal outcomes were reported at fetus\/newborn level to account for multiple gestations. Secondary regression analyses were treated as exploratory. Results: The mean maternal age was 24.3 years (SD 4.7), and 82\/159 women (51.6%) were referred in labor or on admission rather than being known from the study-site antenatal clinics. At baseline, median hemoglobin was 7.5 g\/dL (IQR 6.4-8.75), and 118\/132 women (89.4%) had hemoglobin below 10 g\/dL. The most frequent maternal complications were anemia (93\/159, 58.5%), vaso-occlusive crisis (87\/159, 54.7%), acute chest syndrome (31\/159, 19.5%), recurrent infections (27\/159, 17.0%), postpartum hemorrhage (21\/159, 13.2%), and preeclampsia (17\/159, 10.7%). Maternal death occurred in 15\/159 women (9.4%). Among women with recorded mode of delivery, 107\/137 (78.1%) delivered by caesarean section. The 159 women contributed 166 fetal outcomes, including seven twin pregnancies. Of these, 22\/166 (13.3%) were abortions. Among 144 fetal\/newborn outcomes after exclusion of abortions, 119\/144 (82.6%) were live births and 25\/144 (17.4%) were stillbirths. Early neonatal death occurred in 12\/119 live births (10.1%). Low birthweight occurred in 76\/117 newborns with recorded birthweight (65.0%), and NICU admission was recorded in 83\/118 newborns with recorded admission status (70.3%). Conclusion: Pregnancy among women with SCD receiving tertiary referral care in Uganda was characterized by high maternal morbidity, substantial maternal mortality, and poor fetal and neonatal outcomes. The findings support early identification and referral, structured multidisciplinary antenatal care, reliable transfusion readiness, rapid escalation for acute chest syndrome, preeclampsia and infection, and close coordination between obstetric and neonatal services.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Concordance in pregnancy planning, preconception health behaviours and health information-seeking of pregnant couples: a cross-sectional study","authors":"Carter, T.; Schoenaker, D.; Marron, G.; Colas, L.; Steel, A.","author_corresponding":"Amie Steel","author_corresponding_institution":"Southern Cross University","doi":"10.64898\/2026.07.01.26356192","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"obstetrics and gynecology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26356192.source.xml","abstract":"Introduction:Relational dynamics between partners within a couple planning pregnancy are critical to their preconception health behaviour change and are largely underexamined. Given the need for both reproductive partners to engage in beneficial preconception health behaviours and the influence couples have on each others behaviour, this study examines the concordance between pregnancy planning and preconception health behaviours and health information-seeking within reproductive partner dyads. Methods:A retrospective observational study was undertaken utilizing data from two online cross-sectional 80-item surveys administered simultaneously between December 2020 and September 2021. Eligible study participants were females or birthing people aged 18-49 living in Australia during any stage of pregnancy, and reproductive partners of those that met these criteria. The survey items covered sociodemographic characteristics, level of pregnancy planning, preconception health behaviours, health information seeking, and health history. Cohens kappa (K) (categorical variables) and interclass correlation coefficients (ICC) (continuous variables) were used to identify agreement within the couples. Results:Eighty matched dyads of pregnant females and non-pregnant partners were included. Concordance in pregnancy planning was fair (K=0.27) and was primarily seen in couples where both partners reported the pregnancy as planned (42.5%) or ambivalent (18.8%). Couples had very low similarity (ICC:0.22) in weekday alcohol consumption 3 months preconception (pregnant females: 1.2 standard drinks per day (SD1.7); non-pregnant partners: 2.5\/day (SD3.5)). Approximately one quarter (26.3%) of couples reported similarities in partners attempting and succeeding in preconception health information-seeking 12 months before pregnancy. There was greater concordance in not discussing preconception health topics with GPs, including topics explicitly covered within clinical guidelines. Conclusion:There is notable discordance in couples preparation for pregnancy in many behaviours relevant to positive pregnancy outcomes, and in their health service engagement and experience. There is a clear need to provide care to both reproductive partners to ensure the best possible outcome for the future generations.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Integrative analysis of cfDNA features from ultra-low coverage whole genome sequencing enables robust detection of ovarian cancer","authors":"Hanzlikova, Z.; Styk, J.; Po\u0308s, O.; Biro, O.; Bokorova, S.; Lukyova, L.; Sitarcik, J.; Sladecek, T.; Krampl, W.; Meszaros, A.; Hunyadi, P.; Mate, S.; Egeto, A.; Rigo, J.; Sedlackova, T.; Radvanszky, J.; Budis, J.; Szemes, T.","author_corresponding":"Zuzana Hanzl\u00edkov\u00e1","author_corresponding_institution":"Comenius University in Bratislava Faculty of Natural Sciences: Univerzita Komenskeho v Bratislave Prirodovedecka fakulta","doi":"10.64898\/2026.07.02.26357095","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357095.source.xml","abstract":"Background: Despite advances in circulating tumor DNA analysis, reliable detection of oncological disease from ultra-low coverage whole genome sequencing (ulcWGS) remains challenging, particularly at low tumor fractions. This study leverages cell-free DNA (cfDNA) characteristics to develop and evaluate a robust, integrative binary predictive model  for ovarian cancer (OC) status screening. OC represents a growing global burden and is often diagnosed at advanced stages due to the lack of specific early symptoms and effective screening strategies, highlighting the need for sensitive and broadly applicable early detection approaches.Methods and Findings: We analyzed plasma cfDNA from OC patients (N = 85) and cancer-free controls (N = 41) using ulcWGS (~1x). Participation in the study was voluntary, and all participants provided written informed consent before any study-related procedures under study approval No. 16119-8\/2022\/EUIG. Within an integrated workflow combining standardized laboratory processing, bioinformatic pipelines, and machine learning (ML), we extracted 21 features capturing copy number variations (CNVs) and fragmentomic characteristics to identify complementary signatures distinguishing OC from controls. Predictive models were developed using XGBoost with hyperparameter optimization and evaluated on an independent test set (n = 25% of the cohort). A dual-threshold classification strategy was applied to define an uncertainty zone and optimize screening performance.CNV-derived and fragmentomic features assessed in exploratory analysis on the training-validation set showed moderate discriminative power (AUC 0.569 - 0.946) but substantial overlap between groups. On the test set, the CNV-only model achieved an AUC of 0.855 (sensitivity 85%, specificity 50%), while the fragmentomics-only model reached an AUC of 0.8825 (sensitivity 95%, specificity 30%). Both feature domains captured complementary aspects of tumor-derived cfDNA, with fragmentomics favoring sensitivity and CNV-derived metrics improving specificity. Integration of both feature classes improved performance, yielding an AUC of 0.900, sensitivity of 85.00%, and specificity of 90.00%. SHAP analysis confirmed contributions from both feature types without a single dominant predictor.Conclusions: We present an integrative cfDNA framework for OC detection based on ulcWGS that combines CNV and fragmentomic signals to improve diagnostic performance over single-feature approaches. By enabling robust detection of tumor-associated patterns at ultra-low sequencing depth, this approach demonstrates that meaningful cancer discrimination can be achieved without reliance on deep sequencing. This highlights the potential of cost-effective and scalable liquid biopsy strategies for population-level cancer screening their integration into personalized and preventive oncology.  Keywords: Liquid biopsy, ovarian cancer, ultra-low coverage whole genome sequencing, cell-free DNA, cell-free tumor DNA, cancer detection, copy number variations, insert size, fragmentomics, machine learning","funder":"NA","published":"NA","server":"medRxiv"},{"title":"HABITAT: Evolution of a Cloud-Based, Mesh-Enabled Research Data Ecosystem at an Academic Medical Center","authors":"Jampani, Y.; McClay, J.; Rana, M. K. Z.; Mandhadi, V.; Mcmahon, T.; Niu, X.; Islam, M. S.; Hossain, S.","author_corresponding":"James McClay","author_corresponding_institution":"University of Missouri","doi":"10.64898\/2026.07.01.26357043","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357043.source.xml","abstract":"Academic medical centers face growing demand for clinical data access that traditional informatics infrastructure cannot support at scale. We describe HABITAT, a governed, tiered research data ecosystem at the University of Missouri integrating internal and external sources, including unstructured clinical data, into a layered architecture supporting PCORnet and OMOP common data models. A three-tier model provides self-service feasibility tools, secure cloud analytics, and curated honest broker services under a Five Safes governance framework. From mid- 2022 through February 2026, HABITAT received 1,150 requests with 689 fulfilled and supported 29 externally funded projects. Median fulfillment for internal data requests improved from 30 to 20 days, and an early survey captured 54 scholarly outputs, including peer-reviewed publications in high-impact journals. HABITAT supported coursework to multi-site research without proportional staff increases, while cost r","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Impact of wildfire-related fine particulate matter on tuberculosis notifications in Brazil: a nationwide panel study, 2003-2023","authors":"Pham, T. M.; Mendonca, T.; Zhang, Y.; Mallia, D.; Croda, J.; Cohen, T.; Andrews, J. R.; Requia, W.; Walter, K. S.","author_corresponding":"Thi Mui Pham","author_corresponding_institution":"University of Utah","doi":"10.64898\/2026.07.01.26356762","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26356762.source.xml","abstract":"Background Wildfire activity and smoke exposure are increasing worldwide because of climate and land-use change. Although fine particulate matter (PM2.5) may impair pulmonary immune defences against tuberculosis (TB), population-level evidence remains limited. We estimated the effect of wildfire-related PM2.5 exposure on TB notification rates in Brazil. Methods We conducted a nationwide panel study linking municipality-level monthly TB notifications from Brazil's SINAN system with wildfire-related PM2.5 estimates from GEOS-Chem simulations across 5,545 municipalities (2003-2023). We estimated the impact of high-exposure days (PM2.5 > 25 g\/m3) on monthly TB notifications using Poisson regression with fixed effects for municipalities, state-by-year, and state-by-month, controlling for time-invariant differences, secular trends, and seasonality. Distributed lag effects were estimated over 1-24 months before notification. Models accounted for meteorological conditions, GeneXpert diagnostic coverage, and spatial correlation using Conley standard errors. We computed attributable fractions among exposed municipality-months (AFE). Sensitivity analyses evaluated alternative PM2.5 thresholds (15 and 35 g\/m3), co-pollutants, and agricultural expansion. Findings From Jan 1, 2003 to Dec 1, 2023, 1,758,982 TB cases were reported. Of these, 353,319 (20.1%) had at least one high-exposure day (PM2.5 > 25 g\/m3) 1-24 months before notification. An additional 14 high-exposure days over the 24-month lag period was associated with an average monthly increase of 2.9% [95% CI: 0.9-4.9%] in TB notification rates. Effects peaked at 13 months (IQR: 11-14) prior to notification. Results showed a dose-response relationship across PM2.5 thresholds and were robust to controlling for NO2, O3, and agricultural expansion. Overall, wildfire-related PM2.5 exposure accounted for 2.1% [0.7-3.5%] of TB notifications in exposed municipality-months, corresponding to 7,802 [2,612-12,544] attributable cases. The AFE reached 10.7% [7.1-14.0%] in Pantanal and 7.3% [6.1-8.5%] in Amazonia, areas most impacted by wildfires. Interpretation Wildfire-related PM2.5 exposure may represent an increasingly important and modifiable risk factor for TB. As wildfire activity increases across many regions of the world, these findings highlight the need for integrating air quality into climate adaptation and TB control strategies.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Predictors of carried ESBL-producing Enterobacterales involvement in ICU-acquired infection: insights from a bicentric retrospective cohort study.","authors":"Schimpf, C.; Soussan, R.; de Boissieu, P.; Quesnel, C.; Philippart, F.","author_corresponding":"Francois Philippart","author_corresponding_institution":"Medical and surgical intensive care department. Groupe hospitalier Paris Saint Joseph. Paris, France ; Endotoxins, Structures and Host Response, Department of M","doi":"10.64898\/2026.07.02.26357103","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"intensive care and critical care medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26357103.source.xml","abstract":"Rationale: Infections due to Extended-spectrum {beta}-lactamases-producing Enterobacterales (ESBL-PE) require empirical treatment with carbapenems. ESBL-PE carriage is considered as a risk factor for ESBL-PE involvement during ICU infection. Our aim was to determine factors that may predict the actual involvement of ESBL-PE. Methods: A two-periods bicentric ambispective study including ICU ESBL-PE carriers patients from April 2011 to January 2019. All ESBL-PE carriers who developed an infection were analyzed. Results: 6112 patients and 4902 patients were screened during the two periods. 384 and 232 ESBL-PE carriers were identified. Total number of infectious episodes were 146 and 114, respectively. A total of 144 pneumonias, 42 urinary tract infection and 45 digestive infections were studied. An ESBL-PE was involved in 35 (24.3%) episodes of pneumonia, and 44 (37.9%) of extra-pulmonary infections. The most frequent ESBL-PE involved were K. pneumoniae, E. cloacae and E. coli. Similar species and phenotypes were present in colonisation and infection in 29 (82.8%) of pneumonia and in 40 (90.9%) of extra-respiratory infection. Multivariate analysis identified Klebsiella pneumonia or Enterobacter cloacae carriage as risk factor for ESBL-PE involvement in pneumonia and E. coli carriage and detection of ESBL-PE carriage before ICU admission as protective factors. Conclusion: In our study an ESBL-PE involvement is infrequent in pneumonia. A known carriage before ICU admission and E. coli carriage are factors associated with the absence of ESBL-PE un the episode of respiratory infection. A confirmation of our findings could lead to a reduction in the empirical use of carbapenems in this population.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Gut microbiome signatures associated with self-reported allergic symptoms among Finnish adults","authors":"Lindgren, H. H.; Vartiainen, V.; Muluh, G.; Bayal, N.; Parnanen, K.; Meric, G.; Jousilahti, P.; Ruuskanen, M. O.; Knight, R.; Niiranen, T.; Havulinna, A.; Salomaa, V.; Erawijantari, P. P.; Lahti, L.","author_corresponding":"Pande Putu Erawijantari","author_corresponding_institution":"University of Turku","doi":"10.64898\/2026.07.03.26357002","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"allergy and immunology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.03.26357002.source.xml","abstract":"Background Growing evidence suggests that the gut microbiome influences nasal and ocular allergic inflammation through gut-mucosal immune interactions. Yet, its association with Allergic rhinitis (AR) and allergic eye symptoms (AES) remains incompletely understood in large population-based cohorts. Objective To examine associations between the gut microbiome and self-reported AR and AES in Finnish adults. Methods Shallow metagenomic sequencing was performed on stool samples from a population-based cohort (FINRISK02; n = 7,231). Microbial taxonomic and functional profiles were compared between individuals with AR (n = 1,950), AES (n = 1,554), combined allergies (AR and\/or AES; n = 2,305), and controls without reported symptoms (n = 3,175). Results Allergic groups exhibited lower microbial richness and phylogenetic diversity than controls. Shared microbial and functional signatures were observed across AR and AES, consistent with their high co-occurrence (N = 1,199). Compared with controls, allergic groups showed enrichment of 17 bacterial species, predominantly from the Clostridia class, including taxa previously associated with asthma, chronic obstructive pulmonary disease, and atopic dermatitis. Allergic individuals also exhibited enrichment of pathways related to mucosal carbohydrate processing, shikimate metabolism, histidine turnover, and broader amino acid metabolism. Concurrent enrichment of histidine biosynthesis and degradation suggested altered microbial histidine metabolism. Conclusions Adult allergic symptoms are associated with gut microbiome taxonomic and functional alterations linked to mucosal barrier function and immune-related metabolism, supporting a shared gut-mucosal immune axis across allergic phenotypes.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Human In the Loop Challenges for Quality Annotation of Pre-Cancer Lesions in Clinical Oral Images","authors":"Mandal, S.; Mendonca, P.; Gurushanth, K.; Thakur, H.; Birur, P.; Shetty, A.; Pal, D.","author_corresponding":"Debnath Pal","author_corresponding_institution":"Computational and Data Sciences (CDS), Indian Institute of Science, Bengaluru, India","doi":"10.64898\/2026.07.02.26355859","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"dentistry and oral medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.02.26355859.source.xml","abstract":"Background: The hyperplasia and dysplasia stage (pre-cancer) offers a viable opportunity to reduce the incidence and mortality of oral cancer through early prevention. Smartphone-based Artificial Intelligence (AI) enabled screening of potentially malignant oral lesions offers a scalable solution for this in resource-constrained settings. However, developing accurate and explainable AI segmentation models require high-quality, pixel-level annotated data. This process that is prohibitively expensive, time-consuming, and prone to inter-observer subjectivity among clinical experts. Methods: We designed and empirically validated a Deep Learning-driven Human-in-the-Loop (HITL) framework to pixel-annotate a dataset of 3026 clinical oral images. Using an iterative pseudo-labeling pipeline, we evaluated the model's learning dynamics and performance evolution across five training cycles. We conducted controlled experiments to quantify the networks tolerance to intermediate level of label noise (unreviewed pseudo-labels) to resolve clinical subjectivity using pixel-wise Cohen's Kappa and the STAPLE consensus algorithm. Results: Iterative self-training produced sustained improvements in lesion detection and spatial localization. However, controlled experiments revealed that including even a modest fraction ({approx}10%) of unreviewed pseudo-labels led to a three-to-four-fold increase in training convergence instability and induced a conservative prediction bias that negatively impacted model recall. When measured against multi-expert ground truth, the model's performance converged with the inter-rater reliability ceiling ({kappa} {approx} 0.65), indicating that its predictions fell within the envelope of human agreement. Conclusions: Our findings emphasize that a final expert-driven quality assurance step remains absolutely essential to mitigate training instability, confirmation bias, and clinically unacceptable drops in recall caused by label noise. Overall, this work provides a scalable, empirically validated blueprint for building domain-specific medical imaging datasets in low-resource global health settings, where the dual challenges of annotation cost and inter-observer variability are most acute.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"A simplified antigen-based serological algorithm accurately classifies MPXV exposure and vaccination status","authors":"Abdullahi, A.; Adebisis, G.; Wisso, H.; Osawe, S.; Kampmann, B.; Abimiku, A.; Gupta, R. K.","author_corresponding":"Adam Abdullahi","author_corresponding_institution":"University of Cambridge","doi":"10.64898\/2026.07.01.26357045","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357045.source.xml","abstract":"Reliable serological tools are needed to measure mpox virus (MPXV) exposure, evaluate vaccine-induced immunity, and support population-level surveillance. Using a previously established six-antigen serological reference framework, in which seropositivity was defined as reactivity to [&ge;]4 of 6 MPXV antigens, we evaluated the diagnostic performance of individual antigens and all 15 pairwise combinations. B6R demonstrated the highest overall individual discriminatory performance, whereas A35R showed maximal sensitivity and M1R the highest specificity. The A35R+B6R combination most closely approximated the full multiplex assay (AUC 0.93), supporting simplified, scalable MPXV serological assays for surveillance and vaccine evaluation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Epidemiology of antimicrobial use in Malawi: a cross-sectional study using World Health Organisation core antimicrobial use indicators in faith-based health facilities","authors":"Chirambo, E. C.; Chiumia, F. K.; Nkhoma, D. E.; Mitambo, C.; Thawani, A.; Msiska, T. L.; Odeo, S.; Asin, J.; John, M.; Chuaikan, W.; Angwe, M.; Khomani, P.; Chibwe, I.; Matchado, S.; Chimwaza, C.; Matchere, P.; Chiweza, B.; Mwenyekonde, E.; Kampira, E. K.; Kamanga, E.; Salima, Z.; Banda, C. G.; Makala, H.","author_corresponding":"Evans  Chimayi Chirambo","author_corresponding_institution":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme","doi":"10.64898\/2026.07.01.26357065","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc0","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.07.01.26357065.source.xml","abstract":"Background : Antimicrobial resistance (AMR) is a major public health threat globally, with a disproportionate burden in sub-Saharan Africa. Faith-based health facilities provide essential healthcare services to underserved populations, yet data on antimicrobial use in these settings remain limited.   Aim : To assess antimicrobial use in Christian Health Association of Malawi health facilities using the World Health Organisation core medicine use indicators.   Materials and Methods : A multicentre cross-sectional study was conducted in 29 CHAM health facilities across Malawi between January 2024 and June 2025. Data were collected from facility personnel, inpatient prescriptions, and patient interviews and analysed using descriptive and inferential statistics.   Results : Average availability of key antimicrobials was 33.1% (95% CI: 29.7-36.4), while customised formularies were available in 64.3% of health facilities. Among 660 prescriptions analysed, 90.3% contained an antimicrobial agent, but only 33.2% adhered to standard treatment guidelines and 43.6% were prescribed using full generic names. Facilities with pharmacy professionals were more likely to have a facility-specific formulary (84.6% vs. 46.7%, p = 0.037).   Conclusion : Antimicrobial stewardship gaps remain substantial in faith-based health facilities in Malawi and across sub-Saharan Africa, highlighting the need for targeted stewardship programmes in faith-based health facilities.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Effect of Inhaled Lavender Aromatherapy on Preoperative Anxiety in Patients Undergoing Tooth Extraction: A Randomized Controlled Trial","authors":"Dehkordi, A. M.; Mahdian Dehkordi, A. H.; Ghasemian, B. S.","author_corresponding":"Bahar Sadat Ghasemian","author_corresponding_institution":"Kermanshah University of Medical Sciences","doi":"10.64898\/2026.06.27.26356736","date":"2026-07-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"dentistry and oral medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/04\/2026.06.27.26356736.source.xml","abstract":"Background\/Objectives Dental anxiety remains a significant psychological barrier to oral healthcare, particularly for invasive surgical procedures such as tooth extraction. Aromatherapy using Lavandula angustifolia (lavender) has been proposed as a non-pharmacological adjunct to manage acute preoperative anxiety. This clinical trial evaluated the efficacy of inhaled lavender essential oil on anxiety severity in patients awaiting elective single-tooth extraction. Methods An assessor-blinded randomized controlled clinical trial with limited participant blinding (inherent to the recognizable scent of the intervention), registered with the Iranian Registry of Clinical Trials (IRCT20190920044824N1), was conducted among 60 patients requiring non-surgical tooth extraction. Participants were randomly assigned to an intervention group (n=30), receiving two drops of pure lavender essential oil on a sterile gauze for 20 minutes of inhalation, or a control group (n=30), receiving sweet almond oil as an olfactory placebo. The primary outcome was the severity of somatic anxiety symptoms, measured pre- and post-intervention using the Beck Anxiety Inventory (BAI). Because a significant baseline-by-treatment interaction was detected, a General Linear Model (GLM) retaining this interaction term was used to estimate adjusted group means at the grand-mean baseline, with bootstrap 95% confidence intervals (10,000 resamples). Two pre-specified checks of robustness were performed: (i) an unadjusted, baseline-naive Mann-Whitney U comparison of raw post-intervention scores, and (ii) a sensitivity analysis re-fitting the adjusted model after excluding two baseline outliers identified by inspection of model residuals. Results There were no significant baseline differences between the intervention and control groups regarding sex distribution (p=0.100), mean age (p=0.479), or pre-intervention BAI scores (Mann-Whitney p=0.215). A significant baseline-by-treatment interaction was detected (p<0.001). In the full sample (n=60), the baseline-adjusted GLM estimated a lower post-intervention BAI mean in the intervention group (22.38) than the control group (23.09), an adjusted difference of -0.71 (bootstrap 95% CI: -1.41 to -0.06; p=0.028). However, this signal was not robust: after excluding two patients identified as outliers in the model residuals (n=58), the adjusted difference attenuated to -0.51 and was no longer statistically significant (bootstrap 95% CI: -1.11 to 0.10; p=0.098). The unadjusted comparison of raw post-intervention scores was likewise not significant in the full sample (Mann-Whitney p=0.754). Conclusions A baseline-adjusted analysis of this trial produced an initial signal suggesting a small anxiolytic effect of inhaled lavender, but this signal was not stable under a pre-specified outlier-exclusion sensitivity analysis and was not supported by the unadjusted comparison of raw scores. Taken together, the totality of evidence from this trial is insufficient to conclude that inhaled lavender aromatherapy produces a reliable reduction in acute preoperative dental anxiety. Beyond its clinical findings, this trial offers a concrete, quantified illustration of how baseline imbalance and a small number of influential observations can generate a fragile, model-dependent treatment signal in a modestly sized randomized trial, a methodological caution directly relevant to the design and analysis of future small RCTs in dental and complementary medicine research.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Poor sleep is robustly correlated with accelerated aging but the evidence for causation is mixed","authors":"Whitman, E. T.; Prather, A. A.; Mutz, J.; Arseneault, L.; Baranger, D. A. A.; Elliott, M. L.; Fisher, H. L.; Ireland, D.; Knodt, A. R.; Kositzke, C.; Leng, Y.; Reuben, A.; Sugden, K.; Williams, B. S.; Xie, J. K.; Yuan, A.; Moffitt, T. E.; Caspi, A.; Hariri, A. R.; the Alzheimer's Disease Neuroimaging Initiative,  ","author_corresponding":"Ethan T. Whitman","author_corresponding_institution":"Department of Psychology and Neuroscience, Duke University, Durham, NC, USA","doi":"10.64898\/2026.07.02.26357135","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357135.source.xml","abstract":"Sleep gets worse with age and is correlated with risk for disease and mortality. The possibility that poor sleep causes aging to accelerate has prompted interest in improving sleep to slow aging and prevent disease. However, the existing evidence on the link between poor sleep and accelerated aging is unclear. Here, we tested for correlation and causation between poor sleep and accelerated aging using five independent datasets of adults (total N > 64,000). We found strong evidence for a correlation between poor sleep and fast aging that is consistent across young, middle, and late adulthood and across aging biomarkers derived from different tissues and modalities. We found that this correlation is robust to the influence of chronic disease burden, but not to the influence of shared genetic and early environmental factors among twins. Finally, we found mixed evidence for a causal influence of poor sleep on accelerated aging using Mendelian randomization. Our findings indicate that the correlation between poor sleep and accelerated aging is highly robust; however, the claim that poor sleep causes aging to accelerate is not consistently supported.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Global COVID-19 vaccination uptake across the emergency and early post-emergency periods, 2021-2024","authors":"Brooks, D. J.; Germann, A.; Craw, L.; Dumolard, L.; Nedelec, Y.; Acma, A.; Schultz, C.; Mboussou, F.; Atagbaza, A.; Doshi, R. H.; Pastore, R.; Contreras, M.; Velandia Gonzalez, M.; Leon, R.; Mere, O.; Kissa, J.; Emmanuel Njambe, T. O.; Gonzales, G.; Bayutas, B.; Chang Blanc, D.; Von Dobschuetz, S.; Wilder-Smith, A.; Gacic-Dobo, M.; Van Kerkhove, M. D.; O'Brien, K. L.","author_corresponding":"Katherine L O'Brien","author_corresponding_institution":"World Health Organization, Headquarters, Geneva, Switzerland","doi":"10.64898\/2026.07.02.26356844","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26356844.source.xml","abstract":"COVID-19 vaccination helped change the course of the pandemic and remains critical for protecting high-risk groups. We analyzed data submitted to WHO to describe COVID-19 vaccination coverage during the emergency period from 2021-2023 and annual uptake in 2024, the first post-emergency calendar year after the Public Health Emergency of International Concern designation was lifted. By end-2023, global complete primary series coverage reached 65% in the total population, 82% among older adults, and 91% among health and care workers (HCWs), across reporting countries. Booster coverage was lower, at 33%, 60%, and 69%, respectively. Across indicators, disparities by country income group and region emerged early and persisted through 2024. In 2024, vaccination of older adults and HCWs was limited and heterogeneous. These findings underscore the need for stronger, sustainably financed adult immunization platforms and associated monitoring systems to enhance life-course vaccination benefits and to support future outbreak, epidemic, and pandemic responses.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"COVID-19 mRNA Vaccination Reduces Guillain-Barre Syndrome Risk: Evidence from a Large Longitudinal Cohort Study","authors":"Li, J.; Pan, Y.; Han, Y.; Zhou, C.; Zhao, L.; He, Y.","author_corresponding":"Yongqun He","author_corresponding_institution":"Unit for Laboratory Animal Medicine, University of Michigan Medical School","doi":"10.64898\/2026.07.02.26357163","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357163.source.xml","abstract":"Abstract The association between COVID-19 vaccination and Guillain-Barre syndrome (GBS) has been previously investigated with inconsistent results, largely due to limited data and lack of concurrent controls. To address this problem, a large longitudinal cohort study was conducted using National COVID Cohort Collaborative (N3C) data. While COVID-19 infection was associated with increased GBS occurrence, COVID-19 vaccination was associated with significantly reduced GBS risk relative to unexposed (unvaccinated and uninfected) control, corresponding to a 61% lower 30-day risk (incidence risk ratio: IRR = 0.39, P < 0.01), consistent with multivariable Cox regression showing a similar reduction (adjusted hazard ratio: aHR = 0.41, P < 0.01). This protective association was observed only among recipients of mRNA vaccines (BNT162b2: IRR = 0.38, P < 0.01; mRNA-1273: IRR = 0.24, P < 0.01), but not among recipients of adenoviral-vector vaccines (IRR = 1.38, P > 0.05). Prior COVID-19 vaccination also reduced infection-associated GBS risk. Additional factors associated with GBS risk included sex, vaccine dose, and pre-existing comorbidities such as stroke, neurological disorders, and autoimmune diseases. Overall, our N3C large-scale study provides evidence that COVID-19 mRNA vaccination reduces GBS risk, supporting the safety profile of mRNA vaccines and warranting further mechanistic investigation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Effect of Intensive vs Standard Blood Pressure Control According to APOE \u03b54 Genotype: A Secondary Analysis of SPRINT","authors":"Xu, Y.; Pruzin, J.; Greene, T.; Williamson, J.; Reboussin, D.; Pajewski, N.; Klein, M.; Yau, W.-Y.; Reiman, E. M.; Supiano, M.; Ashton, N.; Chhatwal, J.; Bress, A. P.","author_corresponding":"Yizhe Xu","author_corresponding_institution":"University of Utah","doi":"10.64898\/2026.07.02.26357167","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357167.source.xml","abstract":"Importance: Apolipoprotein E (APOE) {varepsilon}4 is the strongest genetic risk factor for sporadic dementia, yet whether the benefits of intensive systolic blood pressure (SBP) control differ by APOE {varepsilon}4 carrier status remains unknown. This is among the first randomized evaluations of intensive SBP control on all-cause dementia by APOE {varepsilon}4 status in US adults without diabetes. Objective: To compare effects of intensive vs standard SBP control on incident all-cause probable dementia between APOE {varepsilon}4 carriers and non-carriers. Design, Setting, and Participants: Secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT), a multicenter randomized trial of adults [&ge;]50 years with hypertension and increased cardiovascular risk, but without diabetes, prior stroke, or dementia. Primary cognitive follow-up ended July 2018. Participants were further followed with telephone-based outcome assessment from 2019 through 2023. Interventions: Intensive SBP control (goal <120 mm Hg) vs standard SBP control (goal <140 mm Hg). Main Outcomes and Measures: The primary outcome was all-cause probable dementia. Secondary outcomes were mild cognitive impairment (MCI); MCI or dementia; MCI, dementia, or death; and all-cause mortality. APOE {varepsilon}4 status was the primary effect modifier. Results: Of 9,361 randomized participants, 8,390 (89.6%) had APOE genotyping (29% {varepsilon}4 carriers); 7,733 (82.6%) had both genotype and outcome data (mean age, 68 years; 36% female; 28% Non-Hispanic Black). Over a median follow-up of 5.1 years, dementia rates (intensive vs standard) were 9.7 vs 13.2 per 1,000 person-years among {varepsilon}4 carriers (hazard ratio [HR], 0.73; 95% CI, 0.51-1.04) and 6.1 vs 6.7 among non-carriers (HR, 0.91; 95% CI, 0.67-1.23; P-interaction = .35). Four-year risk differences were -1.7% (95% CI, -3.4% to 0%; number needed to treat, 59) among carriers and 0.2% (95% CI, -0.6% to 1%) among non-carriers (P-interaction = .045). Patterns were similar for the composite of MCI or dementia; effects on MCI were similar between APOE {varepsilon}4 subgroups. Conclusions and Relevance: Among US adults at high cardiovascular risk, intensive SBP control yielded larger absolute risk reduction in dementia among APOE {varepsilon}4 carriers than non-carriers; relative effects were similar. These findings may inform APOE {varepsilon}4-stratified blood pressure management for dementia prevention.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Automated Multisource Electronic Frailty Index in Acute Ischemic Stroke: Development and Clinical Utility","authors":"Lin, S.; Foo, W. T.; Ng, Y. S.; Chang, H. M.; laura, T. B. G.; De Silva, D. A.","author_corresponding":"Shawn Lin","author_corresponding_institution":"National Neuroscience Institute","doi":"10.64898\/2026.07.01.26357083","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.01.26357083.source.xml","abstract":"Background: Frailty is common in acute ischemic stroke (AIS) and predicts poor outcomes, but is not routinely captured in acute stroke care. Manual frailty tools are difficult to apply consistently in busy inpatient settings, while existing electronic frailty indices (eFIs) often rely on limited data modalities. We developed a scalable pre-stroke electronic frailty index (eFI) using multisource electronic medical record (EMR) data and evaluated its clinical utility. Methods: We conducted a retrospective cohort study of AIS admissions to Singapore General Hospital from July 1, 2024, to January 31, 2025. A fully automated pipeline derived an eFI from EMR data over a 3-year lookback period, incorporating ICD-10 codes, vital signs, anthropometry, laboratory results, medications, and free-text documentation processed using artificial intelligence?augmented extraction of predefined, clinically interpretable deficits. Candidate variables were screened using a validated 10-step frailty index framework and refined by multidisciplinary expert consensus. Results: Among 501 AIS cases, the pipeline generated 75 candidate variables and a final 33-variable eFI, with scores derived for 492 cases (98.2%). Frail patients had greater premorbid disability, higher stroke severity, longer hospitalization, greater rehabilitation use, worse discharge disability, higher 30-day readmission, and higher cumulative post-discharge mortality. In multivariable analyses adjusted for age, sex, NIHSS, premorbid mRS, and reperfusion therapy, each 0.1-unit increase in eFI was associated with mortality beyond 90 days after discharge (adjusted HR, 1.47; 95% CI, 1.19?1.81), 30-day readmission (adjusted OR, 1.91; 95% CI, 1.43?2.59), longer hospital stay (?, 2.8 days; 95% CI, 1.4?4.2), and discharge to inpatient rehabilitation rather than home (adjusted RRR, 1.66; 95% CI, 1.27?2.16). Conclusions: In a well-documented acute stroke service supported by comprehensive longitudinal EMR data, automated multisource eFI derivation was feasible and clinically informative in AIS, capturing baseline vulnerability beyond conventional stroke measures and supporting frailty-informed risk stratification and discharge planning.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Development of patient-reported outcome for spinal and bulbar muscular atrophy","authors":"Nagae, M.; Yamada, S.; Ito, D.; Kishimoto, Y.; Komori, S.; Kawase, T.; Iida, M.; Ayano, K.; Yamamoto, M.; Alqahtani, A.; Kazmi, N.; Grunseich, C.; Katsuno, M.; Hashizume, A.","author_corresponding":"Atushi Hashizume","author_corresponding_institution":"Nagoya University Graduate school of Medicine","doi":"10.64898\/2026.07.02.26356783","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26356783.source.xml","abstract":"Objectives: To develop and validate a disease-specific patient-reported outcome (PRO) measure for spinal and bulbar muscular atrophy (SBMA). Methods: A three-stage sequential design was adopted. Items were generated through qualitative interviews with patients with SBMA and expert review, refined using quantitative analyses, and evaluated for reliability and validity in independent cohorts from Japan and the United States. Results: Interviews with 12 patients generated 234 candidate items, which were refined into a final 31-item SBMAPRO comprising five domains based on an online survey of 106 patients. Internal consistency across domains ranged from Cronbach's alpha values of 0.651 to 0.901. In the Japanese cohort, test-retest reliability yielded intraclass correlation coefficients of 0.941 for physical function, 0.877 for mental health, and 0.858 for social function. Construct validity was examined through correlations with disease-specific functional measurements and the 36-Item Short Form Survey (SF-36). The SBMAPRO correlated with the SBMA Functional Rating Scale (r = -0.826, p <0.001) and with the SF-36 mental health (r = -0.693, p <0.001) and social functioning (r = -0.617, p <0.001) domains. In subscale analyses, the SBMAPRO social domain was associated with trunk-lower limb-related functional impairment (r = -0.587, p < 0.001). Similar patterns were observed in the American cohort. Conclusion: The SBMAPRO demonstrated reliability and validity in Japanese and American cohorts. Associations between mental and social domains and trunk-lower limb dysfunction suggest that mobility impairment may contribute to psychological burden and restricted social participation in SBMA, indicating that this disease-specific PRO may complement clinician-rated measures.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Comparative Performance of Clinical Scoring Systems for Early Mortality Prediction in Blunt Traumatic Brain Injury","authors":"Abdollahi Sarvi, M.","author_corresponding":"Mostafa Abdollahi Sarvi","author_corresponding_institution":"Iran University of Medical Sciences (IUMS)","doi":"10.64898\/2026.07.03.26357217","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357217.source.xml","abstract":"Background: Early risk stratification in traumatic brain injury (TBI) is essential for timely triage, resource allocation, and clinical decision-making within the critical first hours of admission. This study aimed to compare the predictive performance of five established clinical scoring systems includes the Glasgow Coma Scale (GCS), Revised Trauma Score (RTS), Mechanism, GCS, Age, and Arterial Pressure (MGAP) score, Modified Early Warning Score (MEWS), and Rapid Emergency Medicine Score (REMS) for early mortality prediction in patients with blunt TBI. Methods: This single-center retrospective observational cohort study evaluated 444 patients aged 18 to 89 years with blunt TBI admitted to the intensive care unit of a tertiary trauma center in Tehran, Iran, between March 2022 and March 2025. The primary outcome was early mortality, defined as death within 24 hours of admission. Discriminative performance was assessed using the area under the receiver operating characteristic curve (AUC) with 95% confidence intervals (CI) derived via bootstrap resampling (1,000 iterations). Pairwise comparisons of AUCs were conducted, and optimal diagnostic cutoffs were identified using the Youden Index. Results: Within 24 hours of hospital admission, early mortality occurred in 97 patients (21.8%), while 347 patients (78.2%) survived. The trauma-specific and neurological scoring systems demonstrated the highest discriminative capacities: RTS achieved the highest accuracy (AUC = 0.676, 95% CI: 0.617-0.737), followed closely by GCS (AUC = 0.669, 95% CI: 0.608-0.727) and MGAP (AUC = 0.657, 95% CI: 0.594-0.724). General physiological scores exhibited lower performance, with MEWS achieving an AUC of 0.651 (95% CI: 0.595-0.707) and REMS demonstrating the lowest discriminative ability (AUC = 0.601, 95% CI: 0.538-0.659). Pairwise analysis confirmed that RTS GCS and MGAP significantly outperformed REMS, though no statistically significant differences were observed among RTS, GCS, and MGAP themselves. All evaluated systems demonstrated only modest overall predictive performance (AUC < 0.70). Conclusion: Trauma-specific and neurologically oriented scoring systems (RTS, GCS, and MGAP) provide superior and comparable prognostic accuracy for 24-hour mortality in blunt TBI compared to general emergency scores like REMS. However, the absolute predictive power of all evaluated models remains modest. Traditional systems relying on static admission variables fail to capture the dynamic, multifactorial nature of secondary brain injury, highlighting the critical need for multidimensional prognostic tools incorporating physiological time-series data or machine learning algorithms.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Hemispheric Asymmetry Features and Interpretable Machine Learning for Focal Cortical Dysplasia Classification in Drug-Resistant Epilepsy","authors":"Iraqui, A.; Dang, H.","author_corresponding":"Hoang Dang","author_corresponding_institution":"MIT","doi":"10.64898\/2026.07.02.26357180","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357180.source.xml","abstract":"Focal cortical dysplasia (FCD) is a principal cause of pharmacoresistant focal epilepsy, yet its structural MRI signature, subtle cortical thickening, blurring of the gray-white matter junction, is frequently undetected even by experienced neuroradiologists, delaying or precluding referral for curative surgical resection. Here we develop a machine learning pipeline for FCD detection that prioritizes mechanistic interpretability over model complexity. In a subsample of 50 subjects (25 FCD, 25 age-matched controls) drawn from a public structural MRI cohort, we register all scans to a common stereotactic template and derive hemispheric asymmetry features across 48 cortical regions, exploiting the characteristic unilaterality of FCD pathology. Among four classifiers evaluated under leave-one-out cross-validation, an L1-regularized logistic regression achieves the highest accuracy (78\\%, permutation p=0.02), substantially outperforming tree-based ensembles, which perform at or below chance in this feature-to-sample regime. The fitted model selects a sparse subset of 21 of 96 features, with the largest-magnitude contributions localized to inferior and middle frontal gyri and temporal pole and superior temporal gyrus, regions consistent with the known anatomical distribution of FCD. These findings indicate that hemispheric asymmetry, combined with a sufficiently regularized, interpretable classifier, captures a modest but statistically robust and anatomically grounded signal for FCD detection, offering a transparent complement to existing deep learning approaches for presurgical evaluation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Distinct Clinical Associations of Blood Tau Biomarkers and Neurofilament Light in Amyotrophic Lateral Sclerosis","authors":"Bertran-Recasens, B.; Ortiz-Romero, P.; Lugo-Hernandez, F.; Vidal Notari, S.; De Diego-Osaba, M.; Blasco-Fornies, H.; Jimenez-Moyano, E.; Llop Trujillano, M.; Torres-Torronteras, J.; del Campo, M.; Rubio Perez, M.-A.; Suarez-Calvet, M.","author_corresponding":"Marc Suarez-Calvet","author_corresponding_institution":"BarcelonaBeta Brain Research Center","doi":"10.64898\/2026.07.03.26356752","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26356752.source.xml","abstract":"Background and Objectives To investigate the associations of blood-based tau biomarkers with clinical, electrophysiologic and prognostic measures in amyotrophic lateral sclerosis (ALS), and to determine whether they reflect distinct disease-related processes. Methods We studied 119 patients with ALS from a longitudinal observational cohort. Plasma and serum p-tau181, p-tau217, p-tau231, brain-derived tau (BD-tau), NfL and GFAP were measured using Lumipulse and Simoa assays. Associations with demographic variables, disease severity (ALSFRS-R and slow vital capacity), lower motor neuron (LMN), muscle involvement (creatine kinase [CK] and high-sensitivity cardiac troponin T [hs-cTnT]), disease progression and survival were assessed using multivariable models. Results Tau-related biomarkers, specifically p-tau217 and BD-tau, were associated with greater cross-sectional disease severity, reflected by lower ALSFRS-R scores. Plasma and serum p-tau181, p-tau217, p-tau231, and BD-tau were associated with higher CK and hs-cTnT, whereas p-tau181 and p-tau231 were also associated with greater LMN involvement. In contrast, NfL and GFAP were not associated with muscle or LMN involvement. Across analytical platforms, plasma and serum NfL were associated with faster ALSFRS-R decline and shorter survival. NfL was the only biomarker independently associated with both disease progression and survival. Discussion Blood biomarkers capture distinct dimensions of ALS. Tau-related biomarkers are associated with cross-sectional disease severity, LMN involvement and muscle injury, whereas NfL primarily reflects disease progression and survival. These findings support the complementary use of tau-related biomarkers and NfL for ALS phenotypic characterization and prognosis assessment.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Accelerometry-Derived REM Sleep Behavior Disorder Predicts Future Parkinson's Disease in the UK Biobank","authors":"Mejia, G. R.; Brink-Kjaer, A.; Liu, L.; Zhou, L.; Gunter, K.; Ryu, K. H.; Wickramaratne, S. D.; Parekh, A.; Gan-Or, Z.; During, E.","author_corresponding":"Emmanuel During","author_corresponding_institution":"Icahn School of Medicine at Mount Sinai","doi":"10.64898\/2026.07.02.26356952","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26356952.source.xml","abstract":"Estimating Parkinson's disease (PD) risk years before diagnosis remains an unmet need. We applied a validated machine learning classifier for REM sleep behavior disorder (RBD) detection to 7-day wrist accelerometry data in 87,975 UK Biobank participants followed for 10 years. Participants in the highest RBD risk stratum (>99th percentile) had an approximately fivefold increased hazard of incident PD compared with the lowest-risk group (0-90th percentile), with a dose-dependent relationship across the full score distribution. Among non-converters, higher RBD risk was associated with baseline cognitive deficits and longitudinal enrichment of autonomic and psychiatric prodromal features. The association with incident PD remained independent of PD polygenic risk score, while RBD score and genetic risk were synergistic. The combined high-risk group achieved a positive likelihood ratio of 7.91, approximately threefold higher than questionnaire-based RBD screening. These findings support wrist accelerometry as a scalable approach for prodromal PD risk enrichment in population screening.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Effect of fortified balanced energy-protein supplementation during pregnancy and lactation on infant neurodevelopment: a community-based randomized controlled trial in rural Nepal","authors":"Lama, T. P.; Shrestha, R.; Christian, P.; Tielsch, J. M.; Katz, J.; Khatry, S. K.; LeClerq, S. C.; Erchick, D. J.","author_corresponding":"Tsering  Pema Lama","author_corresponding_institution":"Johns Hopkins Bloomberg School of Public Health: Johns Hopkins University Bloomberg School of Public Health","doi":"10.64898\/2026.07.02.26357185","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"nutrition","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357185.source.xml","abstract":"Introduction: Infant neurodevelopment is associated with maternal nutritional status, yet few studies have evaluated the effects of balanced energy-protein (BEP) supplementation during pregnancy and\/or lactation. Methods: The Maternal Infant Nutrition Trial (NCT03668977) was a 2x2 factorial, household randomized, unblinded, efficacy trial conducted in Sarlahi District, Nepal. Pregnant women were randomized to daily fortified BEP supplementation or no supplementation, and those with a live birth were re-randomized after delivery to supplementation or not until 6-months postpartum. The first 100 infants in each of the four intervention groups were enrolled in a neurodevelopment substudy. At 6-months, these infants underwent a cognitive, motor, language, and socioemotional assessment using the Bayley Scales of Infant and Toddler Development, fourth edition. Results: Baseline characteristics were similar across the four trial groups. A significant interaction (p< 0.05) between pregnancy and lactation supplementation groups was observed in the language domain  only. Infants born to mothers who received BEP supplementation during pregnancy did not differ in standard scores for cognitive (mean difference (MD): 2.0, 95% confidence interval (CI): -0.29, 4.29), motor (MD: 0.98, 95% CI: -1.41, 3.36), or socioemotional (MD: -2.35, 95% CI: -5.27, 0.57) domains compared to the pregnancy control group. Similarly, for these three domains, there were no significant differences among infants whose mothers received BEP in lactation period vs. not. Infants born to mothers supplemented in both pregnancy and lactation had significantly higher mean language standard scores of 2.12 (95% CI: 0.16, 4.08; p-interaction = 0.015), driven by the expressive communication subtest, compared to those with no BEP supplementation in either period.   Conclusion: BEP supplementation during pregnancy and\/or lactation was not associated with improvements in cognitive, motor, or socioemotional domains at 6 months; however, infants of women supplemented in pregnancy and lactation had significant improvements in the language domain. Evaluation at later ages is warranted.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Integrating mental health support into care for placenta accreta spectrum: A qualitative analysis of patient perspectives","authors":"Feldman, N.; Nathan, M. D.; Lipschitz, J. M.; Salama, K.; Campbell, L.; Wang, P.; Mittal, L.; Carusi, D. A.","author_corresponding":"Natalie Feldman","author_corresponding_institution":"Brigham and Women's Hospital","doi":"10.64898\/2026.07.02.26356969","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"obstetrics and gynecology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26356969.source.xml","abstract":"Background: Patients with high-risk pregnancies due to placenta accreta spectrum (PAS) are at high risk of morbidity and mortality, which may increase risk for childbirth related mental health sequelae including postpartum post-traumatic stress disorder (PTSD) and trauma symptoms. However, there has been limited investigation into these patients' mental health needs. We aimed to use qualitative data to understand PAS patients' mental health experiences through their obstetric course, and to generate recommendations for the delivery of mental health support to these patients. Methods: This exploratory study used a focus group format with patients who had a history of PAS. General questions about patient's pregnancies, births, and postpartum experiences were asked by mental health professionals. Using a rapid qualitative analysis approach, transcriptions of these focus groups were coded by three psychiatrists and core themes were extracted. Results: We conducted four focus groups with a total of 22 women. Major emotional themes included fear and isolation during the antepartum period, and grief, anxiety, and trauma in the postpartum period. Both periods were associated with a negative emotional impact on relationships with family members. Sadness & depression were less prominent among participants' experiences. Participants felt that mental health care resources needed to be integrated with their obstetric care, extend further into the postpartum period, and should be as specific as possible to their medical condition. Conclusions: Based on the results of these focus groups, we propose that patients with high-risk pregnancies and\/or a history of traumatic birth should have access to expert mental health care that is integrated with their obstetric care. These patients may benefit from extended obstetric follow-up. Mental health screening in these populations should focus on anxiety and trauma symptoms rather than only screening for depression. Future studies should continue to examine these factors in a broader group of women with high-risk pregnancies beyond PAS.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage protocol","authors":"Jenner, A. L.; Araujo, R. P.; Levi, N. L.; Ungerechts, G.; Engeland, C. E.; Heidbuechel, J. P. W.","author_corresponding":"Adrianne L Jenner","author_corresponding_institution":"Queensland University of Technology","doi":"10.64898\/2026.07.02.26357107","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357107.source.xml","abstract":"Immunotherapies have become a transformative therapeutic strategy for many cancer types in recent years. Bispecific T-cell engagers (BiTEs) are one promising immunotherapy that enhances cellular antitumour immunity by redirecting T cells towards cancer cells. Recent evidence suggests that BiTE efficacy can be augmented by encoding BiTEs in oncolytic measles virus vectors (MV-BiTE). Infection of cancer cells with MV-BiTE causes the local production of BiTEs and has shown safety and efficacy in murine tumour models. However, whether the observed efficacy of this treatment will translate to a heterogeneous human population is unknown. In this work, we generate an in silico clinical trial of MV-BiTE therapy using a system of ordinary differential equations. We capture potential heterogeneity of individual patients using variability in in vivo tumour volume and change in baseline (%) measurements from a Phase II clinical trial. In lieu of human MV-BiTE data, we use the oncolytic virus talimogene laherparepvec (T-VEC) as a surrogate oncolytic virus carrying an immunostimulatory payload. Our predictions imply that the main drivers of heterogeneity are the underlying effector T cell killing rate and BiTE pharmacokinetics. Furthermore, we find that if individuals are classified as non-responders to the Phase II T-VEC clinical protocol, they may respond to more frequent administration of lower dosages. This work highlights how in silico clinical trials can provide predictions for novel therapeutics to generate hypotheses and guide the design of treatment schedules for clinical translation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Toward Clinical Implementation of Polygenic Scores for Substance Use Disorders: A Multi-Ancestry Study","authors":"Lai, D.; Zhang, M.; Schwantes-An, T.-H.; Breese, M. R.; Chartier, K.; Sheerin, C. M.; Plawecki, M. H.; Guo, C.; Ma, Y.-Y.; Pang, Z. P.; Edenberg, H. J.; Foroud, T.; Liu, Y.","author_corresponding":"Dongbing Lai","author_corresponding_institution":"Indiana University School of Medicine","doi":"10.64898\/2026.07.03.26357210","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357210.source.xml","abstract":"Objective: To develop and validate clinically relevant polygenic scores (PGS) for alcohol (AUD), cannabis (CanUD), opioid (OUD), tobacco (TUD), and polysubstance use disorders (polySUD) across African (AA), European (EA), and Latinx (LA) ancestry populations. Methods: Using multiple genome-wide association study summary statistics and PGS methods, substance use disorder PGS were developed and evaluated in Indiana Biobank samples (IB, N: 1,356-24,989), then top-performing PGS were validated in All of Us Research Program samples (AOU, N: 62,389-209,952). Case and controls were defined using ICD-9\/10 codes. All participants were aged 18 years or older (>=21 years for AUD controls). Clinical relevance was defined as an odds ratio (OR) >=2 for individuals with the highest PGS determined based on disorder prevalence compared to everyone else. Results: In EA and LA, all PGS achieved clinically relevant performance in both IB and AOU (ORs: 2.00-9.10; P <= 3.87E-4). In AA, PGS met this threshold in IB (ORs: 2.02-2.71; P <= 2.20E-4) but not in AOU (ORs: 1.28-1.56; P <=0.03). Overall, OUD PGS showed the strongest associations in most analyses, followed by CanUD and polySUD. Generally, compared to female PGS, male PGS had higher or comparable ORs, but the differences were not significant except AUD PGS in AOU LA. Conclusions: PGS demonstrated clinically meaningful risk prediction for substance use disorders in EA and LA, supporting the feasibility of future clinical implementation for population-level screening. However, reduced performance in AA underscores the urgent need for more genetic studies in that population.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"RenalTransLSTM: Multi-Horizon Prediction of Acute Kidney Injury in ICU Patients using a Hybrid LSTM-Transformer Architecture","authors":"Badhon, S. M. S. I.; Adibuzzaman, M.; Mosa, A. S. M.; Bozdag, S.; Cleveland, A. D.; Ding, J.; Hossain, K. S. M. T.","author_corresponding":"K S M Tozammel Hossain","author_corresponding_institution":"University of North Texas","doi":"10.64898\/2026.07.02.26357177","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357177.source.xml","abstract":"Objective: Acute kidney injury (AKI) affects a large proportion of patients in the intensive care unit (ICU) and is a major contributor to morbidity, mortality, and cost. Although electronic health records (EHRs) capture rich longitudinal data, many predictive models fail to detect AKI early enough for effective intervention. Non-temporal methods such as logistic regression and XGBoost treat patient history as aggregated risk factors, discarding the temporal evolution of clinical state. A recent trend is to employ temporal models, such as recurrent neural networks, to capture sequential patterns, but these models struggle with irregular sampling and limited long- range contextual awareness. To address the challenge, we propose RenalTransLSTM, a hybrid temporal deep learning framework for early, multi-horizon AKI prediction and identification of modifiable risk factors. Methods: RenalTransLSTM integrates Long Short-Term Memory (LSTM) networks with Transformer encoders to model both local temporal dynamics and global contextual depen- dencies in ICU time-series data. Using 48-hour patient histories from MIMIC-IV (61,735 admissions), the model predicts AKI at 6-, 12-, and 24-hour lead times. We benchmark the model against SVM, XGBoost, LSTM, TG-LSTM, and a Transformer, and apply Integrated Gradients and counterfactual analysis to identify modifiable risk factors. Results: RenalTransLSTM outperforms all baselines across most horizons and metrics, achiev- ing AUROC above 0.90 and F1-scores reaching 0.85 while maintaining balanced precision and recall on imbalanced data. Ablation studies confirm that combining LSTM and Transformer components improved robustness and predictive performance. Counterfactual analysis identifies clinically meaningful, modifiable risk factors associated with AKI progression. Conclusion: RenalTransLSTM offers an effective, interpretable framework for early AKI prediction in the ICU, supporting proactive intervention and clinical decision support.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Robust Longitudinal Dementia Prediction under Systemic Missingness via Hierarchical Fusion and Test-Time Adaptation","authors":"Zhang, C.; Li, H.; Tian, F.; Mansour L., S.; Orban, C.; Chen, C.; Zhou, J. H.; Yeo, B. T. T.; the Alzheimer's Disease Neuroimaging Initiative,  ; the Australian Imaging Biomarkers and Lifestyle Study of Ageing,  ","author_corresponding":"B.T. Thomas Yeo","author_corresponding_institution":"National University of Singapore","doi":"10.64898\/2026.07.02.26357089","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357089.source.xml","abstract":"Longitudinal dementia progression prediction is essential for clinical decision-making. However, models often degrade on external cohorts due to systemic missingness -- where certain biomarkers available during training are completely absent at test time -- compounded by distribution shifts and patient-specific variability. Here, we propose Progression-aware Feature Fusion with Test-Time Adaptation (ProFuse-TTA), a two-stage hierarchical Transformer for longitudinal dementia prediction. Stage 1 learns per-biomarker temporal representations from irregular observations without imputation. Stage 2 fuses them via cross-feature attention, with simulated modality dropout during training for robustness to systemic missingness. At inference, a lightweight test-time adaptation module performs per-individual calibration. We trained on ADNI and evaluated on three external cohorts comprising 2,316 participants and 13,205 timepoints, with controlled modality ablation experiments isolating the effect of systemic missingness. We compared against six baselines, four from a recent benchmark study and two new baselines including one built on a tabular foundation model. ProFuse-TTA achieved the best cross-dataset performance in 8 of 9 settings across clinical diagnosis, MMSE, and hippocampal volume prediction, and ranked first in 14 of 15 ablation scenarios. The model maintained superior performance across varying input lengths and prediction horizons up to 6 years. Pretrained ADNI models are available at XXX.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Reinforcement Learning for Chronic Care Pathway Optimization: A Unified Framework across Three Clinical Goal Types","authors":"Wang, R.; Chen, H.; Wu, Y.; Li, Z.; Shen, R.; He, F.; Zhao, S.; Zheng, N.","author_corresponding":"Ruilei Wang","author_corresponding_institution":"Guangdong Provincial Hospital of Chinese Medicine, Hainan Hospital","doi":"10.64898\/2026.07.03.26357209","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357209.source.xml","abstract":"Objective: Chronic care requires sequential treatment under competing biomarker, safety, and cost constraints, yet clinical goal structures differ across diseases. We asked whether one physiology-informed reinforcement learning (RL) paradigm adapts to heterogeneous chronic-care goals without disease-specific policy architectures. Materials and Methods: We formalized a Type A\/B\/C clinical goal taxonomy (target cure, stable cruise, cycle completion) as a Physiology-Informed Markov Decision Process registry for gout, chronic kidney disease (CKD), and PCOS-mediated fertility treatment--each with PK\/PD transitions, discrete actions, safety zones, and guideline doctor baselines. Unified BC->PPO training (GAE lambda=0.95) on 500 simulated trajectories per disease. Evaluation: paired seeds (N=50 primary; N=500 bootstrap 95% CIs), 10-seed robustness, ablation, literature sUA calibration, and out-of-distribution stress. McNemar\/Wilcoxon with Benjamini-Hochberg FDR. Results: PCOS (Type C, primary): PPO 72.0% vs. doctor 54.0% at N=50 (+18 percentage points; FDR-significant); at N=500, PPO 69.8% [65.6, 73.8] vs. doctor 52.8% [48.8, 57.2]. Gout (Type A): PPO non-inferior--88.0% vs. 90.0% (McNemar p=1.0). CKD (Type B): doctor 32.0%, BC\/PPO 38.0%. Offline CQL 92.0% on gout trajectories. PK recalibration RMSE 97.4 umol\/L (r=0.809). Conclusions: Shared BC->PPO training generalizes across three goal types without cross-disease weight sharing. PCOS supports RL for bounded cycles; gout confirms guideline non-inferiority; CKD illustrates cruise-control difficulty. This framework offers a reproducible foundation for chronic pathway optimization pending prospective validation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Generative embedding of sparse data with a tabular foundation model for dengue anticipatory action: a machine learning approach","authors":"Pelitro, K. J.; Manzano, J. F.; Matavia, T. O.; Soriano, K.; Bilbao, K.; Garcia, G. M.; Delos Angeles, A. J.; Lagmay, A. M.; Bandoy, D. D.","author_corresponding":"DJ Darwin Bandoy","author_corresponding_institution":"University of the Philippines Resilience Institute, Quezon City, Philippines","doi":"10.64898\/2026.07.03.26357228","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357228.source.xml","abstract":"Background Early outbreak detection often depends on complex, data-intensive models that have limited operational use in sparse surveillance settings. We developed a domain-mechanistic generative embedding that converts case counts and rainfall into a structured representation of dengue transmission for early epidemic-onset detection. Methods We constructed a 132-feature generative embedding from sparse dengue case and rainfall data. A tabular foundation model was evaluated using leave-one-year-out validation with paired cluster-bootstrap uncertainty intervals across 17 Philippine regions and eight dengue-endemic countries. Performance was benchmarked against raw input columns and catch22 time-series features. Findings Raw case and rainfall columns provided weak discrimination for dengue outbreak onset, with AUROC ranging from 0.56 to 0.70. The generative embedding improved prediction to AUROC 0.77 across countries and 0.89 across regions, corresponding to gains of +0.205 and +0.183 over raw columns, respectively, with paired cluster-bootstrap p[&le;]0.006. Calibration error remained low at both regional and country scales, with expected calibration error of 0.067 and 0.149, respectively. Predictability was strongest in highly seasonal settings, including Philippine Type I regions, Mexico, Brazil, and the Philippines, whereas year-round transmission or opposing coastal rainfall regimes produced weaker performance. Country estimates based on only one or two retained epidemic seasons were unstable. Interpretation Under sparse surveillance conditions, the predictive capacity of a tabular foundation model depended strongly on the representation supplied to it. A generative embedding of climate and epidemiological dynamics translated limited case and rainfall inputs into actionable early-warning signals, with accuracy scaling according to local seasonal structure. These findings support mechanism-grounded embeddings as a practical route for extending prospective dengue outbreak surveillance in data-limited settings, especially at regional scales where calibration and deployment are most appropriate.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Romosozumab Safely Restores Bone Mass in Multiple Myeloma via Osteoblast Reprogramming: A Phase IIa Study","authors":"Gration, B.; Chai, R. C.; Young, S. G.; Sergio, C. M.; Skorokhodova, E.; Smith, J. T.; Castro-Martinez, A.; Bray, A.; Lin, X.; Yan, C.; Kao, J.; Perram, J.; Lai, S.; Lau, L.; Weilbaecher, K. N.; Moore, J.; Pocock, N.; Chaffer, C. L.; Center, J.; Phan, T. G.; McCaughan, G.; Croucher, P. I.","author_corresponding":"Peter I. Croucher","author_corresponding_institution":"Garvan Institute of Medical Research","doi":"10.64898\/2026.07.02.26357196","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"hematology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357196.source.xml","abstract":"Multiple myeloma causes devastating osteolytic bone disease. Current antiresorptive therapies slow bone loss but fail to rebuild the skeleton. Consequently, patients continue to fracture and suffer the associated morbidity and mortality. Targeting the Wnt inhibitor sclerostin, with romosozumab, increases bone mass in osteoporosis but has not been leveraged in cancer. We hypothesised that romosozumab would safely restore bone mass in multiple myeloma. In a murine model of myeloma, romosozumab was safe, demonstrating no impact on tumour progression while significantly increasing bone density. We subsequently conducted a Phase IIa proof-of-concept study in 12 multiple myeloma patients refractory to bisphosphonate therapy. Romosozumab was safe, it was well-tolerated and did not promote clinical or clonal myeloma progression. Treatment induced an early, significant rise in serum bone formation markers whilst resorption remained unchanged. This was coupled with significant gains in bone mineral density throughout the skeleton. Additionally, we observed radiological evidence of repair to pre-existing osteolytic lesions and, critically, a reduction in the skeletal morbidity rate from 2.5 to 0.11 events per patient-year. Longitudinal single-cell transcriptomics revealed that romosozumab transiently reprograms the osteoblast lineage to upregulate matrix synthesis and mineralisation programmes. These findings demonstrate that sclerostin inhibition safely rebuilds bone, providing clinical and mechanistic rationale for further randomised studies to restore bone health in myeloma patients.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Clinical Impact, Diagnostic Performance, and Prognostic Implications of Plasma Metagenomic Next-Generation Sequencing in Solid Organ Transplant Recipients","authors":"Spottiswoode, N.; Marra, P. S.; Lydon, E. C.; Chu, V. T.; Radakovich, N.; Rodriguez, J.; Phan, H. V.; Langelier, C. R.; Fung, M.","author_corresponding":"Natasha Spottiswoode","author_corresponding_institution":"Department of Medicine, Division of Infectious Diseases, University of California San Francisco, San Francisco, CA, USA","doi":"10.64898\/2026.07.02.26357172","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357172.source.xml","abstract":"Introduction: Plasma metagenomic next-generation sequencing (mNGS) may detect pathogens in solid organ transplant (SOT) recipients, but optimal patient selection and result interpretation remain uncertain. Methods: Physicians reviewed SOT recipients with first-instance clinical plasma mNGS testing (Karius, Inc.) and determined consensus microbiological diagnoses, clinical impact of results, diagnostic yield, and clinical outcome. mNGS results were compared to microbiological diagnoses. A HIPAA-compliant large language model (GPT-4) was used to analyze electronic medical record (EMR) data and predict risk of infection with atypical bacteria, invasive fungi, mycobacteria, or parasites (collectively: pre-specified organisms of presumed significance, POPS) and identify patients who had positive-impact mNGS testing. Results: Of 145 SOT recipients, 119 (82.1%) had positive tests, 42 (29.0%) had [&ge;] 1 POPS organism, and 27 (19.1%) had [&ge;] 1 organism causing positive clinical impact. Positive impact was highly correlated with POPS status, with 24 (88.9%) of 27 positive-impact organisms categorized as POPS (P<0.001). GPT-4 scores accurately identified patients with POPS diagnoses (AUC 0.86), and assigned higher scores to patients with positive test impact (P=0.001). mNGS testing had highest sensitivity for atypical bacteria (82.4% sensitivity) and lower sensitivity for Aspergillus spp (53.3% sensitivity). Detection of greater numbers of organisms by mNGS was associated with increased mortality risk (odds ratio 1.32 per organism detected). Discussion: Plasma mNGS is a valuable clinical tool in SOT recipients. Positive clinical impact is associated with detection of atypical bacteria, fungi, mycobacteria, or parasites. GPT-4 analysis of EMR data identifies patients at risk of infection from these organisms and most likely to benefit from mNGS testing.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Reimagining youth-responsive TB care: Voices and visions from adolescents and young adults who completed TB treatment in Nairobi, Kenya","authors":"Karisa, R. P.; Ringwald, B.; Awinja, A. C.; Kagima, J. W.; Nyaboke, D.; Simba, J.; Mwirigi, N.; Sakwa, E. N.; Macharia, S.; Ronoh, A.; Millington, K.; Kathure, I.; Mueni, E.; Okoth, C.; Mulupi, S.; Mungai, B.; Chakaya, J.; Thompson, R.","author_corresponding":"Rhoda  Pola Karisa","author_corresponding_institution":"Respiratory Society of Kenya","doi":"10.64898\/2026.07.02.26357188","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357188.source.xml","abstract":"Tuberculosis (TB) services often fail to adequately address the needs of adolescents and young adults in many high-TB-burden settings. Despite evidence on the barriers this age group faces across the TB care pathway, young people are rarely involved in designing solutions to improve care that better meets their needs. This study focused on the perspectives of adolescents and young adults who had completed TB treatment in Nairobi, Kenya, engaging them as partners to examine their treatment experiences and co-create ways to improve youth?responsive TB services. This participatory qualitative study was conducted among young people aged 15-24 years (n=37) who had completed treatment for drug-susceptible TB from six health facilities in Nairobi County. Other study participants included County TB stakeholders, healthcare workers, facility managers and community representatives (n=214). Data were collected in December 2024 through four participatory workshops organised by age and gender to facilitate open discussion of shared lived experiences. Participants in each workshop used visual methods to describe their journey with TB, identified common challenges through group discussions, and proposed solutions to improve TB services for the young people. The findings from the workshops with the young people were subsequently discussed in stakeholder feedback sessions involving healthcare workers, facility managers, community representatives, and county TB actors. Data were analysed thematically across both workshops and feedback sessions. Results were structured around four interrelated themes. First, young people reported experiencing prolonged illness before diagnosis, with symptoms often normalised or attributed to other conditions, leading to disruption of school, work, and social life. Second, participants experienced lengthy and uncertain pathways to TB diagnosis, characterised by repeated healthcare visits and treatment for alternative conditions before TB was recognised. Receiving a TB diagnosis represented a pivotal turning point, evoking both fear and concerns about stigma as well as relief at finally understanding the cause of their illness and accessing treatment. Third, support from family and friends helped young people navigate the challenges of illness, diagnosis, treatment, and repeated health-system encounters. Fourth, participants and stakeholders identified practical service adaptations to strengthen youth-responsiveness, including respectful communication, enhanced counselling, peer support, greater privacy within TB service outlets, and flexible medicine collection such as after 5 pm. Adolescents and young adults with TB navigate multiple social and health systems barriers before reaching diagnosis, initiating treatment, and completing it. Involving young people directly in identifying gaps and priorities in TB care generated feasible opportunities for strengthening youth-responsive services within existing health systems. Further research is needed to evaluate the effectiveness and acceptability of the models proposed by study participants.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B","authors":"Wang, Z.; Tenuta, M.; Ngoc Le, H.; Halling Scensgaard, S. N.; Silva Santos, G. S.; Reeves, D. B.; Breton, G.; Igbokwe, V.; Moraes Nicola, A.; Millard, K.; Winther Andersen, S. D.; Graversen, H.; Zollner, C.; Kluge, M.; Scheck, R.; Weis, N.; Johansen, I.; Dong, D.; Hernandez, B.; Shimeliovich, I.; Dizon, J.; Viera, V.; Fabris, F.; Schwarzmuller, M.; Tober-Lau, P.; Hillus, D.; Demir, M.; Gazumyan, A.; Tacke, F.; Sander, L. E.; Kurth, F.; Rasmussen, T.; Ye, H.; Pan, C.; Jacobson, I.; Wang, Q.; Damsgaard Gunst, J.; Gaebler, C.; Sogaard, O. S.; Caskey, M.; Nussenzweig, M.","author_corresponding":"Michel Nussenzweig","author_corresponding_institution":"The Rockefeller University","doi":"10.64898\/2026.07.03.26357226","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357226.source.xml","abstract":"Chronic infection with hepatitis B virus (HBV) is characterized by persistent expression of hepatitis B surface antigen (HBsAg), which is associated with profound immune tolerance. Although nucleos(t)ide analogue therapy effectively suppresses viral replication, it neither eliminates HBV nor reverses virus-specific immune dysfunction. Here, we report the results of two parallel first-in-human, dose-escalation studies evaluating a single infusion of mAb19-LS, a long-acting IgG1 monoclonal antibody targeting HBsAg, in individuals with chronic HBV infection receiving nucleos(t)ide analogue therapy. mAb19-LS was generally safe and well tolerated and induced a mean 11-fold increase in antigen clearance. The magnitude and duration of HBsAg suppression were dependent on both baseline antigen levels and mAb19-LS dose, with suppression maintained for more than 36 weeks in individuals receiving the highest dose. Reduction of circulating HBsAg was associated with uptake of HBsAg-IgG immune complexes by monocytes and dendritic cells and inflammatory reprogramming of these antigen-presenting cells. Notably, proliferation of both CD4+ and CD8+ T cells, as well as interferon-{gamma}; and TNF-; production in response to HBV antigens, were significantly increased 24 weeks after infusion. Together, these findings demonstrate that mAb19-LS is generally safe and effectively accelerates HBsAg clearance while activating antigen presenting cells and enhancing antiviral T cell responses.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Association between anaemia, micronutrient status, and pneumococcal vaccine responses in young Kenyan children","authors":"Abuga, K. M.; Karanja, H. K.; Gallagher, K.; Walusimbi, B.; Mugure, B. W.; Koli, C. K.; Masinde, B.; Etyang, T.; Karani, A.; Indeje, E. M.; Muriuki, J. M.; Hammitt, L.; Kinyanjui, S. M.; MacLennan, C. A.; Nairz, M.; Scott, J. A. G.; Elliott, A. M.; Nkurunungi, G.; Atkinson, S. H.","author_corresponding":"Kelvin Mokaya Abuga","author_corresponding_institution":"KEMRI-Wellcome Trust Research Programme","doi":"10.64898\/2026.07.03.26357225","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"allergy and immunology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357225.source.xml","abstract":"Introduction: Anaemia and micronutrient deficiencies are common in low- and middle-income countries, where vaccine-induced immune responses are often suboptimal. However, whether pre-vaccination nutritional status influences pneumococcal vaccine immunogenicity in young children remains poorly characterised. Methods: We examined associations between pneumococcal vaccine responses in 670 Kenyan children enrolled in three vaccine trials: PRISM (PCV10; n=195; NCT01028326), FPCV (fractional- and full-dose PCV10\/PCV13; n=306; NCT03489018), and PATH-wSP (whole-cell pneumococcal vaccine; n=169; NCT02543892) and baseline anaemia (FPCV and PATH-wSP) and micronutrient status (iron, folate, zinc, and vitamins A, B12, D, and E). Analyses were performed separately for each trial. Primary outcomes were post-vaccination serotype- or antigen-specific IgG concentrations, opsonophagocytic activity (OPA) titres, and composite IgG or OPA z scores. Results: Vitamin B12 and haemoglobin concentrations were positively associated with composite and serotype- or antigen-specific antibody responses in analyses controlling for age, sex, malnutrition and inflammation. In the PRISM trial, PCV10-induced IgG (serotypes 1 and 6B) and OPA (serotypes 1, 4, 14, and 23F) responses were positively associated with vitamin B12 concentrations. Moderate anaemia was associated with lower IgG responses to serotypes 9V and 14 following full-dose PCV13 vaccination (FPCV) and lower antigen-specific IgG responses following the 1 mg PATH-wSP vaccine. No consistent associations were observed for ferritin, folate, zinc, or vitamins A, D, and E. Conclusion: Vitamin B12 deficiency and anaemia were associated with reduced pneumococcal vaccine responses in young Kenyan children. Optimising nutritional status before vaccination could be a strategy to improve vaccine responses in populations where anaemia and micronutrient deficiencies are common.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Physical Activity, Nutritional Status, and Cardiovascular Disease Prevalence in Geriatric Outpatients: A Cross-sectional Study in Swabi","authors":"Ayub, A.; Batool, S.","author_corresponding":"Azhar Ayub","author_corresponding_institution":"Pakistan Air Force Hospital","doi":"10.64898\/2026.07.05.26355867","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.05.26355867.source.xml","abstract":"Introduction: Cardiovascular diseases (CVD) are the leading cause of death among older people worldwide. Cardiovascular risk is high in the elderly, with modifiable risk factors including inactivity and poor diet. Objectives: To evaluate geriatric physical activity, nutritional status (Mini Nutritional Assessment (MNA)), cardiovascular disease (CVD) prevalence, and to explore the association between physical activity and nutrition with cardiovascular risk. Methodology: A cross-sectional study included 150 geriatrics. A structured questionnaire using a WHO aligned physical activity assessment tool (GPAQ) and the validated six-item MNA screening tool. Statistical analysis was done with IBM SPSS 22.0. Results: Among the participants, 56.7% were physically inactive, while 43.3% were active. CVD was present in 50.7% of participants. The mean MNA score was 8.83+\/-1.98, indicating that a substantial proportion of participants were at risk of malnutrition. Physically active individuals demonstrated significantly lower odds of CVD compared with inactive participants (OR = 0.42, 95% Cl: 0.21 0.84, p = 0.014). Nutritional risk was also significantly associated with increased prevalence of cardiovascular disease (p < 0.05). Conclusion: Physical inactivity and nutritional vulnerability are highly prevalent in this geriatric cohort and are significantly associated with CVD. 58% lower odds of CVD (OR=0.42, 95% CI: 0.21 0.84), though the wide interval precludes a precise estimate of effect magnitude. Keywords: Physical activity, cardiovascular diseases, geriatric, malnutrition, Physical inactivity, Mini Nutritional Assessment, Pakistan, Cross-sectional study.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Microvascular responses to common endothelial stimuli are not related in humans","authors":"Schwartz, K. S.; Evering, M. G.; Goebel, C. E.; Greaney, J. L.; Stanhewicz, A. E.","author_corresponding":"Anna E. Stanhewicz","author_corresponding_institution":"The University of Iowa","doi":"10.64898\/2026.07.02.26357129","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357129.source.xml","abstract":"Background: Cutaneous microvascular responses to local heating and acetylcholine perfusion are widely used to assess nitric oxide (NO)-mediated endothelium-dependent dilation in human health and disease. Despite the increasingly common usage of these approaches, no studies have directly compared responses to these stimuli within individuals. Therefore, we assessed endothelium- and NO-dependent dilation in 80 young adults (40 males\/40 females; 22{+\/-}3 years) to determine the extent to which microvascular responses to these endothelium-dependent stimuli are comparable within an individual. Methods: We examined cutaneous vascular conductance responses to (1) standardized local heating protocols to 39{degrees}C and 42{degrees}C, and (2) graded infusions of acetylcholine (10-10-10-1 M) alone or with 15 mM NG-nitro-l-arginine methyl ester (L-NAME; NO synthase inhibitor). Endothelium- and NO-dependent dilation were calculated and expressed in multiple ways based on commonly published analyses to allow for a thorough comparison within and between each stimulus. Results: Local heating-induced endothelium- and NO-dependent dilation were lower at 39{degrees}C compared with 42{degrees}C (P<0.001). The magnitude of local heating-induced endothelium-dependent dilation was significantly related to the NO-dependent contribution of that response at 39{degrees}C (R2= 0.79) and 42{degrees}C (R2= 0.56). Local heating-induced NO-dependent dilation at 39{degrees}C was not related to that at 42{degrees}C (P>0.05). Acetylcholine-induced endothelium- and NO-dependent dilation were not related to local heating-induced responses (all P>0.05). Conclusions: These data demonstrate that while local heating and acetylcholine perfusion produce robust endothelium- and NO-dependent cutaneous vasodilation, these responses are not comparable within an individual.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Comparing cutaneous NO-dependent vasodilation between young males and females","authors":"Evering, M. G.; Schwartz, K. S.; Goebel, C. E.; Stanhewicz, A. E.; Greaney, J. L.","author_corresponding":"Jody L. Greaney","author_corresponding_institution":"University of Delaware","doi":"10.64898\/2026.07.02.26357121","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357121.source.xml","abstract":"Background: Despite the common use of local heating and intradermal microdialysis perfusion of acetylcholine (ACh) to probe cutaneous endothelium and nitric oxide (NO)-dependent dilation, sex differences in microvascular responsiveness to these stimuli in healthy young adults remain incompletely understood. Methods: Cutaneous vasodilation was assessed in response to local heating to 39{degrees}C and 42{degrees}C and graded perfusion of ACh (10-10 to 10-1 mol\/L) alone or concurrently with 15 mM NG-nitro-L-arginine methyl ester (L-NAME; NO synthase inhibitor) using laser-Doppler flowmetry coupled with intradermal microdialysis in 80 young adults (40 females). Results: Local heating to 42{degrees}C elicited greater endothelium- and NO-dependent dilation than heating to 39{degrees}C in both groups (p<0.001), but no sex differences were observed at either temperature (p=0.65). ACh-induced endothelium-dependent dilation also was not different between sexes (p=0.08), but the NO-dependent component was greater in females than in males (p=0.01). In young females, menstrual cycle day (range: day 2-33) was not associated with endothelium- or NO-dependent dilation in response to any stimulus (all p[&ge;]0.19), regardless of hormonal contraceptive use. Conclusions: Taken together, these findings suggest that sex differences in microvascular NO bioavailability in healthy young adults depend on the stimulus used to elicit cutaneous vasodilation and, in females, microvascular endothelium- and NO-dependent dilation are not meaningfully influenced by menstrual cycle phase.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Efficacy and safety of triple versus dual combinations of antihypertensive drugs: A systematic review and meta-analysis of double-blind randomized clinical trials","authors":"Dhurjati, R.; Pant, R.; Satheesh, G.; Mittal, A.; Rodgers, A.; Salam, A.","author_corresponding":"Abdul Salam","author_corresponding_institution":"The George Institute for Global Health, Hyderabad, Telangana, India; The George Institute for Global Health, University of New South Wales, Sydney, New South Wa","doi":"10.64898\/2026.07.03.26356990","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26356990.source.xml","abstract":"We evaluated the blood pressure (BP) lowering efficacy and safety of triple vs dual therapy of antihypertensive drug (AHTD) combinations, among adults with hypertension. Seventeen randomized, double-blind trials (41 comparisons and 13,461 participants) comparing triple versus dual therapy for 3 weeks identified by multiple literature databases searches including PubMed, Cochrane Central Register of Controlled Trials (CENTRAL) until October 2024 were included in the meta-analysis. Triple therapy achieved a greater reduction in systolic BP (SBP) compared with dual therapy (26.9 vs. 21.7 mmHg, mean difference 5.4 mmHg [95% CI, 4.7 to 6.2]). Among patients receiving dual therapy at submaximal and maximal doses, the addition of a third drug further reduced SBP by 7.5 and 3.6 mmHg, respectively. BP control was significantly better with triple therapy (60% vs. 47%, RR=1.34 [1.27 to 1.41]). Withdrawal due to adverse events was slightly higher in the triple therapy group (4% vs. 3%, RR=1.5 [1.2 to 1.8]). Triple AHTD therapy provides superior BP reduction and is well-tolerated compared to dual therapy.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Oral and Maxillofacial Surgeon Accuracy in Anticipating Supplemental Opioid Use Following Third Molar Extraction","authors":"van den Dries, S. R.; Panchal, N.; Wang, S.; Habib, R. A.; Ford, B. P.; Secreto, S. A.; Hersh, E. V.; Theken, K.","author_corresponding":"Katherine Theken","author_corresponding_institution":"University of Pennsylvania School of Dental Medicine","doi":"10.64898\/2026.07.02.26357136","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"dentistry and oral medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357136.source.xml","abstract":"Background: Accurately identifying patients who will require opioids after third molar extraction could improve pain management while supporting opioid stewardship. This study evaluated surgeon accuracy in predicting supplemental opioid use following treatment with ibuprofen and acetaminophen. Methods: Patients (N=85) undergoing third molar extraction were treated with a standardized analgesic regimen of ibuprofen+acetaminophen, with supplemental opioid if needed. Four surgeons independently reviewed preoperative radiographs, assessed surgical difficulty using the Pederson scale, and rated the likelihood of supplemental opioid use on a 5-point Likert scale. Inter-rater reliability was assessed using intraclass correlation coefficients (ICC). The relationship between surgeon ratings and postoperative opioid use was evaluated using logistic regression and receiver operating characteristic (ROC) analysis. Results: Seventeen patients used supplemental opioid analgesics. Inter-rater reliability among surgeons was moderate (ICC3=0.606, 95%CI: 0.505-0.700), while reliability of the average rating across surgeons was good (ICC3k = 0.860, 95% CI: 0.804-0.903). Median surgeon rating was not associated with postoperative opioid use (OR: 0.800, 95% CI: 0.414-1.51, p=0.496) and demonstrated poor discrimination (AUC: 0.551, 95% CI: 0.392-0.710). Surgeon ratings were positively associated with Pederson score (beta=0.073, 95%CI: 0.050-0.096; p<0.001). Conclusions: Surgeons demonstrated moderate agreement, but these assessments did not accurately identify patients who ultimately required supplemental opioids. Surgeon judgments appeared to be influenced by anticipated surgical difficulty. Practical Implications: Clinicians should follow current recommendations against routine \"just-in-case\" opioid prescribing after third molar extraction. Future studies should focus on identifying clinical and biological predictors of inadequate analgesic response to NSAIDs to support individualized pain management strategies.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Association between glycated hemoglobin A1c and automated abdominal aortic calcification: the UK Biobank Imaging Study","authors":"Abraha, H. N.; Gebre, A. K.; Smith, C.; Herat, L. Y.; Webster, J.; Saleem, A.; Gilani, Z.; Girgis, C. M.; Rasmussen, N. H.; Leslie, W. D.; Schousboe, J. T.; Harvey, N. C.; Sim, M.; Lewis, J. R.","author_corresponding":"Haftom Niguse Abraha","author_corresponding_institution":"Edith Cowan University School of Medical and Health Sciences","doi":"10.64898\/2026.07.02.26357193","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"endocrinology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357193.source.xml","abstract":"Background: Poor glycemic control is associated with cardiovascular disease (CVD) risk. However, it is unknown whether glycemic control is related to abdominal aortic calcification (AAC), a marker of subclinical CVD. We investigated the association between glycated hemoglobin (HbA1c) and moderate-to-high automated AAC among middle-aged to older adults from the general population. Methods:We included UK Biobank Imaging Study participants free of atherosclerotic CVD at baseline. HbA1c was measured at baseline (2006-2010) and categorized as normoglycemia (<39.0 mmol\/mol), prediabetes (39.0-47.9 mmol\/mol), undiagnosed diabetes (HbA1c [&ge;]48 mmol\/mol), and diagnosed diabetes. Machine learning-derived AAC24 (ML-AAC24) scores were estimated using a validated automated algorithm applied to dual-energy X-ray absorptiometry lateral spine images (2014-2022). The associations of HbA1c with moderate-to-high ML-AAC24 (defined as a score [&ge;]2) were assessed using logistic regression adjusting for cardiovascular risk factors. Results: Of the included 48,912 participants (mean {+\/-} SD age 55 {+\/-} 7.6 years, 52% women), 9.7% had prediabetes (HbA1c 39.0-47.9 mmol\/mol [5.7-6.4%]), 0.4% had undiagnosed diabetes, and 2.7% had diagnosed diabetes. Each 1-SD increase in log-transformed HbA1c was associated with higher odds of moderate-to-high ML-AAC24 (adjusted odds ratio [aOR] 1.12, 95% CI: 1.09-1.16). Amongst individuals with normal HbA1c, this association was consistent but somewhat weaker for each 1-SD increase in log-transformed HbA1c (aOR 1.07, 95% CI 1.03-1.10). Compared to participants with normal HbA1c, those with prediabetes (aOR 1.19, 95% CI: 1.08-1.30) or diagnosed diabetes (1.64, 95% CI: 1.39-1.94) had higher odds of moderate-to-high ML-AAC24. These associations were consistent in stratified analyses by sex, age groups, body mass index, smoking status and total cholesterol Conclusions: Linear associations between HbA1c levels and ML-AAC24 were observed in UK adults, even in those with normal HbA1c levels. These findings indicate that AAC may develop early in the dysglycemic continuum, supporting earlier cardiometabolic risk assessment even amongst people with ?normal? levels.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"its2s: a Python package for two-stage interrupted time series analysis using machine learning","authors":"Wilner, L.; Casey, J. A.; Mooney, S. J.; Do, V.; Ma, Y.; Benmarhnia, T.; Dey, A. K.","author_corresponding":"Lauren Wilner","author_corresponding_institution":"University of Washington","doi":"10.64898\/2026.07.02.26357175","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357175.source.xml","abstract":"When randomized controlled trials are infeasible, researchers may leverage natural experiments for causal inference. Interrupted time-series (ITS) designs compare observed post-event trends to counterfactual predictions from pre-event data. Two-stage ITS designs use flexible models to generate optimized counterfactual predictions in the first stage, then estimate intervention effects by comparing observed to predicted outcomes in the second stage. Fitting high-dimensional versions of these models is challenging, requiring systematic infrastructure to ensure rigor and reproducibility. In response, we developed its2s, an open-source Python package implementing the two-stage ITS design with machine learning. its2s allows users to specify an intervention date and training\/testing periods, select among built-in model architectures (e.g., Prophet-XGBoost, NeuralProphet), and generate confidence intervals via moving block bootstrap, preserving temporal autocorrelation in residuals. its2s layers defaults, configuration files, and runtime overrides to support workflows ranging from rapid default implementations to highly tailored analyses. We validated its2s using two case studies: a simulation with a 12% policy effect, recovering the true effect as 11.77%, and an analysis of the 2021 Pacific Northwest heat dome, finding 53% excess injury mortality over the following three weeks. its2s provides a flexible, reproducible framework for ITS-based quasi-experimental research, lowering barriers to rigorous machine learning-based counterfactual modeling.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Integrated epidemiology and toxicology reveals the protective effects of TMAO against chemical neurotoxicity in children","authors":"de Leeuw, V. C.; Maitre, L.; van Oostrom, C. T.; Renard-Dausset, E.; Anguita, A.; Chatzi, L.; Coen, M.; Grazuleviciene, R.; Heude, B.; Ibarluzea, J.; Julvez, J.; Keun, H. C.; Piersma, A. H.; Maria, L. S.; Marquez, S.; Ruiz-Rivera, M.; Subiza-Perez, M.; Brantsaeter, A. L.; Toledano, M. B.; Vrijheid, M.; Wright, J.; Hessel, E. V.; Hoyles, L.; McArthur, S.","author_corresponding":"Simon McArthur","author_corresponding_institution":"Institute of Dentistry, Faculty of Medicine & Dentistry, Queen Mary, University of London, Blizard Institute, London, UK","doi":"10.64898\/2026.07.02.26357012","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357012.source.xml","abstract":"Interest in microbiota-host co-metabolism and the effects of its derived co-metabolites on biological processes is increasing rapidly. In addition to their demonstrated associations with mammalian metabolic health and cognition, microbiota-host co-metabolites (MHCMs) represent lifelong contributors to the endogenous exposome. We have previously shown the MHCM trimethylamine N-oxide (TMAO) to exert beneficial effects on murine blood-brain barrier integrity and cognition. Here we investigated whether these positive neural effects of TMAO extended to humans, analysing how TMAO exposure associates with neurodevelopmental outcomes in children and whether an in vitro human neuronal-astrocyte co-culture could contribute to further investigation of the underlying mechanism(s) and neuronal processes related to these associations. In a cohort study of childhood mental health (N=1,203), TMAO was associated with fewer internalising problems, while its precursor microbial metabolite trimethylamine was associated with more behavioural problems in both the cross-sectional and an independent longitudinal study from 1 to 15 years of age (N=630-820). Given prior associations between TMAO exposure and exposure to the environmental pollutants mercury and arsenic, we investigated how the effects of TMAO interacted with these known neurotoxicants. TMAO had a protective effect, modifying the relationship between arsenic exposure and poorer neurodevelopmental outcomes. Furthermore, TMAO activated synaptogenesis-related gene expression and was functionally protective against the negative effects of mercury in our in vitro model. Together, our findings emphasise the importance of interdisciplinary approaches to evaluate associations and potential pathways of MHCMs (endogenous) and environmental (exogenous) metabolites on neurodevelopment in exposome studies.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Lassa fever epidemiology and predictors of mortality in Ebonyi State, Nigeria - A five-year retrospective analysis from 2019 to 2023","authors":"Nwojiji, E. C.; Nwambeke, N. O.; Shih, P.-W.; Chukwunenye, C. U.; Odeh, E. C.; Ekuma, M. I.; Azuogu, B.; Iroezindu, M. O.; Liesenborghs, L.; Dijck, C. V.","author_corresponding":"Eric  Chinonso Nwojiji","author_corresponding_institution":"Ebonyi State Ministry of Health Abakaliki, Nigeria","doi":"10.64898\/2026.07.02.26357189","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357189.source.xml","abstract":"Lassa fever (LF) is a viral disease that is widespread throughout West Africa, with significant global health consequences. Nigeria bears the highest burden (1309 confirmed cases in 2024) of LF among all endemic countries. Within Nigeria, Ebonyi State bears a high burden of cases. Clinical observations suggest that there may be an increase in the geographic spread and case fatality rate of LF across the State. Ebonyi State case-based data on confirmed cases from 2019 to 2023 collated on the Nigeria Centre for Disease Control and Prevention (NCDC) Surveillance, Outbreak Response Management and Analysis System (SORMAS) platform were analyzed. Descriptive statistics, spatial distribution and time series analysis were performed. Multivariate logistic regression analysis was used to identify predictors of LF mortality and factors associated with PCR positivity. A total of 1,624 suspected cases were reported, 1,343 and 273 were laboratory negative and positive respectively, while 8 probable cases were reported. The yearly number of cases remained stable throughout the study period. Out of the 273 confirmed, 107 died from LF, resulting in a case fatality rate (CFR) of 39.2%. CFR increased non-significantly over time, ranging from 28.6% to 55.8%. Variations in geographic distribution were observed; in 2019 ten local government areas (LGAs) were affected compared to twelve in 2020. A higher incidence was observed between January and March annually. Age above 44 years, bleeding and seizures were significant predictors of mortality. Lower incidence of cases was consistently reported in the Southern LGAs. PCR positivity was associated with individuals who reside in Ebonyi LGA and who have had contact with confirmed cases. The increase in CFR and identification of high-burden areas will help shape policies, allocate resources and provide actionable intervention strategies to combat LF in the State.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Individual-level Social Vulnerability and Cognitive Function Among Older Adults in the United States National Health and Nutrition Examination Survey","authors":"Arboleda-Merino, L.; Walker, E.; Fansler, S. D.; Joshi, S.; Needham, B.; Park, S. K.; Bakulski, K. M.","author_corresponding":"Kelly M Bakulski","author_corresponding_institution":"University of Michigan, School of Public Health","doi":"10.64898\/2026.07.02.26356711","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26356711.source.xml","abstract":"Background: Cognitive function is crucial for healthy aging, and its impairment reduces quality of life and increases healthcare and societal burden. Social vulnerability, shaped by factors like income, education, and access to healthcare, has been associated with cognitive health, but reliance on community-level assessments may limit understanding of risk at the individual level. Objectives, Design, Setting, Participants: We examined the cross-sectional association between a proposed individual-level Social Vulnerability Index (iSVI) and cognitive function among 5,989 participants aged [&ge;]60 years in the US National Health and Nutrition Examination Survey (NHANES) 1999-2002 and 2011-2014 cycles. Measurements: Cognitive performance was measured using the Digit Symbol Substitution Test (DSST). iSVI was constructed by summing six risk indicators (income, education, health insurance, employment, housing tenure, and food security). Health insurance and employment were scored on a three-level scale (0\/0.5\/1); other indicators were binary (0\/1). Survey-weighted linear regression estimated associations between iSVI and DSST scores, adjusting for age, sex, race and Hispanic origin, and survey cycle. Estimates were benchmarked against adjusted associations between age and DSST. Results: Higher iSVI was associated with poorer cognition, with each one-unit increase corresponding to a 5.30-point lower DSST score (95% CI: -5.71, -4.89). This difference was comparable to nearly 5 years of age-related difference in DSST performance, as each additional year of age was associated with a 1.08-point lower DSST score (95% CI: -1.14, -1.03). Conclusions: Increased iSVI was associated with lower cognitive function in older adults, highlighting individual-level social vulnerability as a key intervention opportunity to prevent cognitive impairment.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Extreme temperature exposure and the risk of miscarriages in Italy: a nationwide small-area study of 4.5 million births","authors":"Gudziunaite, S.; Ceccarelli, E.; Hirst, J. E.; Pirani, M.; Maraschini, A.; Moshammer, H.; Minelli, G.; Blangiardo, M.","author_corresponding":"Marta Blangiardo","author_corresponding_institution":"Imperial","doi":"10.64898\/2026.07.02.26356686","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26356686.source.xml","abstract":"Background: The effect of extreme temperatures on miscarriage is not well understood. Even less understood is the gestational period most vulnerable to extreme temperature exposure, as early miscarriages are often missed in incident datasets. We employ a birth-rate based approach to infer the risk of miscarriage in response to extreme temperature exposure by gestational week. Methods: We conducted a population-based ecological study using birth registry data from the 7,948 municipalities of Italy between 2013 and 2024 (4.5 million births). The analyses were stratified by five climatically coherent macro-regions (Ecoregions). To infer unreported pregnancy losses, we regressed birth rates dated from the last menstrual period against weekly temperatures across gestational weeks 3-21, accounting for temporal seasonality and spatial heterogeneities. Findings: Exposure to heat (mean weekly temperature of 30.4 degree\/C) during gestational weeks 3-4 was associated with a reduction of birth rates of 1.62 (0.71 - 2.51)%, and of 1.91 (0.92 - 2.88)% to mean weekly temperature of 1.6 degree\/C. Whilst heat was found to be harmful during gestational weeks 3-4 and 18-21, cold spells were found to be consistently harmful from the 3th up to the 12th week, depending on the Ecoregion. Interpretation: Pregnancies are vulnerable to extreme temperatures during the post-conceptual period and the second trimester. The findings underscore the need for a pre-conceptual cohort to clarify the mechanisms of loss, and urge public health action to protect pregnancies from the beginning of gestation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Traumatic Brain Injury Increases Risk of Psychiatric Disorders Following Neurological Disease: Evidence from the UK Biobank Cohort","authors":"Revill, G.; Poole, N.; Carlisi, C.; David, A. S.; Bell, V.","author_corresponding":"Vaughan Bell","author_corresponding_institution":"University College London","doi":"10.64898\/2026.07.02.26357128","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357128.source.xml","abstract":"Background: Traumatic brain injury (TBI) is common in older adults and frequently co-occurs with neurological conditions such as dementia, stroke, and Parkinson's disease. Both TBI and neurological disease independently increase vulnerability to psychiatric disorders, yet the long-term impact of lifetime TBI exposure on mental health outcomes within these neurological populations remains poorly understood. Methods: Using data from the UK Biobank cohort (N = 502,154), we examined associations between TBI and subsequent psychiatric diagnoses in individuals diagnosed with dementia, stroke, or Parkinson's disease. Participants were assigned to one of four exposure groups (no TBI and no neurological disease, TBI only, neurological disease only, TBI plus neurological disease), and mixed-effects logistic regression estimated psychiatric risk across these groups and within each neurological condition. Kaplan-Meier curves and Cox proportional hazards models assessed 10-year cumulative risk. All analyses were adjusted for demographic and socioeconomic factors. Results: The combined presence of TBI and neurological disease produced the greatest psychiatric risk, exceeding that observed for either condition alone. Across dementia, stroke, and Parkinson's disease, TBI most reliably increased the odds of mood disorders, while associations for anxiety were less consistent. Ten-year cumulative incidence analyses demonstrated higher risk of mood and overall mental health disorders across all three neurological cohorts. Conclusions: Lifetime TBI exposure is associated with increased likelihood and long-term risk of psychiatric disorders in individuals with dementia, stroke, and Parkinson's disease, with mood disorders being the most consistent outcome across conditions. These findings highlight the importance of recognising TBI history when assessing and managing psychiatric risk in ageing neurological populations and underscore the need for integrated clinical pathways that address both neurological and mental health needs.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Cardiovascular risk scores for primary prevention: head-to-head validation of 16 established and contemporary models","authors":"Hu, Y.; Hu, S.; Dong, Z.; Wei, J.; Zhang, Z.; Jiang, P.; Huang, H.; Li, T.; Zou, J.","author_corresponding":"Jian Zou","author_corresponding_institution":"Department of Statistics, School of Public Health, Chongqing Medical University","doi":"10.64898\/2026.07.02.26357120","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357120.source.xml","abstract":"Background and Aims: Cardiovascular risk scores guide primary prevention, but their comparative performance remains uncertain. We externally validated 16 established and contemporary cardiovascular risk-prediction models in a common primary-prevention evaluation framework. Methods: UK Biobank participants free from cardiovascular disease and cancer at baseline were included. 16 models, corresponding to 19 configurations, were implemented as published and evaluated against a harmonized incident CVD endpoint. Performance at 5 and 10 years was assessed using discrimination, calibration, Brier score, decision curve analysis, and TRIPOD+AI reporting quality. Results: Among 438,640 participants, 45,003 incident cardiovascular events occurred over a median follow-up of 13.5 years. Ten-year area under the curve ranged from 0.668 for QRISK3 to 0.734 for PREDICT, and C-index from 0.655 to 0.717. Calibration varied substantially: PROCAM, Framingham, ASSIGN, and QRISK1 overestimated risk, whereas PREVENT, PREDICT, SCORE, SCORE2, SCORE2-OP, and China-PAR generally underestimated risk. QRISK2 showed the best calibration, while PREVENT had the lowest Brier score. At higher treatment thresholds, net benefit diverged, with PREVENT and PCE performing most consistently. Composite assessment favored PREVENT, QRISK2, PREDICT, PCE, and northern China-PAR variants. Conclusions: Direct application of cardiovascular risk scores across populations can produce clinically important differences in calibration and net benefit. Model selection for primary prevention should require external validation, local recalibration, and assessment of clinical utility, rather than reliance on discrimination alone. PREVENT, QRISK2, PREDICT, PCE, and northern China-PAR variants showed the most balanced performance in this cohort.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Association of white matter hyperintensities, white matter microstructural changes, hippocampal and amygdala volumes with neuropathology in a community cohort using 7T postmortem in situ MRI","authors":"Liou, J.-J.; Martin, M.; Rodriguez, R.; Grinberg, L.; Santini, T.; Ibrahim, T.; Otaduy, M.","author_corresponding":"Jr-Jiun Liou","author_corresponding_institution":"University of Pittsburgh","doi":"10.64898\/2026.06.30.26356455","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"pathology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.06.30.26356455.source.xml","abstract":"INTRODUCTION: We integrate visual and quantitative metrics in white matter and medial temporal lobe to examine relationships with neuropathology in a community cohort. METHODS: Postmortem in situ MRI (T1, T2, DWI) was performed in 25 human brains, followed by visual ratings (Fazekas, MTA, ERICA, Koedam). Neuropathology included ADNC, LATE-NC, hippocampal sclerosis, PART, ARTAG, Lewy pathology, and CAA. RESULTS: Increased Fazekas score was linked to aging, lower education, hypertension, higher basilar artery wall thickness, and greater Braak NFT stage. WMH volume also correlated with lacunes, Thal phase, and CERAD score that was not observed using Fazekas. Hippocampal volumes were lower in elderly, less educated people and were associated with higher atrophy scores and higher Braak NFT stage. Higher amygdala volume was only associated with higher CERAD score. DISCUSSION: Quantitative MRI may detect neuropathologic associations more sensitively than visual ratings. Tau pathology is a key predictor of WMH burden and hippocampal atrophy.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"High-frequency oscillations and interictal epileptiform discharges predict infantile spasms","authors":"Hautala, S.; La Grassa, S.; Lauronen, L.; Peltola, M.; Paloma\u0308ki, M.; Metsa\u0308honkala, E.-L.; Metsa\u0308ranta, M.; Jonsson, H.; Gaily, E.; Harju, M.; Al-Sa'd, M.; Mikkonen, K.; Nevalainen, P.","author_corresponding":"Sinikka La Grassa","author_corresponding_institution":"Epilepsia Helsinki, full member of ERN EpiCare, Division of Child Neurology, Children's Hospital and Pediatric Research Center, University of Helsinki and Helsi","doi":"10.64898\/2026.07.03.26357202","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"pediatrics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357202.source.xml","abstract":"Early acquired brain injury is a major risk factor for infantile epileptic spasms syndrome (IESS), which may impair cognitive development, especially if diagnosis and treatment are delayed. However, individual-level prediction of which infants will develop IESS is currently not possible. We assessed whether high-frequency oscillations (HFOs) in scalp EEG or recurrent interictal epileptiform discharges (IED) during the first months of life could predict forthcoming IESS. Our population-based cohort included 36 infants with cortical injury due to infarction, haemorrhage, infection or trauma involving a large cortical area ([&ge;] anterior\/posterior cerebral artery territory or [&ge;] half of the middle cerebral artery territory), or hypoxic-ischaemic encephalopathy with cortical and deep grey matter involvement. The infants underwent repeated EEGs during the first year of life until 12 months of age or until IESS diagnosis. HFOs during sleep were scored both visually and automatically, whereas IEDs were assessed visually only. We tested whether HFO rate increased during the first year of life using a mixed-effects model with within- and between-subject random effects. Using only EEGs recorded prior to IESS diagnosis, we evaluated whether HFO rate or recurrent IEDs could predict IESS development by training a ridge-regularized logistic regression model with exhaustive leave-2-subjects-out cross-validation. Eleven infants (31%) developed IESS. HFO rate increased with age in both groups but more steeply in the IESS group [within person slope {beta} = 2.43 (IESS) vs. 0.06 (no-IESS) units\/month, P < 0.001]. The logistic regression model showed that both HFO rate [AUC 0.801 (95% CI 0.668, 0.936)] and recurrent IEDs [AUC 0.826 (95% CI 0.720, 0.932)] were able to predict forthcoming IESS. However, in a multivariable model, only recurrent IEDs remained independently associated with IESS, and HFO rate did not add predictive value. The marked increase in HFO rate toward IESS diagnosis supports their role as a biomarker of epileptogenesis. During the first months of life, HFOs and recurrent IEDs performed equally well in predicting subsequent IESS. However, IEDs are easier to apply to clinical practice.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Evaluating an Adjusting Alcohol Purchase Task as a Brief Measure of Behavioural Economic Demand for Alcohol in a Large Sample of Community Adults","authors":"Coelho, S. G.; Belisario, K. L.; Keough, M. T.; MacKillop, J.","author_corresponding":"James MacKillop","author_corresponding_institution":"McMaster University","doi":"10.64898\/2026.07.02.26357139","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357139.source.xml","abstract":"Alcohol demand is commonly assessed using hypothetical alcohol purchase tasks (APTs), from which individual demand curves are constructed and yield multiple indices of reinforcing value. Procedurally, APTs can confer participant burden, and existing brief alternatives cannot produce demand curves or derived indices. Thus, we evaluated a novel, adjusting APT that efficiently and idiographically assesses alcohol demand while preserving the benefits of a full task. Adults reporting past-six-month alcohol use (n=897) completed either the adjusting or full APT, the former utilizing a binary-search-style algorithm to administer six prices from the full APT's price set based on level of alcohol demand. The adjusting APT reduced item burden by 49% and produced well-fitting individual demand curves. Average demand intensity and elasticity estimates did not differ significantly by modality, whereas Omax and breakpoint estimates were significantly higher on the adjusting APT, though only by $3 each. All demand indices from both APTs were positively associated with alcohol use and problems, with similar magnitude by modality. Results provide support for the adjusting APT as a brief measure of alcohol demand that retains demand-curve-based indices of reinforcing value.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Brain Ageing in Social Anxiety Disorder: An ENIGMA-Anxiety Mega-Analysis Across 26 International Cohorts","authors":"Blake, K. V.; Ipser, J. C.; Amod, A. R.; Kaufmann, T.; Bar-Haim, Y.; Bauer, J.; Bayram, A.; Beesdo-Baum, K.; Blanco-Hinojo, L.; Borgers, T.; Bu\u0308low, R.; Cano, M.; Cardoner, N.; Ching, C. R. K.; Choi, S.-H.; Dannlowski, U.; Davey, C. G.; Doruyter, A. G. G.; Flinkenflu\u0308gel, K.; Fonzo, G. A.; Furmark, T.; Grotegerd, D.; Grabe, H. J.; Hahn, T.; Harrison, B. J.; Heeren, A.; Hilbert, K.; Hirano, Y.; Hirsch, J.; Hofmann, D.; Isobe, Y.; Jahanshad, N.; Jamalabadi, H.; Jamieson, A. J.; Jansen, A.; Kim, J. E.; Kircher, T.; Kitagawa, H.; Klahn, A. L.; Koch, S. B. J.; Krug, A.; Kugel, H.; Lee, D.; Leehr, E","author_corresponding":"Kimberly V Blake","author_corresponding_institution":"Department of Psychiatry and Mental Health, Neuroscience Institute, University of Cape Town, South Africa","doi":"10.64898\/2026.07.02.26357108","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357108.source.xml","abstract":"Social anxiety disorder (SAD) is among the most prevalent anxiety disorders, and it has been associated with signs of advanced biological ageing. Despite this, brain age research on anxiety disorders remains limited. This mega-analysis investigated brain ageing in adults with SAD within the ENIGMA-Anxiety Working Group. Structural MRI scans from 576 participants with SAD and 1 355 non-affected healthy controls (HCs) across 26 international samples were included. Brain age was estimated from 77 cortical and subcortical regions using a publicly available ENIGMA brain age model. The brain-predicted age difference (brain-PAD) was calculated as the difference between brain age and chronological age. Group and subgroup differences (comorbidity, medication) were assessed using linear mixed-effect models. In the full sample, there was no group difference in brain-PAD ({beta}diagnosis (SE)=0.70 (0.37) years, p=0.061). In a subgroup of participants with SAD with comorbid anxiety disorders (n=184 SAD, n=1 355 HCs), a brain-PAD of +2.39 (0.93) years (Cohen's d=0.23, pFDR=0.003) was observed. This brain-PAD became smaller after exclusion of participants with comorbid agoraphobia and specific phobia, suggesting that these disorders may partly drive the advanced brain-PAD. In conclusion, this ENIGMA-Anxiety mega-analysis did not find evidence of advanced brain ageing in the full sample of adult participants with SAD relative to HCs. However, a sub-analysis suggested that SAD with co-occurring phobic disorders, or the phobic disorders themselves, are associated with neurostructural patterns typical of older brains. Future research could utilise transdiagnostic samples with information on age of onset and disorder duration to further clarify this relation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Exploring the Factors Influencing Resilience Among Returnee Migrants in Nigeria","authors":"Awoleye, O. J.; Uthman, K. A.; Sanni, O. F.; Uchendu, F. N.","author_corresponding":"Olatunji Joshua Awoleye","author_corresponding_institution":"OREEP NIGERIA LIMITED, ASOKORO, ABUJA, NIGERIA","doi":"10.64898\/2026.07.02.26357141","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357141.source.xml","abstract":"Background: Returnee migrants in Nigeria often face significant psychosocial and economic challenges during reintegration, necessitating resilience to adapt and recover. This study examined factors influencing resilience among returnee migrants in Nigeria. Methodology: A mixed methods design was employed, involving 1316 returnees selected through multistage sampling across Nigeria six geopolitical zones. Quantitative data were collected using the Connor Davidson Resilience Scale and analyzed using SPSS version 28. Qualitative data was obtained through eight focus group discussions and analyzed thematically. Result: Social support from family and friends was inconsistent (70.8% reported occasional support), while community support was largely absent (85.9%). Financial insecurity was widespread (gt 90%). Male gender (AOR = 6.092, plt 0.001), ethnicity, and higher education were significant predictors of resilience. Qualitative findings highlighted the role of family support, faith, adaptive coping, and skill acquisition in strengthening resilience. Conclusion: Resilience among returnee migrants in Nigeria is limited by weak structural and economic support, despite moderate personal coping capacity. Strengthening economic opportunities, community integration, and access to mental health services is essential for sustainable reintegration. Keywords: Returnee migrants, resilience, Reintegration, and psychosocial factors.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Evaluating Student Use, Access, and Perceptions of a Campus Sexual Health Vending Machine","authors":"Sheng, G.; Gualtieri, L.","author_corresponding":"Grace Sheng","author_corresponding_institution":"Tufts University School of Medicine","doi":"10.64898\/2026.07.03.26357232","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357232.source.xml","abstract":"Background: Sexual health vending machines have emerged as a promising approach to expanding access to contraception and other sexual health products on college campuses. This study evaluated patterns of use, perceived accessibility, and student attitudes towards the sexual health vending machine at Tufts University. Methods: This mixed-methods evaluation combined an online survey with vending machine refill data. Analyses included descriptive analysis, chi-square tests, and thematic analysis of open-ended responses. Results: The survey was open from October to December 2025 and included 118 respondents. Self-reported use suggests students engage with the vending machine on an as-needed basis. Users were significantly more likely to agree that it increased their likelihood of using a condom, compared with non-users. However, both groups expressed strong support for the vending machine, reporting that it improved access to sexual health resources, offered satisfactory product variety, and should be provided by the university. Although many students appreciated its visibility and role in reducing stigma, concerns about privacy and discretion were the most commonly reported reasons for non-use. Restock data indicated sustained year-round utilization, with expected decreases during vacation periods. Conclusion: Overall, these findings suggest that sexual health vending machines represent a scalable strategy for expanding access to sexual health resources in university settings. Offering a unique combination of immediacy, affordability, and convenience, this low-barrier resource may also promote preventive sexual health behaviors across campus, even among non-users, and support broader efforts to prevent sexually transmitted infections and unintended pregnancy among young adults.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Cross-Domain Knowledge Transfer from Expert-Annotated Gated CT via Synthetic Ungated CT Improves Coronary Artery Calcium Scoring on CT Attenuation Correction Scans","authors":"Shanbhag, A.; Miller, R. J.; Killekar, A.; Marcinkiewicz, A. M.; Zhou, J.; Lemley, M.; Kamagate, A.; Van Kriekinge, S. D.; Kavanagh, P. B.; Feher, A.; Miller, E. J.; Liang, J. X.; Berman, D. S.; Dey, D.; Leahy, R. M.; Slomka, P.","author_corresponding":"Piotr Slomka","author_corresponding_institution":"Cedars-Sinai Medical Center","doi":"10.64898\/2026.07.02.26356002","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"radiology and imaging","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26356002.source.xml","abstract":"Background: Coronary artery calcium (CAC) is an established measure of coronary atherosclerosis from computed tomography (CT). While deep learning (DL) can quantify CAC from non-dedicated CT, the accuracy is limited by image quality. Purpose: We derived and validated a novel method for DL CAC segmentation on ultra-low dose CT attenuation correction (CTAC) scans that is trained with synthetic low-dose, ungated images. Materials and Methods: Models were trained using one center and externally tested in two other centers. Synthetic, ungated CT scans were generated so that expert segmentations from dedicated CAC scans could be used as ground truth for perfectly registered synthetic images through knowledge adaptation (KAD-CAC). We evaluated agreement between CAC scoring methods vs expert readers on a per-patient and per-vessel basis, as well as associations with the primary outcome of death or myocardial infarction (MI). Results: The DL models were externally tested on 5969 patients with a median age of 64 (IQR 56 - 73), of whom 50.2% were male. The KAD-CAC model had higher Cohens kappa K (0.86, 95% CI 0.85 - 0.87) compared to previous convolutional LSTM model (K 0.78, 95% CI 0.76 - 0.80, p<0.01), or models trained with only gated images (K 0.81, 95% CI 0.80 - 0.82, p<0.01). Net reclassification improvement for CAC stratified risk of death or MI, was greatest for the KAD-CAC model over baseline including age, sex, hypertension, diabetes, dyslipidemia, family history, smoking, stress total perfusion deficit, and left ventricular ejection fraction. Conclusion: We use paired synthetic ungated scans to transfer expert gated CAC annotations into the ungated domain, resulting in substantially better vessel-level CAC scoring and improved risk stratification.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Evaluating the autoantibody reactome in giant cell arteritis","authors":"Porteous, M.; Maughan, R. T.; Sorensen, L.; Zulcinski, M.; Aslam, A.; Mackie, S. L.; Pericleous, C.; Tomlinson, J.; Luqmani, R. A.; Pickering, M. C.; Morgan, A. W.; Peters, J. E.","author_corresponding":"James E. Peters","author_corresponding_institution":"Imperial College London","doi":"10.64898\/2026.07.02.26357160","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"rheumatology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357160.source.xml","abstract":"Objective: To determine whether autoantibodies are present in giant cell arteritis (GCA) using a high-dimensional autoantibody array. Methods: Serum was collected from patients with GCA (n=20), other related vascular inflammatory diseases (Takayasu arteritis n=12, IgG4-RD n=5, Behcet's disease n=6), SLE (n=5) and healthy controls (n=12). Autoantibodies to 15,312 protein targets were measured using the GeneCopeia OmicsArray proteomic antigen microarray panel. Results: Differential abundance analysis revealed no autoantibodies significantly elevated in GCA or other related vascular inflammatory diseases. In contrast, the SLE group showed a strong and promiscuous autoantibody response, with 175 significantly associated autoantibodies (Benjamini-Hochberg-adjusted P <0.05). Conclusions: No autoantibodies were significantly elevated in GCA. We identified known and novel autoantibodies in SLE.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Complementary choroid plexus and locus coeruleus dysfunction in Parkinson's disease progression","authors":"Li, H.; Jia, J.; Wang, J.; Hu, X.; Shao, X.; Liu, K.; Chen, J.; Chen, Z.; Jin, L.; Wang, H.","author_corresponding":"He Wang","author_corresponding_institution":"Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, China","doi":"10.64898\/2026.07.02.26357179","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357179.source.xml","abstract":"Parkinson's disease (PD) is a progressive neurodegenerative disorder commonly accompanied by cognitive decline, yet the mechanisms linking disrupted brain homeostasis to progressive cognitive impairment remain unclear. Emerging evidence suggests that the choroid plexus (ChP) and the locus coeruleus (LC) are involved in cerebrospinal fluid dynamics and norepinephrine regulation, respectively, but their longitudinal alterations and interrelationships in PD have not been systematically examined. We conducted a two-year longitudinal study including 90 PD patients and 51 healthy controls (HCs) undergoing multimodal MRI. ChP volume (ChP-V) was derived from T1-weighted structural imaging, ChP blood flow (ChP-BF) was assessed using pseudo-continuous arterial spin labeling, and LC integrity was ascertained with the contrast-to-noise ratio of the LC (LC-CNR) in neuromelanin-sensitive MRI. Group differences, longitudinal alterations, and associations with neuropsychological performance were examined. Over two years, PD patients showed progressive increases in ChP-V (F = 12.45, p < 0.001), reductions in ChP-BF (F = 18.98, p < 0.001), and declines in LC-CNR (F = 16.80, p < 0.001). Baseline LC-CNR was already reduced in PD compared with HCs (t = 3.023, p = 0.003). The longitudinal changes were more pronounced in male patients. ChP-BF was positively correlated with LC-CNR at baseline (r = 0.293, p = 0.006). Moreover, reductions in ChP-BF and LC-CNR were associated with worsening cognitive performance. While LC dysfunction was evident early in the disease course, progressive ChP alterations, particularly in ChP perfusion, provided additional information on longitudinal disease progression, supporting their combined value and highlighting the importance of gender-specific longitudinal monitoring.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Association of Lacunes with Risk Factors, Cognition, and Atrophy: The Multi-Ethnic Study of Atherosclerosis (MESA)","authors":"Wang, D. H.; Azhar, F.; Shamsudeen, N.; Gutierrez, J.; Charisis, S.; Ransara Brandigampala, S.; Kern, K. C.; Rashid, T.; Jensen, P. N.; Nasrallah, I. M.; Ware, J. B.; Hiatt, K.; Tanley, J.; Bryan, N.; Longstreth,, W. T.; Launer, L. J.; Seshadri, S.; Hughes, T. M.; Heckbert, S. R.; Habes, M.","author_corresponding":"Mohamad Habes","author_corresponding_institution":"The University of Texas Health Science Center at San Antonio May Cancer Center","doi":"10.64898\/2026.07.02.26357192","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357192.source.xml","abstract":"Abstract Background: Lacunes are 3-15 mm cavities originating from small perforating artery disease and are a hallmark of cerebral small vessel disease (cSVD). Prior prevalence studies relied on manual rating, which is prone to inter-rater variability and cannot quantify volume. We applied deep learning to quantify lacunes in a diverse community-based cohort. Methods: In this cross-sectional analysis of 1,038 Multi-Ethnic Study of Atherosclerosis (MESA) participants, with longitudinal cognitive follow-up, we quantified lacunes, confirmed them with a trained rater, and classified them as deep or lobar. Regression models examined associations of lacunes with cardiovascular risk factors, other small vessel disease lesions, brain atrophy, and cognition. Structural equation modeling evaluated whether deep lacune burden mediated associations of age or Framingham All-Cardiovascular Disease (CVD) Risk Score with atrophy and cognition. Results: Overall, 182 participants (17.5%) had at least one lacune (deep: 9.2%; lobar: 9.6%). Hispanic participants had lower lacune burden than White participants. Age, Framingham All-CVD Risk Score, PREVENT 10-year Total CVD Risk Score, and hypertension were associated with overall and deep lacunes, while lobar lacunes showed no associations. Deep lacunes were associated with white matter hyperintensities, enlarged perivascular spaces, and cerebral microbleeds, as well as SPARE-BA, SPARE-AD, and cortical and hippocampal atrophy. Deep lacunes were cross-sectionally associated with decreased global cognition and language\/semantic performance, and longitudinally with accelerated executive function decline independent of count. Deep lacune burden significantly mediated associations of age and Framingham All-CVD Risk Score with SPARE-AD, SPARE-BA, and global cognition. Conclusions: In this multi-ethnic community-based cohort, deep lacune burden demonstrated stronger associations with vascular risk, other cerebral small vessel disease markers, brain atrophy, and longitudinal executive function decline than lobar burden. By providing a continuous measure of lesion volume, automated quantification captured information beyond lacune count.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Population Dynamics and Short-Horizon Forecastability of the Burst-Suppression Ratio After Cardiac Arrest: Implications for Closed-Loop Brain-State Monitoring","authors":"Gorenshtein, A.; Adiniaev, Y.; Liba, T.; Klang, E.; Daniel, O.","author_corresponding":"Alon Gorenshtein","author_corresponding_institution":"Beth Israel Deaconess Medical Center,  Department of Neurology, Boston, MA, USA","doi":"10.64898\/2026.07.02.26357133","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357133.source.xml","abstract":"Objective. Closed-loop brain-state control uses the burst-suppression ratio as its manipulated variable, assuming the signal is estimable, non-saturated, and predictable over the control horizon. Whether the injured brain's burst-suppression ratio meets these conditions under routine care is unknown. Approach. We analysed continuous electroencephalography from 607 comatose cardiac-arrest survivors across 5 hospitals in the International Cardiac Arrest Research Consortium database. For each patient we streamed one 24-minute window near 24 hours after return of spontaneous circulation, computed the algorithmic burst-suppression ratio on a 5-second grid, and derived non-saturated occupancy, within-window stability, and short-horizon forecastability. Forecastability was benchmarked against temporal-shuffle surrogates. Main results. The burst-suppression ratio occupied a non-saturated band (0.10 to 0.90) for a median of 0.250 of monitored time (95% CI 0.200 to 0.306) and sat toward suppression (median operating level 0.824). The operating level was stable within the window yet not forecastable beyond its mean: absolute out-of-sample R-squared was near zero at 1 to 5 minute horizons, matched temporal-shuffle surrogates, remained near zero in higher-occupancy windows, and was not improved by a sequence model. An autoregressive forecast showed an apparent skill of 0.46 against a persistence baseline, an artifact exposed by the surrogate analysis. Greater occupancy and a lower operating level were associated with good discharge outcome after adjustment (adjusted odds ratio 2.34 and 0.38; both p <= 0.002). Significance. Passive burst-suppression-ratio history provided little multi-minute predictive information beyond the current operating level, although that level was itself estimable and stable within the window. A closed-loop system with a reliable actuator could still regulate the signal by feedback, but model-predictive control from passive dynamics alone would add little.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"AI-Driven Precision Nutrition for Predicting Iron Deficiency Using Genomics, Polygenic Risk Scores, Dietary Patterns, and Personalized Dietary Recommendations","authors":"B, S.; S, V.; Bhandary, Y.; Vijayalaxmi,  ; Otihal, S. R.","author_corresponding":"Vijetha S","author_corresponding_institution":"RV College of Engineering","doi":"10.64898\/2026.07.06.26357351","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"nutrition","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.06.26357351.source.xml","abstract":"Background: Iron Deficiency Anemia (IDA) is one of the most prevalent nutritional disorders globally and a leading cause of Disability Adjusted Life Years (DALYs). Conventional diagnostic methods fail to detect deficiencies at an early stage and rarely account for individual genetic5 predisposition. Methods: This study proposes an end-to-end AI-driven precision nutrition pipeline integrating public Genome-Wide Association Study (GWAS) data and NHANES phenotypic data encompassing demographics, dietary intake, anthropometrics, and hematology. A synthetic genotype matrix was simulated for 400 GWAS-filtered SNPs using Hardy-Weinberg Equilibrium. Data preprocessing included missing value imputation, feature engineering, and SMOTE class balancing. Four machine learning models namely, Logistic Regression, Random Forest, Artificial Neural Network (ANN), and XGBoost were implemented and evaluated for both IDA classification and haemoglobin regression tasks. Results: XGBoost achieved state-of-the-art performance with ROC-AUC = 0.9981 for classification and R2 = 0.9903 for haemoglobin prediction. Polygenic Risk Score (PRS) stratification classified participants into low (73%), moderate (18%), and high (9%) risk tiers. Pathway burden analysis identified the Hepcidin Regulation pathway as the highest burden pathway in high-risk individuals. Conclusion: The integration of genomics, machine learning, and nutritional science through a Pathway-Burden Precision Nutrition Engine produced gene-specific, evidence-graded dietary recommendations, demonstrating significant potential for early and personalised IDA prevention.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"The voices of patients and caregivers - a qualitative interview study on what influences levels of mobility, among patients hospitalized following hip fracture surgery","authors":"Lindholm, S. T.; Skibdal, K. M.; Bandholm, T.; Pedersen, M. M.; Kirk, J. W.; Hansen, M. S.","author_corresponding":"Sofie Tscherning Lindholm","author_corresponding_institution":"Physical Medicine & Rehabilitation Research - Copenhagen (PMR-C), Department of Physical and Occupational Therapy, Department of Orthopedic Surgery, Department ","doi":"10.64898\/2026.07.03.26357215","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"orthopedics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357215.source.xml","abstract":"Purpose To explore patient and caregiver perspectives on factors influencing mobility during hospitalization after hip fracture surgery, and how these are experienced and negotiated in everyday hospital practice. Materials and methods A qualitative interview study informed by a hermeneutic-phenomenological perspective was conducted in a hospital setting in Denmark. Using purposive sampling with maximum variation, ten patients and nine caregivers were interviewed during hospitalization. Data were analyzed using reflexive thematic analysis following Braun and Clarke. Results Five interrelated themes were identified; (1) Body and mind in transition; (2) Communication as a prerequisite for safety and mobility; (3) Structural barriers and ambiguities in responsibility; (4) The physical environment and ward culture; and (5) Mobility as preparation for life after discharge. Across themes, mobility emerged as a socially shaped and negotiated practice through everyday interactions, communication, organizational routines, and situational support during hospitalization. Conclusions Mobility during hospitalization after hip fracture surgery emerged as a context-dependent and socially shaped practice rather than a purely physical task. These findings suggest that rehabilitation during hospitalization may need to attend not only to mobility prescription, but also to relational, communicative, and contextual aspects of everyday ward routines that shape patients' confidence and participation.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Characterization of Leukodystrophy Penetrance Using Large-Scale Integration of Genomic Population Screening and Electronic Health Records","authors":"Happ, H.; Christensen, B.; Knight, S.; Novoa, A.; Isakson, D.; Nadauld, L.; Quinlan, A.; Bonkowsky, J. L.","author_corresponding":"Joshua L. Bonkowsky","author_corresponding_institution":"University of Utah","doi":"10.64898\/2026.07.04.26356970","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.04.26356970.source.xml","abstract":"Background and Objectives: Leukodystrophies are rare genetic diseases affecting the central nervous system white matter, leading to progressive disabilities and death. Although early diagnosis is critical for therapies, the penetrance and phenotypic spectrum of many leukodystrophies remain poorly defined. Here, we integrate sequencing population screening with longitudinal electronic health record (EHR) data. Our goals were to assess the prevalence of undiagnosed leukodystrophy, characterize phenotypic variability among genotype-positive individuals, and estimate penetrance across multiple leukodystrophies. Methods: We analyzed 19 genes associated with 13 leukodystrophies in pediatric and adult individuals recruited via the HerediGene Population Study, a 5-year study conducted primarily of healthy individuals in the U.S. intermountain west. Sequencing was performed on 210,983 individuals, consisting of genome sequencing for 34,033 and SNP panel imputation for 176,950. Variant results were cross-referenced to comprehensive and longitudinal (20+ years) clinical data in the Intermountain Health Enterprise Data Warehouse and to the Utah Leukodystrophy Program. Results: Pathogenic variants were identified in 4 genes (CSF1R, PLP1, POLR3A, SNORD118) in 9 individuals, none of whom had a clinical leukodystrophy diagnosis or characteristic MRI findings. These findings suggest that missed clinical diagnoses of most leukodystrophies are uncommon in a centralized healthcare system, but also demonstrate that for some leukodystrophies there may be variable or reduced penetrance, or broader phenotypic spectra than recognized. We used published incidence estimates and the observed leukodystrophy-associated genotypes to infer penetrance ranges that varied from wide for ultra-rare leukodystrophies, to tightly bounded for more prevalent conditions. Discussion: In this predominantly healthy population, we did not find any patients with leukodystrophy who had been genetically undiagnosed but then identified by sequencing. However, we identified 9 individuals with genotypes previously reported to result in leukodystrophy, but none of whom had clinical symptoms or MRI features associated with the specific leukodystrophy. Our results support a revised model in which leukodystrophies exist along a continuum of penetrance and expressivity, with implications for newborn screening, variant interpretation, and risk stratification.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Feature Selection with Quantum Annealing for Biomedical Machine Learning Applications","authors":"Dudgeon, S. N.; Lee, S. J.; Durant, T. J.; Nelson, B.; Young, H. P.; Ohno-Machado, L.; Taylor, R. A.; Schulz, W. L.","author_corresponding":"Wade L. Schulz","author_corresponding_institution":"Yale University","doi":"10.64898\/2026.07.02.26357174","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357174.source.xml","abstract":"Feature selection is a commonly used method in biomedical artificial intelligence and machine learning to identify a subset of high-quality variables that can be used to train downstream predictive models. It has been suggested that quantum feature selection (QFS), which takes advantage of the properties of quantum computers, may better identify variables that are correlated with the outcome while simultaneously reducing redundancy between selected variables. However, there are a limited number of studies evaluating their performance, particularly in real-world data sets. Here, we assess the performance of two QFS methods compared to random forest (RF) feature selection based on feature stability and the performance of a downstream classification algorithm when used to predict urinary tract infections in the emergency department from 211 original features extracted from the electronic health record. We found that a quantum binary quadratic model (BQM) and constrained quadratic model (CQM) had similar performance to RF feature selection (median F1 score of 0.60, 0.61, and 0.61 respectively) when 10 features were selected for an XGBoost classification model. The BQM and RF also had similar feature stability (0.91 and 0.94, respectively) while the CQM had lower stability (0.72). These findings show that QFS can be used with large, clinical data sets to identify features with high stability and predictive performance. As the capacity and quality of quantum computers continue to increase, these methods may offer additional benefits to classical feature selection methods.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Standardizing COVID-19 surveillance data into the OMOP common data model: a first implementation case study from Senegal","authors":"Diop, O.; Odhiambo, R.; Diouf, O.; Momanyi, R.; Ochola, M.; Diallo, A. S.; Padane, A.; Cygu, S. B.; Barasa, M.; Iddi, S.; Kiragga, A.; Sarr, M.; Mboup, S.; Mboup, A.","author_corresponding":"Ousmane Diop","author_corresponding_institution":"Institut de recherche en sant\u00e9 de surveillance \u00e9pid\u00e9miologique et de formations (IRESSEF)","doi":"10.64898\/2026.07.01.26357078","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.01.26357078.source.xml","abstract":"The COVID-19 pandemic highlighted the need for interoperable health data infrastructures supporting reproducible observational research. The Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) provides a widely adopted standard for harmonizing heterogeneous health data, but adoption remains limited in francophone Africa where language barriers and non-standardized surveillance systems pose additional challenges. We developed a complete Extract-Transform-Load (ETL) pipeline to convert a heterogeneous Senegalese COVID-19 surveillance dataset into OMOP CDM version 5.4. Source data recorded in French were translated into English through an iterative process interleaved with vocabulary mapping using ATHENA and Usagi. Semantic standardization used SNOMED CT for conditions, LOINC for measurements, and RxNorm for drugs. All 214 mappings underwent expert review by clinical and data science specialists. Data quality was assessed using the OHDSI Data Quality Dashboard (DQD) and Achilles. The standardized database achieved complete transformation (100%) for eight of the eleven source-populated domain tables, including person, visit_occurrence, measurement, and death. Partial transformation was observed for condition_occurrence (95.3%) and observation (68.1%), primarily due to incomplete vocabulary coverage for occupation categories and context-specific variables. The DQD produced an overall pass rate of 97% and a corrected pass rate of 98%, comparable to other published African OMOP implementations. Among the 19 data-quality failures, conformance and completeness issues predominated; the conformance failures were largely foreign-key checks, reflecting placeholder concept values (concept_id = 0) for metadata fields without meaningful equivalents in surveillance data. Iterative translation refinement was required when French-to-English translations did not align with OHDSI vocabulary terminology. This work documents, to our knowledge, the first OMOP CDM implementation on COVID-19 surveillance data in Senegal and francophone West Africa and provides a reusable methodological blueprint for future OMOP deployments in the region.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Genomic Epidemiology of Multi-Modal ESBL Gene Transmission among Enterobacterales in a Neonatal Unit","authors":"Parker, M. J.; Hopkins, K. M. V.; Chau, K. K.; Cregan, J.; Oakley, S.; Barrett, L.; Jeffery, K.; Butcher, L.; Paulus, S.; Young, B. C.; Eyre, D. W.; Fowler, P. W.; Stoesser, N.; Sanderson, N. D.; Bejon, P.","author_corresponding":"Philp Bejon","author_corresponding_institution":"Modernising Medical Microbiology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK","doi":"10.64898\/2026.07.03.26357218","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.03.26357218.source.xml","abstract":"Antimicrobial resistance genes (ARGs) can spread via horizontal transfer or clonal expansion. We investigated the genomic epidemiology of extended-spectrum beta-lactamase (ESBL)--producing Klebsiella pneumoniae and Escherichia coli in a neonatal unit. Between January and November 2023, 53 ESBL isolates were obtained from 23 neonates via routine screening and clinical sampling. Long-read nanopore sequencing identified blaCTX-M-15 as the dominant ESBL gene, alongside blaCTX-M-65 and blaCTX-M-27. Among 49 blaCTX-M-15 isolates, 33 carried the gene on plasmids and in the remainder it was located on the chromosome. ESBL isolates belonged to one of seven MLST sequence types; E. coli isolates were dominated by ST131\/ST131-like\/ST5640 lineages, while K. pneumoniae were predominantly ST13. Plasmids (ESBL and non-ESBL-associated) clustered into 18 communities, five of which contained plasmid-bearing blaCTX-M genes. The largest cluster comprised IncFIB(K) plasmids from K. pneumoniae ST13, although these were predicted as \"non-mobilizable\" by MOB-suite and belonged to isolates from a clonally disseminated strain. No evidence of blaCTX-M dissemination via shared plasmids was identified. Meanwhile, chromosomal phylogenetic analysis identified four distinct clonal clusters with [&le;]7 SNP differences (n = 10, 5, 5, and 2 patients). In this setting, genomic analysis supported clonal dissemination of several blaCTX-M-associated strains as the main outbreak mechanism, affecting 20\/23 neonates, rather than plasmid-mediated transmission.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Post-vaccination expansion of extrafollicular Th10 and regulatory Tfr cells distinguishes strong from weak influenza vaccine responses in older adults","authors":"Mahajan, A. S.; Ravichandran, S.; Marches, R.; Yazici, Y. Y.; Nelson, S.; Aydillo Gomez, T.; Kshitija, K.; Rojo Fernandez, A.; Nehar-Belaid, D.; Kenyon Pesce, L.; Klimes, D.; Jung, H.; Sage, P. T.; Pascual, V.; Wilson, P.; Garcia Sastre, A.; Banchereau, J.; Kuchel, G. A.; Ucar, D.","author_corresponding":"Duygu Ucar","author_corresponding_institution":"The Jackson Laboratory for Genomic Medicine","doi":"10.64898\/2026.07.02.26357118","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nd","category":"allergy and immunology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357118.source.xml","abstract":"Despite the superior efficacy of high-dose influenza vaccines, over one-third of older adults fail to respond. Yet, the mechanisms underlying this impaired vaccine responsiveness remain poorly understood. Here, we performed longitudinal profiling of older adults (n=60) receiving high-dose influenza vaccination to identify immune programs associated with vaccine responsiveness. Strong responders exhibited a primed baseline immune state characterized by elevated plasma cytokines and chemokines, followed by enhanced IFN-{gamma} responses and coordinated transcriptional and epigenetic activation of cDC2 cells at day 1. By day 7, CD4+ T-cell trajectories diverged: strong responders preferentially expanded influenza-specific activated cTfh1 (CXCR5+ CXCR3+ ICOS+ CD38+) and influenza-specific Th10 (CXCR5- CXCR3+ PD1+ IL10+) cells, whereas weak responders expanded regulatory cTfr (CXCR5+ FOXP3+) cells. Th10 expansion correlated with plasmablast and antibody responses and was independently validated in a larger influenza vaccination cohort, including younger adults. Functionally, Th10 cells promoted memory B-cell differentiation into plasmablasts and production of influenza-specific IgGs. TCR analyses revealed minimal clonal overlap between Th10 and cTfh1 cells. Together, these findings identify divergent helper and regulatory CD4+ T cell programs associated with vaccine responsiveness and establish Th10 cells as a previously unrecognized component of vaccine-induced humoral immunity.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Global shifts in thermal suitability and population at risk for dengue transmission by Aedes spp.  mosquitoes under CMIP6 scenarios","authors":"Ryan, S. J.; Lippi, C. J.; Johnson, L. R.; Meredith, J.","author_corresponding":"Sadie Jane Ryan","author_corresponding_institution":"University of Florida","doi":"10.64898\/2026.07.02.26357126","date":"2026-07-06","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2026\/07\/06\/2026.07.02.26357126.source.xml","abstract":"Dengue fever risk and burden has increased globally in the past decade, with record-breaking outbreaks driving high case numbers, outbreaks increasing in existing transmission suitable regions, and occurring in new locations. A combination of global change processes, including climate change, have provided the environmental backdrop for introductions and resurgences of mosquito-transmitted dengue virus. Understanding shifts in exposure risk is integral to public health preparedness. This study provides global mapping of the thermal suitability of dengue transmission for CMIP6 climate scenarios, across a range of general circulation models (GCMs), and we created spatially explicit demographic projections of transmission risk using year-matched RCP-SSP frameworks for demographic and emissions scenarios. Globally, poleward shifts in projected distributions of suitability for transmission for both Ae. aegypti and Ae. albopictus suitability are shown in both the near term (2030s) and longer term (2050). Under a 'middle of the road' climate scenario (CMIP6 SSP2-4.5), regions in Africa and Asia are the major areas driving increases in year-round (12 months) population at risk (PAR) through 2050, with an anticipated net gain in 932 million people at risk for Ae. aegypti transmission and 24 million for Ae. albopictus, which includes multiple regions losing areas of year-round suitability as temperatures exceed the higher thermal boundary for transmission. In contrast, the estimated net increase in PAR for one or more months of transmission suitability at a global scale by 2050 is 3.29 billion people for Ae. aegypti transmission and 3.30 billion for Ae. albopictus transmission. This snapshot of a 'middle-of-the-road' combination of climate and demographic driven increases in potential dengue transmission exposure emphasizes the importance of both expanding suitability in new areas, and growing populations in areas approaching and becoming exposed year-round. Globalization, urbanization, and shipping will continue to provide the potential for introductions into newly suitable areas as season lengths increase, sparking outbreaks in unexposed populations. This is compounded and becomes ever more probable as the number of people and places at year-round risk also increases. This project provides all global gridded outputs for onward mapping and reuse, to add to the toolkit to anticipate and prepare for prevention and response to dengue in a changing world.","funder":"NA","published":"NA","server":"medRxiv"}]}